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Abstract 
A method of 3D modelling of high intensity focused ultrasound (HIFU) treatment 
through ribcage using patient data is described. This is further tested experimentally to 
derive at various parameters which could be indirectly useful in defining amount of 
energy and alteration needed in treatment protocols for the upper abdominal pathologies 
covered under ribcage. 
In the last ten years, feasibility and safety of HIFU treatment have been tested in 
a growing number of clinical studies. However, there are still challenges, such as the 
treatment through the ribcage. HIFU propagates through the ribs could lead to insufficient 
energy delivery to the focal target and heat deposition at the ribs may lead to surrounding 
soft tissue damage due to the bones properties of absorption and reflection to the 
ultrasound wave. Current research has not involved the physical human anatomical 
structures into the experimental study of the HIFU treatment through the ribcage. 
Therefore, our aim was to build a patient-specific physical ribcage model that possesses 
human anatomical structures to investigate its effect on HIFU treatment. 
Ribcage model was reconstructed based on patient data. This prototyping model 
possessed human anatomical structures and provided useful information in the treatment 
planning by applying HIFU sonication on tissue mimicking phantoms. In order to 
determine the optimal phantoms for medical imaging and HIFU application, the 
properties of tissue mimicking materials (TMMs) were characterised, including acoustic, 
thermal and elastic properties. Acoustic pressure distribution, acoustic power delivery 
and focus splitting were investigated with and without the presence of ribcage model in 
the focused ultrasound field. 
Multi-channel phased array transducer was applied to investigate the changes in 
temperature at focus and temperature was monitored by magnetic resonance imaging 
(MRI) thermometry. Sonications on phantom with varied focal lengths and ribcage 
locations using robotic arm were performed. Thermometry revealed that heating at focus 
can be controlled either by changing power or duration of application in order to achieve 
optimal results. Focal temperature change related to the shadow area on the transducer 
elements caused by the ribcage model in HIFU beam path. The experimental data based 
X 
 
on the patient-specific ribcage model may contribute to design and optimise the 
sonication protocol in pre-clinical planning stage. It is believed that the HIFU sonication 
experiments using realistic phantoms based on patient data would be a step towards 
translation of this technology into more widespread clinical practice. 
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Chapter 1 Introduction 
1.1. Background 
High intensity focused ultrasound (HIFU, also referred as focused ultrasound 
surgery or FUS) applies high intensity focused ultrasound energy to locally heat and 
destroy diseased or damaged tissue through ablation. Ultrasound beam can be focused 
geometrically through lens or a spherically curved transducer, or electronically by 
adjusting the relative phases of elements in an array of transducer. Since HIFU penetrates 
the overlaying tissue safely and only destroys the tissue at focal region deep in the body, 
it is considered as a non-invasive modality of treatment. Compared with traditional 
surgical resection and chemotherapy, HIFU provides remarkable advantages. Working 
with medical imaging technology, HIFU can perform precise tissue ablation with image 
guidance. The procedure of treatment can be monitored in real time and its result can be 
evaluated by medical imaging. Nowadays, HIFU has been an important component in 
cancer therapy and has been applied to treatment such as uterine fibroids, cancers of liver, 
kidney prostate and breast (Madersbacher et al. 2000; Poissonnier et al. 2003; Wu et al. 
2003a; Wu et al. 2004a; Wu et al. 2004b; Wu et al. 2004c; Azzouz & de la Rosette 2006). 
However, there are a number of challenges to overcome which obstruct the 
widespread development of HIFU applications. In abdominal HIFU applications, when 
the tumours are behind the ribcage, the presence of ribs in focused ultrasound beam path 
has become a main issue and received considerable critical attention. When applying 
extracorporeal HIFU through ribs, high acoustic absorption and reflection coefficient of 
ribs (Goss et al. 1978) may lead to tissue damage surrounding the ribs and insufficient 
energy delivered to target (Kennedy et al. 2003; Kennedy et al. 2004; Li et al. 2006; Cao 
et al. 2012). This not only reduces the efficacy of the treatment but also produce side 
effects such as the overheating of healthy tissues. 
A lot of work has been done to address the ribs issue, especially numerical 
computing of the focused ultrasound wave propagation in tissues through the ribcage. 
Some studies applied animal ribs or several pieces of human ribs attaching to a frame, 
which can partially mimic human anatomical structures. Nevertheless, no research can 
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provide full effect of the practical ribcage with human anatomical structures on HIFU 
therapy so far, because to apply human ribs in the HIFU experiment is difficult to achieve 
due to the restriction of approval by local institutional review board (IRB) (Association 
2008). Even it is possible to implement human experiment, the power used on the patient 
for pre-treatment planning stage must stay lower than that used in the treatment stage for 
safety reason. Results from this power level, therefore, cannot provide enough 
information for the treatment planning. The complex structures of the human body and 
variety of acoustic and thermal properties of bio-tissues result in a challenge in the control 
and evaluation of HIFU ablation. A prediction of HIFU treatment process through ribcage 
was required for every individual patient. The determination of patient-specific treatment 
plan called for investigation using patient’s own anatomical structures. 
Therefore, for a customized treatment planning, a physical patient-specific ribcage 
model, which possessed human anatomical structures, was needed to investigate the 
effect of the presence of ribs on HIFU treatment. For this purpose, a 3D modelling 
technology was required to convert the image data of the patient to a physical 3D model. 
With the patient-specific model, full effect of ribcage on HIFU treatment can be 
investigated before the treatment. Therapeutic parameters of HIFU treatment through 
ribcage can be determined according to the prediction and optimisation based on the 
characterisation results. 
1.2. Project aims and objectives 
The primary aim of this research is to bridge the gap from HIFU technology to 
clinical applications. This calls for overcoming the challenge of the presence of ribcage 
located in the focused ultrasound beam in HIFU treatment. In order to investigate the 
ribcage effect on HIFU application, a physical ribcage model, which possesses human 
anatomical structures, is needed to implement the HIFU sonication test through the 
ribcage. 
There is a list of objectives to be achieved: 
 To develop a rapid image-based modelling technique, which can translate medical 
image data into 3D models that possess human anatomical structures and can be 
used as human tissue substitutes 
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 To determine best materials with similar properties to human tissues for HIFU 
experiment 
 To provide image guidance to determine the focal region, image monitoring to 
verify the HIFU beam path, and temperature measurement to evaluate the lesion 
caused by HIFU 
 To electrically and mechanically steer the focus or move the HIFU transducer to 
achieve multi-focus in the experiment 
 Finally, to verify the results of phantom study on a cadaver model, which should 
have human anatomical features and tissue properties 
The technical obstacles include reconstruction of the ribcage model with patient 
anatomical structures, determination of tissue substitutes used in HIFU experiments, 
image guidance to locate the focus and determine the beam path of HIFU, measures of 
temperature monitor during HIFU application, and accurate movement of the focal target 
or ribcage model position using mechanical device. 
1.3. Contents of thesis 
This thesis consists of six chapters: Chapter 1 and Chapter 2 is on background and 
literature review; Chapter 3, Chapter 4 and Chapter 5 present the experimental techniques; 
Chapter 6 concludes the current work and provides the suggestions for future work. 
Chapter 1 introduces the background and aim of the study. 
Chapter 2, the literature review, starts with development and current status of 
HIFU technology, and followed by the challenges of the HIFU treatment and current 
research to overcome the challenges. The HIFU system and technology of tissue 
mimicking material phantoms are also presented in this chapter. 
Chapter 3 focuses on the development of 3D modelling reconstruction of patient-
specific ribcage models. Fabrication and characterisation of tissue mimicking materials 
were conducted and suitable materials were determined according to their acoustic, 
thermal and elastic properties. 
Chapter 4 presents the investigation of the effect of ribcage on focused ultrasound 
field. Measurements were arranged to determine the acoustic pressure distribution, 
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acoustic power delivery, and focal temperature elevation with the presence of ribcage 
models. The setup included different locations to cover both transcostal (with the focused 
ultrasound beam axis on a rib) and intercostal (with the beam axis between the ribs) 
position. Results were analysed according to the anatomical structures of the ribcage and 
verified using the projection of the ribcage on the HIFU transducer. 
Chapter 5 depicts HIFU experiment on a cadaver model, which has life-like 
flexibility and tissue quality. Before applying experiment on cadaver, flow effect on focal 
temperature change was evaluated on phantom and ex-vivo tissues. 
Chapter 6 provides the conclusions of the current work and suggestions for future 
work. 
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Chapter 2 Literature Review 
This chapter reviews the history, development and clinical applications of HIFU 
in section 2.1. Limitations and challenges of HIFU treatment is discussed together with 
the current research development to overcome these limitations and challenges in section 
2.2. Section 2.3 describes the HIFU system and section 2.4 reviews the tissue mimicking 
materials used as tissue substitutes in the study of HIFU performance. 
2.1. Development and current status of HIFU 
2.1.1. Development and clinical experiences of HIFU 
HIFU is a modality of therapeutic ultrasound, involving non-invasive methods to 
direct acoustic energy into the body. By applying high intensity focused ultrasound 
energy at a selected target, heat deposited within the tight focal volume induces high 
temperature at focus, which destroys tissues within the body without damaging 
surrounding tissues. It has been widely used from the 1990s because of the development 
of imaging techniques for targeting and monitoring. Resent research and development 
have explored the applications of HIFU, including application in neurosurgery, 
ophthalmology, gynaecology, urology and oncology. 
The first work to investigate the bio-effect of focused ultrasound was reported in 
1942 (Lynn et al. 1942). A focused ultrasound generator was designed, built, and operated 
by Lynn et al. and local brain effect in animals produced by focused ultrasound of high 
intensity was demonstrated. In the 1950s and 1960s, HIFU was used to produce lesions 
(the damaged tissue volume is commonly known as a ‘lesion’) in brain (Fry et al. 1954; 
Fry 1955; Fry 1958; Fry & Fry 1960). The first application of HIFU in human was the 
treatment of Parkinson’s disease and painful neuromata reported in 1960 (Ballantine et 
al. 1960; Fry & Fry 1960). However, this treatment was not taken further probably 
because of the development of the drug L-dopa. What is more, the early studies were 
limited because technology for precise image guidance and damage monitoring was not 
available. With the development of image guidance and phased array technology, 
ultrasound phased array transducer and computed tomography (CT) scans have been used 
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to achieve a non-invasive adaptive focusing in the transcranial surgery in the early 21st 
century (Clement & Hynynen 2002; Aubry et al. 2003). In 2009, the first report on 
successful clinical application of transcranial magnetic resonance-guided focused 
ultrasound (tcMRgFUS) in functional brain disorders shows all treatments were well 
tolerated, without side effects or neurological deficits (Martin et al. 2009). 
In 1950s, HIFU was applied in the treatment of ophthalmology (Lavine O 1952). 
HIFU has been demonstrated to produce lesions in the vitreous, lens, retina and choroid 
(Purnell et al. 1964; Lizzi et al. 1978; Coleman et al. 1985a; Coleman et al. 1985b) in the 
following years. The laser surgery limited the progress of the research development of 
HIFU on ophthalmology because of the simplification of the newer technology. 
Ultrasonic lesions were performed on animal liver and kidney to study the properties of 
focused ultrasound in tissues by applying HIFU during the 1970s and 1980s (Linke et al. 
1973; Frizzell et al. 1977; Frizzell 1988). 
In the late 1990s and the beginning of the 21st century, focused ultrasound was 
evaluated and clinical used for the treatment of prostate cancer, benign prostatic 
hyperplasia (BPH) and cancer tumours of the kidney and liver (Mulligan et al. 1997; 
Nakamura et al. 1997; Visioli et al. 1999; Paterson et al. 2003). 
Successful clinical trial results were reported on treatment of prostatic diseases in 
the 1990s (Foster et al. 1993; Gelet et al. 1993). However, the long-term results were 
disappointing because 43.8% of patients required a salvage trans-urethral resection of the 
prostate (TURP) within 4 years (Madersbacher et al. 2000). HIFU seems unlikely to be 
accepted as an alternative in the treatment of prostate cancer, but more studies are under 
way (Poissonnier et al. 2003; Azzouz & de la Rosette 2006). The first experimental study 
of focused extracorporeal pyrotherapy on treatment of bladder tumours was reported in 
1996 and showed 67% of 20 patients with primary tumour had not recurrent tumours 
(Vallancien et al. 1996). Up to 2012, over 15,000 patients with prostate cancer have been 
treated worldwide (Al-Bataineh et al. 2012). 
Also in the 1990s, HIFU inducing coagulative necrosis in renal parenchyma and 
renal tumours has been demonstrated in animal experiments (Chapelon et al. 1992; 
Adams et al. 1996; Watkin et al. 1997). More clinical data of treatment of abdominal 
tumours was reported in the 2000s (Wu et al. 2001a; Wu et al. 2001b; Kennedy et al. 
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2004; Wu et al. 2004c). From these trials, extracorporeal treatment of hepatocellular 
carcinoma (HCC) with HIFU proved to be safe, effective, and feasible. Kidney tumours 
were not ablated as reliably as liver tumours, but encouraging results were reported in 
China (Wu et al. 2003a) and in a Western population (Illing et al. 2005). Flank pain 
disappeared in 9 of 10 patients with advanced stage renal cell carcinoma after HIFU 
treatment (Wu et al. 2003a). 
The first clinical trial of magnetic resonance-guided focused ultrasound surgery 
(MRgFUS) for uterine leiomyomas was performed with a clinical MR imaging–
compatible focused ultrasound system ExAblate 2000 (Tempany et al. 2003). Patients’ 
response to MRgFUS was assessed and results showed MR imaging–guided focused 
ultrasound led to surgery symptomatic improvement, sustained to 12 months after 
treatment in the following research (Fennessy et al. 2007). 119 consecutive patients with 
187 uterine fibroids were treated with HIFU using imaging and histopathologic 
examination in China from May 2004 to June 2005 (Ren et al. 2007). Imaging and 
histopathologic evidence directly validate HIFU ablation as an effective treatment of 
uterine fibroids. 
HIFU applications were also investigated in the treatment of bone tumours (Wu 
2006; Gianfelice et al. 2008; Liberman et al. 2009) and breast cancer (Wu et al. 2003b; 
Wu et al. 2004a). In the 2000s, a group in Chongqing, China, led by Dr. Feng Wu et al., 
has demonstrated the focused ultrasound surgery to be safe, effective and feasible in over 
one thousand patients with liver cancer, breast cancer, malignant bone tumour, soft tissue 
sarcoma and other malignant tumours (Wu et al. 2001a; Wu et al. 2004a; Wu et al. 2004c). 
In the study of pain palliation in patients with bone metastases treated using ExAblate 
system, 72% of the patients reported a significant pain reduction (Liberman et al. 2009). 
In early Chinese clinical experience (Wu et al. 2004c), breast cancer patients who 
received breast conservation treatment with FUS were alive in the follow-up time (range 
10 to 36 months) and all but one was disease-free. 
Other studies with very small numbers of patients include pancreatic (Wu 2006), 
testicular cancer (Kratzik et al. 2006) and thyroid nodules (Esnault et al. 2011). HIFU has 
been used in lipolysis recent years (Shalom et al. 2013) and proved to be well tolerated 
and safe by evaluating the complications, blood tests, and urine analysis of the patients. 
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2.1.2. Safety issues of clinical applications of HIFU 
The risk factors in HIFU treatment which may contribute to post-ablation 
complications must be taken into account and optimised. Local pain, postoperative fever, 
pelvic hematoma and skin burns have been reported as the complications of HIFU 
treatment (Stewart et al. 2003; Kennedy et al. 2004; Wu et al. 2004c; Li et al. 2007). The 
most severe treatment-related adverse events have been transient pain (7 in 11) and 
superficial skin burns (3 in 11) in the clinical trial using JC HIFU system (Chongqing 
Haifu Medical Technology Co. Ltd., Chongqing, China) in Oxford, UK (Kennedy et al. 
2004). Based on the results of clinical applications of HIFU in cancer, complications were 
summarised in a cancer treatment review paper (Al-Bataineh et al. 2012) from a clinical 
point of view, as shown in Table 2.1. 
 
Table 2.1 Complications of HIFU therapy in different applications (Al-Bataineh et al. 
2012) 
Object of HIFU therapy Complications 
Prostate cancer 
Urinary retention, urinary infection, urethral stenosis, 
dysuria, recto-urethral fistula 
Liver tumours 
Skin redness and burns, biliary obstruction, 
symptomatic pleural effusions , fistula formation 
Pancreas tumours 
Tumour-duodenal fistulas, duodenal stent, a third-
degree burn of the anterior abdominal wall 
Bone malignancies 
Third-degree skin burn, peripheral nerve damage, bone 
fracture, ligamentous laxity, epiphysiolyses, secondary 
infections 
 
Two severe complications were reported including superior mesentery arterial 
infarction (patient with the superior mesentery artery running out from the centre of 
tumour) and perforation of the terminal ileum (patient with metastatic tumours close to 
the terminal ileum) (Li et al. 2007). 
Tolerance of HIFU ablation in patients with HCC was investigated (Cheung et al. 
2012). To identify factors that affect the tolerance, the risk factors for patients developing 
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serious complications were examined using univariate analysis. Parameters included 
patient age, preprocedure levels of serum bilirubin, albumin, alanine transaminase and 
aspartate transaminase, platelet count, international normalised ratio, total diameter of 
HCC, ablation time, ablation energy, presence of cirrhosis on imaging, and comorbid 
illness. Results showed that HIFU ablation is a generally well-tolerated treatment 
modality. Patient age is the only factor that was found to be significant in HIFU 
intolerance in Cheung et al.’s study. 
In terms of HIFU device technology, the potential risks resulting from the high 
power levels required for effective therapy, should be considered. The safety issues for 
HIFU transducer design was reported by Fleury et al. (Fleury et al. 2005). They listed the 
failure modes that may present risk to the patient, including over- (or under-) estimation 
of acoustic power, lack of control of the acoustic beam, lack of localization of the targets 
to be treated, transducer damage or failure, and error in operation. Meanwhile, 
suggestions were given to ensure safe use. 
2.2. Challenges in HIFU treatment of abdominal tumours 
Despite HIFU has a lot of advantages, the application of HIFU has challenges 
which have to be taken into consideration. In general, structures filled with air and bones 
in the pathway of the ultrasound wave, blood flow, and organ motion are the main 
challenges, which are described in section 2.2.1. The development of current research in 
HIFU treatment through ribs will be illustrated in section 2.2.2. 
2.2.1. Challenges 
In the treatment of abdominal organs, ribs as obstruction in the pathway of focused 
ultrasound may affect the efficacy of the treatment and lead to undesired interference in 
healthy tissues (Kohrmann et al. 2002; Kennedy et al. 2003; Wu et al. 2004b; Li et al. 
2006). The effect of a ribcage on focused ultrasound field has been investigated and 
results show 50% acoustic pressure reduced using ribcage model and 73% decreased 
using porcine ribs at transcostal propagation (Cao et al. 2012). Because of the absorption 
of the acoustic energy by the interposed ribs, it was not successful to apply HIFU on the 
upper pole of the kidney (Kohrmann et al. 2002). High absorption coefficient of the bones 
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(Goss et al. 1978) can also lead to overheating on the ribs and surrounding tissues (muscle, 
fat and etc.) during the treatment. There is an unacceptable temperature rise on the rib 
surface if the rib position approaches the focal plane (Kennedy et al. 2003). Experiments 
on goats indicate that obvious damage resulted from ribcage was found on the skin surface, 
ribs and corresponding liver surface (Li et al. 2006). Clinical results of skin damage 
during liver HIFU treatment also have been reported (Kennedy et al. 2004; Wu et al. 
2004a; Li et al. 2007). The rate of skin burn has decreased (less than 5%) compared with 
that at the beginning of the clinical trial (10 - 20%), because of the improvement of 
performing HIFU ablation and evaluating damaged-skin changes on real-time ultrasound 
imaging (Wu et al. 2004a). Apart from the effect of the ribcage, ultrasound cannot 
propagate through air filled structures. HIFU therefore is not suitable for damaging the 
tumours located in lung or bowel. 
The effect of blood perfusion on the ablation of abdominal organs using HIFU has 
been considered as another challenge in HIFU application, because the heat transfer from 
warmer regions to cooler regions affects the heat deposition to the focus. Animal 
experiments have been applied to investigate the effect of blood perfusion on lesion size 
(Chen et al. 1993a) and the effect of flow rate on total energy consumption of the target 
tissues (Bu et al. 2013). The lesion size obtained with normal blood flow on the livers of 
anaesthetized rats was significantly smaller than that with reduced blood flow by ligating 
hepatic artery and portal vein (Chen et al. 1993a) (hepatic blood flow was reduced by 98% 
due to the ligating), when the exposure time was longer than 3 s. The energy consumption 
reduced with the decrease in perfusion rate of dual-vessel perfusion, of portal vein 
perfusion alone, and of hepatic artery perfusion in an isolated porcine liver perfusion 
model (Bu et al. 2013). Phantom experiment also confirmed that the blood flow near 
HIFU beam significantly reduced the HIFU efficacy (Hariharan et al. 2007; Dasgupta et 
al. 2009). 
Organ motion due to respiration during the treatment is another limitation and 
could compromise treatment efficacy. When significant movements occur, the ultrasound 
beam could focus on surrounding tissues and lead to overheating on healthy tissues and 
insufficient energy delivery to the target. The quantity of organ motion has been reported 
in several studies. For pancreas, the average respiratory excursion was 1.8 cm in the 
supine position, 1.9 cm when prone, and 2.2 cm in the lateral decubitus position (Bryan 
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et al. 1984). Abdominal organs can move up to 20 mm during a respiratory cycle, 
reaching speed up to 15 mm/s (Ross et al. 1990; Davies et al. 1994). 
2.2.2. Current research in HIFU treatment through ribcage 
Several techniques have been developed to investigate the effect of the ribs, to 
enhance the efficacy of HIFU and to avoid or minimize overheating of the ribs and 
surrounding tissues. To minimize the overheating on ribs and surrounding tissues from 
clinical point of view, partial rib resection has been used to create a better acoustic 
window for therapy when no other treatment options are available (Wu et al. 2004b; Zhu 
et al. 2009). There was no significant difference in liver and renal function of the patients 
before and one week after partial rib removal and no severe skin burn occurred in this 
HIFU treatment. However, this approach has potential morbidity and diminishes the 
attributed advantages of HIFU as a non-invasive therapy. 
More numerical studies were presented to study the ultrasound filed and address 
this issue (Liu et al. 2007; Khokhlova et al. 2010; Liu et al. 2010; Gelat et al. 2012b; Gao 
et al. 2014). The ultrasound focus could be split by the ribs as obstacle in the pathway of 
the ultrasound beam. Focus splitting associated with the propagation of focused 
ultrasound through the ribcage has been investigated theoretically (Khokhlova et al. 
2010). Khokhlova et al. have shown that the variation in the intensity at focus in the 
presence/absence of the ribcage depends on three parameters: the position of the radiator 
axis relative to the middle of the intercostal space, the ratio of the width of the intercostal 
space to the period of the spatial structure of ribs, and the number of ribs within the beam 
aperture. They are for models of an idealized ribcage consisting of a regular array of 
reflectors. The maximum intensity at the focus is reached when the beam area is obscured 
by ribs is minimal.  
In order to reduce the deposition energy at the ribs, medical images were applied 
to compute the deactivated elements of the transducer in the HIFU focusing through 
ribcage (Liu et al. 2007; Liu et al. 2010; Quesson et al. 2010). Based on the relative 
position of the focus and the ribs, as identified from anatomical image data, elements that 
covered by the shadow of the ribs were deactivated. Compared with all elements active, 
benefit of deactivating selected elements for avoiding overheating at ribs and ensuring 
enough temperature for ablation at focus was demonstrated. 
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In recent years, the CT scan data of a human ribcage was used instead of the 
regular strips as the topology in the computational simulation (Gelat et al. 2011, 2012a; 
Gelat et al. 2012b). This was a step forward to mimic the realistic human structures in the 
HIFU field. However, the practical experiment was still required to validate the 
computational simulation. 
Gao et al. (Gao et al. 2014) investigated the factors affecting the acoustic beam 
patterns with propagation of focused ultrasound through the ribcage by experimental 
exploration using regular sectional absorbers (Aptflex F28, Precision Acoustics, 
Dorchester, Dorset, UK) instead of the ribcage and by numerical study using a 2D model 
based on the absorbers used in experimental setup. The rib substitute with rectangular 
cross section was also used in computational study (Lin et al. 2013) and experimental 
study (Qiao et al. 2013). Lin et al. calculated the propagation of focused ultrasound in 
tissue with rib-like structures. Qiao et al. applied the acoustic absorber strips to validate 
their simulation results of turning off the elements blocked by the ribs. The acoustic 
absorber material possessed similar acoustic properties to the ribs and the structures as 
strips were close to the ribcage. 
Some researches applied animal ribs in the focusing experiment using a 
therapeutic phased array combined with simulation (Aubry et al. 2008; Bobkova et al. 
2010). Two approaches were proposed by Bobkova et al. (Bobkova et al. 2010), one 
based on geometric acoustics and the other accounting for diffraction effects associated 
with propagation through the ribcage were tested theoretically and experimentally. The 
ability to produce thermal lesions with a split focal pattern in ex-vivo porcine tissue placed 
beyond the rib phantom was also demonstrated. Time reversal method (Aubry et al. 2008) 
was utilised to decrease the effect of the ribs and a fresh porcine ribcage was used in the 
experiment. However, as time reversal required an acoustic source at the target location, 
which made this technique invasive, it can hardly be used in HIFU treatment through the 
ribs. Pigs under anesthesia were selected as the target in the transcostal (Marquet et al. 
2011) and intercostal (Quesson et al. 2010) HIFU ablation in the liver. 
To address the numerical predictions applying no experimental practice with the 
structure of human anatomy, human ribs were also used by attaching three human ribs to 
a frame in the experiment (Cochard et al. 2009; Marquet et al. 2011). However, it is 
difficult to fully establish the human ribcage structures with separated human ribs. Other 
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experimental data reporting on the ribs and surrounding soft tissues so far has been limited 
to animal ribs or tissue mimicking phantoms fabricated for this purpose. The reported 
data may not be applicable to humans, as anatomy and structure of ribs and surrounding 
structures have little or no resemblance to real patients. 
A wide variation exists in anatomical features of ribs in clinical practice (Sedlin 
et al. 1963; Dansereau & Stokes 1988; Abrams et al. 2003; Bellemare et al. 2003). The 
geometric structure of the ribcage varies within each rib and between ribs and is affected 
by factors such as age, sex and disease (Sedlin et al. 1963; Bellemare et al. 2003). For the 
cross section area of rib cortex (Sedlin et al. 1963), it increased until skeletal maturity. 
The area then decreased sharply until 35 years old and this decline in area became less 
dramatically after age 35. These values reached minimum in the eighth decade, which 
was approximately 25% less than those of the early twenties. In the sex differences study 
(Bellemare et al. 2003), the mean ribcage size was smaller in females than males in total 
40 subjects (21 normal male and 19 normal female). The cross sectional geometry of five 
non-embalmed human cadavers (59 ± 13 years, 71 ± 30 kg, 3 male, 2 female) was 
measured (Abrams et al. 2003). Results show that the standard deviation of the cross 
section area is approximate half of the mean value (no specific SD was given). This 
indicates the data points could be spread out over a large range of values. Overall, there 
are significant differences in rib cross section area among humans. The data from 
phantoms and animals may not be sufficient to plan HIFU therapy. A patient-specific 
reconstructed model that fully possesses human anatomical structures is required to 
investigate the ribcage effect on each individual patient and determine the customized 
treatment plan. 
2.3. HIFU system 
HIFU system provides focused ultrasound therapy transducer and solutions of 
locating the target and monitoring the process of the treatment. During procedure of HIFU 
application, anatomical feature is acquired via medical imaging modality such as MRI 
and ultrasound imaging. The imaging modalities are also used for monitoring the process 
of the treatment. Characterisation of the HIFU system plays an important role in the 
development of the pre-surgical planning. To ensure the safety and efficacy of HIFU 
treatment, a fundamental knowledge of the acoustic field and energy output of HIFU 
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system is required to predict and control the size and the location of the focal lesions. This 
section reports the physical principles of HIFU and the characterisation of HIFU system. 
2.3.1. Physical principles of HIFU 
The piezoelectric effect was first demonstrated in 1880 (Curie & Curie 1880). The 
piezoelectric material will produce an internal mechanical strain when an electrical field 
is applied, which can lead to generating ultrasound wave towards the axis of the 
ultrasound transducer. For HIFU transducer, to generate a tight ellipsoid lesion at focus 
curved bowl or multi-element phased array are needed to produce ultrasound beams, as 
shown in Figure 2.1. 
 
 
Figure 2.1 Principle of HIFU ablation (Jenne et al. 2012) 
 
The ultrasound wave propagates through coupling medium and multi-layer tissues 
before reaching the focal spot (Figure 2.1). At each tissue interface, part of the ultrasound 
wave will be reflected with the rest of them transmitting. If the acoustic properties are 
similar at interfaces, the transmission coefficient is close to unity. On the other hand, the 
regions with different acoustic properties from tissues (e.g. between transducer and skin) 
reflect, absorb and scatter the incident wave, resulting in a reduction of acoustic intensity 
in the direction of ultrasound propagation. For an extracorporeal HIFU treatment, 
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therefore, coupling the ultrasound energy to the skin surface is required. The coupling 
medium could be a water balloon, coupling gel, or other suitable liquid path, because 
most soft tissues in the human body have acoustic properties similar to those of water or 
water based gel. 
For most tissues, the attenuation coefficient, used to describe the loss in incident 
acoustic energy in a medium, is related to the ultrasound frequency (Hill et al. 2004). 
According to the research at the beginning of 21st century, the attenuation coefficient of 
most tissues increases with heating and HIFU ablation (Clarke et al. 2003; Zderic et al. 
2004). There is little absorption of ultrasound during the propagation in the pathway by 
the homogeneous tissue with a proper coupling medium. This causes the heating rate of 
the normal tissue less than the cooling rate in the beam propagation path. Therefore, HIFU 
does not heat the tissue out of the focal region, which avoids intervening normal tissues. 
The acoustic energy deposition occurs only at the focus and results in local temperature 
rise to cause tissue necrosis. As a result, by using HIFU system, the focal region obtains 
the most energy deposition to kill the cells whereas in the sharply demarcated surrounding 
tissue there is no evidence of cell damage (Chen et al. 1993b). 
2.3.2. HIFU devices 
In the early years, focused ultrasound was generated from quartz crystals which 
were either concave in shape (Lynn et al. 1942) or were planar with polystyrene lens 
placed in front of the vibrating crystal for focusing (Fry et al. 1954). Quartz has been 
replaced by the low loss forms of lead zirconate titanate (PZT). This material may be used 
in the form of a concave bowl shape (Warwick & Pond 1968) or as a plane disk/plastic 
lens combination (Terhaar et al. 1989). A single element HIFU transducer (transducing 
electrical to mechanical energy) normally contains a piezoelectric element in bowl shape, 
backing layer, casing and electrical connection. In Figure 2.2, an electric field from 
electrical connection of high-frequency alternating current can be applied to the 
piezoelectric element through its front and back faces. The piezoelectric material in 
spherical shape vibrates and generates a focus proximal to its centre of curvature. The 
backing layer is located behind the piezoelectric element to prevent excessive vibration. 
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Figure 2.2 Cross-sectional view of the schematic of a HIFU transducer showing its 
components 
 
In the 1990s, phased array technology for HIFU applications has led to the design 
of transducer that allows electronic ultrasound beam steering and controlling the focal 
size without physically moving the transducer (Hynynen et al. 1996; Wan et al. 1996). 
Because the phased array transducer is made of multiple small elements, each of which 
can be pulsed independently, the ultrasound beam can be steered electronically by shifting 
the phases of the ultrasound waves radiated by each element (Figure 2.3). 
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Figure 2.3 Comparison of (a) single element and (b) phased array transducer 
(Khokhlova & Hwang 2011) 
 
In HIFU treatment, the focused ultrasound wave penetrates a coupling medium 
(e.g. a water balloon) and overlaying tissue to focus in the targeted area. A small volume 
of focal tissue is then heated rapidly and protein is denatured due to the high local 
concentration of acoustic energy. The skin and overlaying tissues are unaffected or show 
only a negligible temperature rise. 
For the treatment of a larger tumour, single lesions have to be repeated without 
gaps to cover the entire tumour tissue. According to the principle in conventional surgery, 
the extent of HIFU should include the tumour lesion and its marginal tissue about 1.5 - 
2.0 cm around the tumour (Wu et al. 2003b; Wu et al. 2004c). This is to ensure the 
ablation of any adjacent microsatellites and to obtain a sufficient tumour-free margin. The 
focus of HIFU system is usually 1 to 3 mm in width and about 10 mm in length according 
to the -6 dB ultrasonic beam size (Zhou 2011). The HIFU therapy is a time consuming 
procedure, because a lot of single sonications are required to allow the ablation of a large 
tumour and a defined cooling time is necessary to prevent adjacent healthy tissue from 
heat deposition and overheating between two single sonications. This geometrical size of 
focal region requires the movement of the focus to completely cover the larger treatment 
target. For scanning the target with focus, HIFU system should be able to physically move 
or rotate the transducer with a fixed focus, or use phased array technology to electrically 
steer the focus of a multi-element HIFU transducer. 
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To allow accurately locating the target tissue, focused ultrasound devices require 
imaging guidance to implement the ablation within the body. MRI is capable of providing 
images with high resolution as well as temperature measurement. However, MRI 
guidance is expensive and not suitable for all patients, such as patients who have 
pacemaker, artificial joints, or metal artery stent. Moreover, the HIFU device must be 
specially designed for compatibility and cannot contain ferromagnetic metals for usage 
with MRI. In comparison, ultrasound guidance is more convenient than MRI guidance 
and compatible with the HIFU device. It allows real time imaging during the treatment, 
but the image quality of ultrasound imaging is not as good as MRI. Another drawback of 
ultrasound guided HIFU is the lack of monitoring of the temperature. Both MRI and 
ultrasound imaging guidance possess advantages and disadvantages, therefore, patient-
specific circumstances should be taken into consideration to determine a suitable 
treatment plan. 
With the capability of damaging a selected region of tissue with minimal effects 
to surrounding tissues, HIFU has been applied to treat target tissues located within the 
body and used to manufacture medical devices for the treatment of those diseases. 
Modern HIFU devices operate at focal intensity levels from 1000 W/cm2 to greater than 
25000W/cm2 in situ (Canney et al. 2008). The focused ultrasound tumour therapeutic 
system Model-JC and Model-JC 200 (Chongqing Haifu Medical Technology Co. Ltd., 
Chongqing, China) have been developed in China and are widely used for liver tumour 
and uterine fibroids treatment (Wu et al. 2004b). Another focused ultrasound system 
guided by diagnostic ultrasonography is HIFUNIT 9000 tumour therapy system 
(Shanghai Aishen Technology, Shanghai, China). An MRI guided system, ExAblate 2000 
(InSightec, Tirat Carmel, Haifa, Israel), has been approved by Food and Drug 
Administration (FDA) for treatment of uterine fibroids in October 2004. This system 
performed with MRI for HIFU sonication, image guidance and temperature monitoring. 
A clinical trial of uterine surgery using ExAblate 2000 was reported in 2003 (Tempany 
et al. 2003). ExAblate 2100 for bone treatment and ExAblate 4000 for transcranial 
surgery have been undergoing the evaluation of safety and effectiveness. Sonablate 
(SonaCare Medical, NC, USA) and Ablatherm (EDAP-TMS, Lyon, France) are 
transrectal devices for the treatment of benign prostatic hyperplasia and prostate cancer 
(Madersbacher et al. 1994; Chaussy & Thüroff 2000). 
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2.3.3. Characterisation of HIFU field  
HIFU system has the ability to generate high temperatures within tissue guided by 
medical imaging modality. However, different route of the ultrasound wave and varied 
tissue properties require different levels of the acoustic power utilised for diseased tissue 
ablation. To ensure the energy delivering to correct location using accurate energy level, 
it is necessary to evaluate the acoustic power carried by the ultrasound wave and monitor 
the procedure of wave propagation before and during the treatment. Therefore, accurate 
measurement and characterisation methods of the HIFU system are required. The most 
commonly used measurement methods of HIFU fields are the hydrophone to determine 
focal acoustic pressure distribution and the radiation force balance (RFB) to determine 
total output acoustic power. 
2.3.3.1. Ultrasound beam profile characterisation 
The acoustic intensity distribution as a function of position within planes of 
interest can provide a visualised profile of the ultrasound beam. Ultrasonic needle 
hydrophone and polyvinylidene fluoride (PVdF) membrane are widely used to 
characterise ultrasound fields. However, hydrophone techniques are limited to relatively 
low intensities to avoid sensor damage. Measurements were thus carried out at low output 
level and the pressure distribution at high output levels could be extrapolated based on 
linear propagation model (Hill et al. 1994). Stepper motors scanned the hydrophone 
across a plane in the focal region of the transducer (perpendicular to the direction of the 
ultrasound beam). The focal region was defined as the volume enclosing the full width 
half maximum dimensions (Hill et al. 1994; Kun & Wan 2004). Hill et al. proposed that 
spatial average linear intensity (Isal) was determined by the intensity spatially averaged 
over the area enclosed by the half-pressure-maximum contour in the focal plane under 
linear conditions. 
Fibre optic hydrophone is another tool to measure acoustic pressure. It was 
originally developed for measurement of shock waves of high pressure amplitude in 
lithotripter acoustic output field (Staudenraus & Eisenmenger 1993; Wurster et al. 1994). 
The sensitive region determined by the small size of fibre diameter, which is typically a 
few microns, offers the prospect of providing acoustically small element sizes. Infrared 
(IR) thermography can be used to gain qualitative information about ultrasound fields 
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from the heating pattern within the absorbing material (Adam & John 2010). One of the 
drawbacks of IR thermography technique is that the ultrasound must be incident on an 
acoustically reflective air interface, because of the presence of the air interface between 
the IR camera and the heated surface. 
2.3.3.2. Nonlinearity 
For an ultrasound wave at intensity (order of 1000 W/cm2) typically used in HIFU 
and at higher intensity used in newer HIFU devices (order of 10000 W/cm2) (Canney et 
al. 2008), it increases local temperature and local speed of sound in a compressible 
material. As a harmonic sine wave propagates through a nonlinear homogeneous media, 
it provides compressive and tensile forces during the corresponding phases. The wave 
travels faster during the high pressure phase of the oscillation than during the lower 
pressure phase. The wave self-distorts as shown in Figure 2.4. These acoustic nonlinear 
effects lead to the appearance of additional higher harmonics in the initial wave spectrum, 
the formation of shock fronts in the wave profile, and correspondingly, the increase in the 
absorption of the ultrasound wave energy and in the efficiency of tissue heating 
(Filonenko & Khokhlova 2001). In this study, the characterisation of focused ultrasound 
beam profile was investigated using low power input in linear wave propagation 
conditions. 
 
 
Figure 2.4 Numerical results of modelling HIFU in gel with (solid lines) and without 
(dash lines) accounting for the effects of nonlinear propagation: axial waveforms at the 
focus (Filonenko & Khokhlova 2001) 
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2.3.3.3. Acoustic power 
The ultrasound output power of a HIFU system is a key parameter to estimate the 
efficiency of the system and describe the energy delivery at focal target during clinical 
treatment. It is typically characterised by measuring the radiation force on a target which 
intercepts the entire field. RFB has been widely used to measure ultrasound power as 
current primary standard method (Greenspan et al. 1978; Fick 1999; Beissner 2002). If 
the target is large enough to intercept the entire ultrasound beam and is connected to a 
force-measuring device, the change in force with the transducer power-on is proportional 
to the acoustic power contained in the ultrasound beam (Shaw & Hodnett 2008). If an 
absorbing target was used, the acoustic power can be obtained by equation (2.1): 
𝑃 = 𝑐𝑚𝑔                                                               (2.1) 
where P is the acoustic power, m the change in mass, g the acceleration of gravity and c 
the temperature-dependent speed of ultrasound in the coupling medium (usually water). 
Some types of target have been designed for RFB, including acoustic absorbing material 
target, reflecting target and brush target made by placing long flag plastic fibres (Hynynen 
1993; Maruvada et al. 2007). Another way to determine the acoustic power is the 
buoyancy method (Shaw 2006; Shaw 2008; Srinath & Adam 2012), which has been 
validated using a radiation force method at frequencies of 1 MHz and 3 MHz for acoustic 
powers in the range 1 W to 350 W, and the extended method is validated in the frequency 
range 3.151 MHz to 9.541 MHz using an improved target and applied powers in the range 
100 mW to 1 W. 
2.4. Tissue mimicking material phantoms 
The characterisation of HIFU field requires phantoms to mimic the ultrasound 
propagation through tissues. The phantoms are made of tissue mimicking materials 
(TMMs), which possess similar properties to biological tissue and can provide a 
reproducible medium for the studies of ultrasound field under known propagation 
conditions. The TMMs mainly consist of water and can be shaped into arbitrary solid 
structures. Moreover, the TMM phantoms can be used as the focal target to evaluate the 
results of HIFU treatment. The desired HIFU phantom as a tissue substitute should 
possess similar density, acoustic properties thermal properties and elastic properties to 
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human tissues (King et al. 2011). This section reviews the applications and properties of 
TMMs. 
2.4.1. Applications of TMM phantoms 
TMM phantoms bridge the gap in translational research without the need of direct 
experimentation on humans or animals. The advantage of phantoms is that idealized 
tissue models can be constructed with well-defined acoustic properties, dimensions and 
internal features (Culjat et al. 2010). With these benefits, the propagation of ultrasound 
can be better understood or predicted. To develop diagnostic imaging technologies, the 
phantoms designed with TMMs are essential for assessing the imaging devices, and for 
training and research. To determine the safety and effectiveness of therapeutic HIFU 
devices, it is necessary to characterise the devices by developing TMM phantoms for 
visualizing the temperature change and coagulated necrosis caused by HIFU. 
Various kinds of TMMs have already been used in ultrasound imaging research, 
HIFU dosimetry investigation, specific organ fabrication etc., such as gelatine, agar, 
silicone, polyvinyl alcohol (PVA) gel and polyacrylamide (PAA) gel (Alexei et al. 2003; 
Surry et al. 2004; Takegami et al. 2004; Zell et al. 2007). Agar and gelatine based 
phantoms are easily fabricated and can achieve a range of acoustic properties by adding 
scattering particles, but they can be easily damaged. Silicone is insensitive to rough 
handling compared with agar and gelatine phantom and can be stored for months or even 
years. PVA based phantom has high structural rigidity but its fabrication procedure is 
time consuming. PAA is highly carcinogenic and neurotoxic, which may limit PAA 
phantom being widely used. 
The research of ultrasound phantoms has been started since the end of the 1970s 
(Madsen et al. 1978). TMMs for ultrasound imaging and for assessing ultrasonic imaging 
system performance have been investigated in the following years (Madsen et al. 1980; 
Madsen et al. 1982a; Madsen et al. 1982b, c). Agarose (Mitchell et al. 1986; Kraft et al. 
1987; Howe 1988) and PVA gel material (Mano et al. 1986) has been used as a relaxation 
modifier in MRI phantom since the 1980s. Ni ions and Cu ions were doped into the 
agarose gel phantom to further affect their proton relaxation characteristics (Mitchell et 
al. 1986; Kraft et al. 1987; Howe 1988). T1 (spin-lattice relaxation time) depends more 
on copper ions than on agarose, and T2 (spin-spin relaxation time) depends more strongly 
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on agarose than on copper ions (Mitchell et al. 1986). MRI phantom equivalent to human 
tissues has been reported in 2005 (Kato et al. 2005). The ingredients of these phantoms 
are carrageenan as the gelling agent, GdCl3 as a T1 modifier, agarose as a T2 modifier, 
NaCl as a conductivity modifier, NaN3 as an antiseptic, and distilled water. Multi-imaging 
phantoms have been developed in the recent years, because three dimensional multi-
modality images used in combination with one another might enhance the effectiveness 
of treatment planning (D'Souza et al. 2001; Madsen et al. 2003). 
Another application of phantoms is for HIFU dosimetry studies, which allows the 
visualisation of temperature rise and lesion formation. Polyacrylamide hydrogel mixed 
with egg white protein was reported as an optically transparent HIFU TMM (Takegami 
et al. 2004). A thermally sensitive indicator protein Bovine Serum Albumin (BSA) with 
polyacrylamide hydrogel was introduced as a phantom for HIFU exposures (Lafon et al. 
2001; Lafon et al. 2005). However, polyacrylamide with egg white material is toxic and 
non-reusable because of protein denaturation. For HIFU exposure experiment, it is 
important that the material should be repeatable and stable under HIFU environment. A 
nontoxic and reusable hydrogel with dispersed oxide particles and other chemicals has 
been developed for the acoustic and thermal characterisation of HIFU devices (King et 
al. 2011). 
Manufactured organ phantoms are widely used because of their reduced cost, 
long-time stability, and non-existent ethical regulatory requirements (Opik et al. 2012). 
A wide range of organ phantoms have been reported, such as prostate phantom, liver 
phantom, kidney phantom and breast phantom. Prostate tissue mimicking materials for 
multi-imaging modality (D'Souza et al. 2001) and for the detection of prostate cancer 
using shear wave elastography (Cao et al. 2013) have been reported. High fidelity liver 
and kidney phantom organs have recently been used to validate robotic surgical system 
performance (Opik et al. 2012). A phantom consist of degassed water and an open cell 
sponge was created to simulate the echotexture of liver (Hopkins & Bradley 2001). Breast 
phantoms were fabricated using oil-in-gelatin dispersions for testing elastography 
systems (Madsen et al. 2006). To mimic internal structures such as tumour in the organs, 
simple or complex TMM targets were embedded within the phantoms (Skretting et al. 
2010; Chmarra et al. 2013). 
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Apart from the manufactured phantoms, there are a number of commercial TMM 
phantoms available in the market which can provide more precise tissue simulation. 
Those phantoms include Zerdine (CIRS Inc., CT, USA), Gammex ultrasound phantom 
(GAMMEX Inc., WI, USA), ATS rubber-based phantom (ATS Laboratories Inc., 
Bridgeport, CT, USA), and Daily Quality Assurance (DQA) gel phantom (ATS 
Laboratories Inc., Bridgeport, CT, USA). The TMM phantoms are also available from 
other companies, such as Limb & Things (UK), Blue Phantom (WA, USA), The Phantom 
Laboratory (NY, USA), and Supertech (IN, USA). 
2.4.2. Acoustic properties of TMMs 
To mimic human tissue in ultrasound research, the substitute materials should 
possess acoustic properties similar to the tissues. This allows the ultrasound wave 
propagating in a tissue-like circumstance. The relevant parameters of acoustic properties 
mainly contain the acoustic impedance, the speed of sound, and acoustic attenuation. 
TMMs with a broad range of acoustic parameters are needed and the TMMs could 
be mixed in order to achieve the desired properties similar to the different types of tissues, 
because the acoustic properties of real tissues are not constant among people, or even in 
different parts of tissues within a human body (Culjat et al. 2010). 
A wide range of acoustic attenuation coefficient was found in the measurement 
results of normal (fatty) breast tissue (Bamber 1983). Approximately 3 dB/cm was the 
highest attenuation coefficient value at 1 MHz, while the lowest value was less than 
1 dB/cm (No specific attenuation coefficient values were given in the original reference). 
This range became larger with the increase of the frequency of the ultrasound applied. 
Previously reported acoustic properties of mammalian tissues and human tissues (Goss et 
al. 1978; Culjat et al. 2010) are summarised in Table 2.2. The average acoustic velocity 
in soft tissue was reported as 1561 m/s in the range of 1478 m/s (fat) and 1595 m/s (liver). 
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Table 2.2 Acoustic properties of tissues (Culjat et al. 2010) 
Material 
Velocity 
(m/s) 
Density 
(kg/m3) 
Attenuation 
(dB/cm 
MHz) 
Acoustic 
Impedance 
(MRayl) 
Air 330 1.2 - 0.0004 
Blood 1584 1060 0.2 1.68 
Bone, Cortical 3476 1975 6.9 7.38 
Bone, Trabecular 1886 1055 9.94 1.45 
Brain 1560 1040 0.6 1.62 
Breast 1510 1020 0.75 1.54 
Cardiac 1576 1060 0.52 1.67 
Connective tissue 1613 1120 1.57 1.81 
Cornea 1586 1076 - 1.71 
Dentin 3800 2900 80 8.0 
Enamel 5700 2100 120 16.5 
Fat 1478 950 0.48 1.40 
Liver 1595 1060 0.5 1.69 
Marrow 1435 - 0.5 - 
Muscle 1547 1050 1.09 1.62 
Tendon 1670 1100 4.7 1.84 
Soft tissue 
(average) 
1561 1043 0.54 1.63 
Water 1480 1000 0.0022 1.48 
 
For bones, 3360 m/s and 20 dB/cm were reported for skull bone at 1 MHz 
(Hendee & Ritenour 2003). For trabecular (cancellous) bone specimens, the speed of 
sound was in the range 1500 m/s to 1650 m/s (Laugier et al. 1997). The mean value and 
standard deviation for the attenuation of calcaneus samples was 9.94 ± 5.74 dB/cm/MHz 
(Wear 1999). In a review of literatures (Goss et al. 1978), the highest value of acoustic 
attenuation of embalmed human skull reached as high as 214 dB/cm (approximate 3 to 
4 MHz). It can be considered that the values of the results were in a slightly wide range. 
Bone is not uniform solid material, which contains compact (outer layer) and trabecular 
(interior) bone tissue. This may lead to different results in acoustic properties 
measurement at different location of the same type of bone. The cross-section area of rib 
cortex was found to be varied with age (Sedlin et al. 1963), which may indicate the 
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acoustic properties of bones changed with age. As a result, the speed of sound in bones 
was in the range of 1500 m/s to 3360 m/s. The attenuation coefficient was in the range of 
9.94 dB/cm/MHz to 214 dB/cm at 3 to 4 MHz. The range of speed of sound and 
attenuation coefficient of soft tissues and bones from literatures is summarised in Table 
2.3. 
 
Table 2.3 Range of acoustic properties of soft tissues and bones 
Parameters Range of soft tissues Range of bones 
Speed of sound (m/s) 1478-1595 1500-3360 
Acoustic attenuation 
coefficient (dB/cm/MHz) 
0.2-4.7 9.94-214 (at 3 to 4 MHz) 
 
To mimic the acoustic properties of those tissues, the acoustic properties of a large 
number of TMM phantoms have been reported (Alexei et al. 2003; Browne et al. 2003; 
Lafon et al. 2005; Zell et al. 2007; King et al. 2011), including agar, PAA, PVA, silicone, 
and some homemade phantoms (Lafon et al. 2005; King et al. 2011). Zell et al. (Zell et 
al. 2007) summarised tissue mimicking phantoms under different conditions for the 
development of phantoms used in photoacoustic and ultrasound imaging. In their study, 
PVA fits best to human breast tissue especially up to 10 MHz in photoacoustic and 
ultrasound imaging; agar is well for quick and easy preparation without the need for long-
term stability; silicone is good for stable phantoms; PAA seems to be less appropriate for 
phantom production because of its toxicity (Zell et al. 2007). 
The wide range of acoustic properties of biological tissues requires phantoms with 
adjustable acoustic properties. The acoustic properties can be adjusted by varying the 
concentration of specific compositions. Evaporated milk and powdered graphite was used 
to change attenuation and scattering properties in agarose-based material (Madsen et al. 
1998). Al2O3 powder SiC can achieve the similar aims in agarsoed-based phantom 
(Ramnarine et al. 2001). Graphite or talcum powder was used as scattering agents to vary 
attenuation and n-propanol was used to control the speed of sound in the magnesium 
silicate gels manufacture (Sheppard & Duck 1982). The speed of sound in foam phantom 
can be varied by altering the concentration of NaCl (Lerski et al. 1982). 
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It is noted that the values of these acoustic properties are not constant in different 
environment. Temperature and frequency are considered as the main influential factors 
of the changes in acoustic properties. Acoustic properties of common TMMs, including 
commercial phantoms and customized designed phantoms, were assessed with variations 
with both frequency and temperature (Browne et al. 2003; Zell et al. 2007). Acoustic 
velocity remained constant (± 3 m/s) with increasing frequency, while attenuation was 
found to increase with increasing frequency. It was found that the acoustic velocity of the 
agar, Zerdine (CIRS Inc., CT, USA) and condensed milk increased with increasing 
temperature by a rate of approximately 1.5 m·s-1·°C-1. Whereas, the acoustic velocity of 
the urethane rubber TMM (GAMMEX Inc., WI, USA) decreased with ascending 
temperature, by a rate of 2.5 m·s-1·°C-1 (Browne et al. 2003). A wide range of acoustic 
attenuation coefficient was found in the measurement results of normal (fatty) breast 
tissue as shown in Figure 2.5 (Bamber 1983). This range was getting larger with the 
increase of the frequency of ultrasonic wave. 
 
Figure 2.5 Range of mean attenuation coefficients of breast cancer and normal (fatty) 
breast in 7 specimens; 56 positions, 3 to 5 positions per average (Ca: breast cancer; 
Normal: normal breast) (Bamber 1983) 
 
The acoustic properties of some phantoms also changed during the heating and 
coagulation process of HIFU sonication, such as PAA egg white phantom (Takegami et 
al. 2004; Lafon et al. 2005; Divkovic et al. 2007). Investigations revealed that the protein 
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denaturation in the phantom material has an impact on the acoustic attenuation. The 
coagulated phantom material showed an enhanced absorption and a threefold higher 
attenuation coefficient in comparison with the non-coagulated phantom at a 1 MHz 
frequency (Divkovic et al. 2007). For 7% BSA concentration, the attenuation coefficient 
was an approximately linear dependence in the frequency range between 1 to 5 MHz 
(Lafon et al. 2005). 
The acoustic properties of some commonly used TMMs are summarised in Table 
2.4. 
 
Table 2.4 Acoustic properties of soft tissue substitutes (Culjat et al. 2010) 
Material 
Velocity 
(m/s) 
Density 
(kg/m3) 
Attenuation 
(dB/cm MHz) 
Acoustic Impedance 
(MRayl) 
Agarose-based 1498-1600+ 1016-1100 0.04-1.40 1.52-1.76+ 
Gelatin-based 1520-1650 1050 0.12-1.5 1.60-1.73 
Magnesium 
Silicate-based 
1458-1520 - 0.85 - 
Oil Gel-based 1480-1580 1040-1060 0.4-1.8 1.54-1.67 
Open Cell 
Foam-based 
1540 - 0.46 - 
Polyacrylamide 
Gel-based 
1540 1103 
0.7dB/cm @ 
5MHz 
1.7 
Polyuerethane 1468 1130 0.13 1.66 
Polyvinyl 
Alcohol-based 
1520-1610 - 0.07-0.35 1.60-1.77 
Water-based 1518-1574 1000+ - 1.48-1.60 
Condensed 
Milk-based 
1540 - 0.5 - 
Urethane 
Rubber 
1460 900 0.5-0.7 1.31 
Zerdine 1540 - 0.5-0.7 - 
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2.4.3. Thermal properties of TMMs 
In addition to the acoustic properties, thermal properties which determine the heat 
transmission through the materials are also important in fabricating and investigating 
TMM phantom. The thermal conductivity (k) is the quantity of heat transmitted due to a 
unit temperature gradient, in a direction normal to a surface of unit area in unit time under 
steady-state conditions and where heat transfer is dependent only on the temperature 
gradient. The thermal diffusivity (α) determines the relative time rate of temperature 
change, and is thus a measure of the ability of a thermally perturbed system to relax back 
to steady-state conditions. Another thermal quantity, the specific heat capacity (c) of a 
substance is the amount of heat per unit mass required to raise the temperature by one 
degree in temperature. 
The heat effect induced by focused ultrasound is able to provide important 
information for the evaluation of HIFU field and allow the sonication results predictable 
via theoretic calculation. Furthermore, the phantoms possessed tissue mimicking thermal 
properties provide an environment similar to tissue for acoustic energy delivery and heat 
conduction and diffusion. Thus, to study the focal temperature in HIFU sonication, the 
phantom needs both tissue mimicking acoustic properties and thermal properties. 
Similar to acoustic properties, the thermal properties varied in different part of 
tissues. The thermal properties of animal and human tissues and organs were summarised 
according to previous researches (Bowman et al. 1975). Bowman et al. summarised the 
thermal properties of a wide range of tissues and organs based on different investigators’ 
studies. The thermal properties of tissues and organs of human were selected and listed 
in Table 2.5. 
 
31 
 
Table 2.5 Thermal properties of human and animal tissues and organs (Bowman et al. 
1975) 
Materials and conditions 
Thermal conductivity 
(W·m-1·°C-1) 
Thermal diffusivity 
(m2·s-1) 
Human brain, white, 71% water 0.503 1.34 & 1.40 × 10-7 
Human brain, gray, 83% water 0.566 1.43 × 10-7 
Human brain, whole, 78% water 0.528 1.37 & 1.38 × 10-7 
Human fat 0.200 NA 
Human heart, 81% water 0.587 1.48 × 10-7 
Human kidney, 84% water 0.545 1.32 × 10-7 
Human liver, 77% water 0.566 1.50 × 10-7 
Human muscle 0.385 NA 
Human spleen 0.545 1.32 & 1.38 × 10-7 
Human blood 0.488 NA 
Human blood 0.506 NA 
Sheep kidney, corticomedyllary 
junction, anesthetized with anectine 
and nembutal 
1.281 4.31 × 10-7 
Canine liver, 75% water 0.623-0.901 1.66-2.39 × 10-7 
Canine liver, 73% water 0.670-0.796 1.78-2.11 × 10-7 
 
A reference text (Duck 1990) includes a wide range of tissue thermal properties 
measured by different researchers under different conditions. Thermal diffusivity of soft 
tissue was reported in the range between 0.53 × 10-7 m2·s-1 for cow fat (7% water) to 2.03 
× 10-7 m2·s-1 for rabbit liver. Thermal conductivity was between 0.23 W·m-1·°C-1 in 
human fat and 0.612 W·m-1·°C-1 in human aorta. For tissue specific heat capacity, the 
range was between 2250 J·kg-1·°C-1 for pig fat to 3930 J·kg-1·°C-1 for human blood 
plasma. Combined with the results in Table 2.5, the range of thermal properties of soft 
tissues can be summarised in Table 2.6. 
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Table 2.6 Range of thermal properties of soft tissues 
Parameters Range of soft tissues 
Thermal conductivity (W·m-1·°C-1) 0.23-0.901 
Thermal diffusivity (m2·s-1) 0.53-4.31 × 10-7 
Specific heat capacity (J·kg-1·°C-1) 2250-3930 
 
In 2005, a standard for contact transient methods of measurement of 
thermophysical properties was reported (Tye et al. 2005). This standard provided the 
basic requirements in the thermophysical properties measurement. PAA and BSA based 
phantom materials are more stable at high temperature in thermal therapy compared with 
those gel material, such as agar and gelatin, which have lower melting temperatures (Mark 
et al. 2004). As a result, these two kinds of materials are more widely used in the thermal 
properties research. The thermal response of a phantom consists of a mixture of PAA and 
18% w/w BSA has been developed and tested in order to calibrate thermal therapy devices 
(Bouchard & Bronskill 2000). The research on the thermal properties of PAA egg white 
phantoms, which is used for visualisation of HIFU lesions, has been reported in 2007 
(Divkovic et al. 2007). Thermal conductivity and specific heat capacity of a PAA 
phantom with 10% to 11% (w/w) dissolved egg white protein was measured using hot 
wire method and conventional calorimetry. The results for the thermal conductivity (0.59 
± 0.06 W·m-1·°C-1) and the specific heat capacity (4270 ± 365 J·kg-1·°C-1) capacity were 
similar to the values of water (0.6 W·m-1·°C-1 and 4182 J·kg-1·°C-1). The observed faster 
temperature rise in the coagulated focus compared to the normal phantom material 
indicates an increased absorption in this PAA material. This result was in good agreement 
with the changes in acoustic attenuation coefficient of canine liver tissue with and without 
coagulation (Techavipoo et al. 2004). The acoustic attenuation coefficient in canine liver 
tissue was proved to be dependent on both tissue coagulation effects and temperature 
elevation. 
The thermophysical properties of PAA egg white phantoms with vaired egg white 
concentration for HIFU exposures were provided by the previous researchers in Dundee 
ultrasound group (Gao et al. 2012). Various egg white concentrations 0% to 40 % were 
used to fabricate the phantoms and step-wise transient plane source (TPS) method 
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(Kubicar & Bohac 2000) was utilized in the measurement. The results, including thermal 
conductivity, thermal diffusivity, specific heat capacity and R-squared values, are shown 
in Table 2.7. 
 
Table 2.7 Measured thermophysical properties of egg white phantoms with different 
egg white concentrations (0% to 40%) (Gao et al. 2012) 
Egg white 
concentration 
(v/v %) 
Thermal 
conductivity 
(W·m-1·°C-1) 
Thermal diffusivity 
( m2·s-1) 
Specific heat capacity 
(J·kg-1·°C-1) 
0 0.722 1.866×10-7 4230.5 
10 0.737 1.826×10-7 4304.9 
20 0.744 2.019×10-7 3670.4 
30 0.747 2.221×10-7 3743.9 
40 0.759 2.253×10-7 3271.9 
R2 0.95 0.88 0.84 
 
2.4.4. Elastic properties of TMMs and elastography 
The elastic properties describe the resistance of an object or substance to being 
deformed elastically when a force is applied to it. The variations in elastic properties of 
tissues have been considered as diagnostic sign of diseases such as cancer. Imaging of 
elastic properties of normal and diseased tissues is carried out either by approaches that 
estimate displacement and strain or modulus reconstructions in response to a quasi-static 
deformation (O'Donnell et al. 1994; Bilgen & Insana 1996; Bamber 1999; Madsen et al. 
2005) or dynamic approaches for reconstructing the mechanical properties of tissue using 
external vibration or methods that utilize localized acoustic radiation force to perturb 
small volumes of tissue (Fatemi & Greenleaf 1999; Nightingale et al. 2002; Urban et al. 
2011). 
ShearWaveTM elastography (SWE) (Bercoff et al. 2004; Bercoff et al. 2008) is a 
quantitative technique based on estimation of the shear wave speed or velocity, which is 
used to assess true tissue elasticity by displaying a colour coded image superimposed on 
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a B-mode image (Figure 2.6). The stiffness of tissue, quantified by the Young’s modulus 
E (kPa), is related to the shear modulus (µ) by equation (2.2): 
E = 2×µ (1+υ) ≈ 3µ                                                 (2.2) 
where υ denotes the Poisson’s ratio. Under the assumption of tissue incompressibility i.e. 
υ ≈ 0.495, E ≈ 3µ. The shear modulus is related to the density (ρ) and the shear wave 
propagation velocity (vsw) through equation (2.3). 
µ = ρ × vsw2                                                         (2.3) 
 
 
Figure 2.6 Ultrasound B-mode and Young’s modulus image of a human patient’s 
prostate obtained by tracking shear wave propagation based on supersonic shear 
imaging 
 
By measuring the speed of the propagation of the shear wave at every point in the 
scanned region under the assumption of uniform and constant value of the tissue density, 
the stiffness of the tissue can be quantified in terms of the shear modulus. In SWE, the 
elasticity image measured in kilopascals (kPa) is refreshed in real time with the image 
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resolution around 1 mm (Bercoff et al. 2004). However, SWE is an evolving for the 
detection of prostate cancer and many parameters need to be standardised. 
As the cancerous tissues were stiffer than normal tissues, they normally showed a 
larger Young’s Modulus. The Young’s Modulus of liver tumour was reported as 30.1 ± 
10.7 kPa (n = 31), while it was 6.9 ± 0.9 kPa (n = 13) for normal liver tissue (Venkatesh 
et al. 2008). Prostate cancerous tissue is stiffer properties in the range of 58.0 kPa and 
90.5 kPa based on patients data using shear wave elastography (Zhai et al. 2010; Barr et 
al. 2012). Zhang et al. (Zhang et al. 2008) have reported that the complex Young's 
modulus of normal and cancerous prostate of 15.9 ± 5.9 kPa (n = 8) and 40.4 ± 15.7 kPa 
(n = 9) at 150 Hz using stress relaxation tests. 
Krouskop et al. (Krouskop et al. 1998) measured the Young's modulus of a larger 
number of prostate specimens using compression loading at two different pre-
compression levels of 2% and 4% and for three different loading frequencies of 0.1, 1 and 
4 Hz respectively. At a 1 Hz testing frequency and 2% pre-compression they reported 
Young's modulus values of 62 ± 17 kPa (n = 32) in the normal anterior and 69 ± 17 kPa 
(n = 32) in the normal posterior of the prostate. BPH was reported to be softer than the 
normal prostate at 36 ± 9 kPa (n = 21). Significant differences were observed in the 
Young's modulus of prostate cancers with an increase in the pre-compression from 2 to 
4%, with values increasing by a factor of two from 100 ± 20 kPa (n = 28) to 221 ± 32 kPa 
respectively. These reports demonstrate that the Young's modulus values obtained by 
compression test can change with the testing frequency and pre-compression levels for 
different prostate tissue types. Therefore, the Young’s Modulus of cancerous tissues was 
in a wide range of 30.1 kPa (liver tumour) to 221 kPa (prostate tumour). 
 
Table 2.8 Range of Young’s Modulus of tumours 
Parameter Range of tumours (kPa) 
Young’s Modulus 30.1-221 
 
TMM phantoms play an important role in ultrasound and elastography research 
through simulating normal and diseased tissues for standardisation (D'Souza et al. 2001; 
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Alexei et al. 2003; Takegami et al. 2004; King et al. 2011). Various kinds of TMMs have 
already been used in ultrasound research, such as agar, silicone and PAA gel (D'Souza et 
al. 2001; Alexei et al. 2003; Takegami et al. 2004; King et al. 2011). The Young's 
modulus is an important parameter for elastography phantoms. Madsen et al. (Madsen et 
al. 1994) have demonstrated the use of TM phantoms for standardization of both 
ultrasound imaging of the prostate and elastographic imaging, using agar and gelatin 
materials. Anderson et al. (Anderson et al. 2011) have also presented the effect of graphite 
concentration on shear wave speed in the gelatin based phantoms. Aldehyde 
concentration was used to increase the stiffness of the gelatin by controlling the amount 
of collagen crossing-linking (Phantom materials for elastography). 
Ultrasound elastography is a rapidly developing technology and several of the 
approaches discussed above have been implemented in commercial clinical diagnostic 
systems. This non-invasive technique has since then been reported in clinical trials in 
different anatomical areas using various perturbation techniques (Xu et al. 2010; Urban 
et al. 2011; Aboumarzouk et al. 2012; Barr et al. 2012; Brock et al. 2012; Evans et al. 
2012; Zhai et al. 2012). Commercial systems include: VirtualTouch (Siemens Medical 
Solutions USA, Inc., Malvern, PA, USA), SonixTablet (ULTRASONIX, British 
Columbia, Canada), ElastoQ (Toshiba Medical Systems, Otawara, Japan), 
ShearWaveTM elastography (SuperSonic Imagine, Aix-en-Provence, France) etc. 
2.5. Summary 
Since there is a growing number of interests and clinical applications of HIFU, the 
efficacy and safety of the treatment has to be taken into consideration and the challenges 
of HIFU need to be overcome. 
The ribcage of the patient, which blocked part of the beam path of the focused 
ultrasound wave and declines the efficacy of HIFU, was one of the challenges in the 
treatment of abdominal organs. To address this issue, a number of numerical analysis of 
HIFU procedures through ribcage have been reported, including wave propagation and 
its correction provided together with potential solutions. However, none has applied the 
physical experimental practice with the structure of human anatomy. Experimental data 
reporting on acoustic properties of ribs and surrounding soft tissues so far has been limited 
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to animal ribs, TMM phantoms or single piece of human rib without full anatomical 
structure (e.g. rib spacing). The reported experimental data may not be applicable to 
humans as anatomy and structure of ribs and surrounding structures have with little or no 
resemblance to real patients. Therefore, a physical model possesses human anatomical 
structures was necessary for assessing the role of the ribcage in HIFU treatment through 
ribs. In order to reconstruct human anatomical structures, it is the best way to use medical 
images of the patients. As the properties of human tissues have been known, a practical 
model could be created for pre-treatment planning based on image data from patients 
using proper TMMs. 
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Chapter 3 Patient-specific 3D Model 
Reconstruction, Fabrication and 
Characterisation 
The ribcage is an obstacle in the ultrasound wave propagation in HIFU treatment 
of abdominal tumours and it is necessary to create a physical ribcage model to fully 
understand the effect on the focused ultrasound field. This chapter describes a rapid 
modelling technique for 3D reconstruction of the ribcage based on patient specific data, 
thus modelling human anatomical structures. The procedure of fabricating ribcage and 
surrounding tissue using selected tissue mimicking materials for imaging and HIFU 
applications is included. 
To mimic human anatomical structures, a 3D modelling technique was utilised 
based on clinical images (e.g. CT and MRI). Digital Imaging and Communications in 
Medicine (DICOM) is the standardised data exchange format between medical systems. 
In this study, Simpleware (Simpleware Ltd, Exeter, UK) software was used to create the 
3D models using the DICOM data from four patients CT scans with prior institutional 
approval (Caldicott/CSAppFY021211). The reconstruction procedure is described in 
section 3.1. The physical ribcage model was then produced from the profile of the 
computational model by rapid prototyping. 
The fabrication of TMM phantoms is described followed by their characterised 
and comparison with the properties of human tissues. The TMMs for every part of the 
phantom in HIFU sonication must have approximate properties. Those properties 
included acoustic, thermal and elastic parameters. The lesion formed on different 
phantom caused by HIFU sonication was compared for selecting the phantom as 
sonication target in the following studies in section 4.4 of next chapter. The fabrication 
of several types of commonly used phantoms in ultrasound research is described in 
section 3.3. Measurement and result of TMMs properties are illustrated in section 3.4. 
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3.1. 3D reconstruction of patient’s ribcage 
Since mid-1990s, 3D modelling techniques have been used for reconstruction of 
the accurate details of the complex geometries not only of the surface but also of the 
internal tissue. They can provide the important information for surgical planning and 
computer aided simulation. There are many 3D modelling techniques available. For 
example, 3D Slicer (an open source software package, Surgical Planning Laboratory of 
Brigham and Women’s Hospital, MA, USA) has been used in assisting planning of the 
surgical separation of conjoined twins (Norwitz et al. 2000). Analyze software 
(AnalyzeDirect Inc., KS, USA) can be used to create a virtual 3D models to design and 
manufacture a mould for correlating the images with histopathology (Shah et al. 2009). 
Rapid prototyping (RP) techniques, which convert a computer reconstructed 3D 
model into a prototype, are widely used in manufacturing and in medical applications. RP 
can provide a realistic impression of complex structures and precise reproduction of 
objects, thus surgical planning and fabrication of prostheses have gained most benefits 
from RP technique in medical applications. 
In the current study, 3D modelling and rapid prototyping were used for 3D 
reconstruction from patients’ data. The procedure included creating a computer generated 
model from clinical images, prototyping a physical model and fabricating TMM 
phantoms based on the 3D models. 
3.1.1. Patient data 
Anatomical features and structures, for example, the width and spacing of ribs, 
vary greatly from patient to patient. The best way to obtain patient-specific anatomical 
structures is from clinical images, such as CT and MRI. Here image data from four 
patients was used for the ribcage reconstruction and the difference in ribcage dimensions 
is presented in this section. 
Four patients, with different gender and age, were selected for the ribcage model 
reconstruction. Patient No.1 was an 80 years old male; No.2 was a 54 years old female; 
No.3 was male, 44 years old; and No.4 was female, 47 years old. The CT scan data 
obtained from Ninewells hospital was used with prior institutional ethical approval and 
patients consent (Caldicott/CSAppFY021211). 
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Spacing between the 9th and 10th ribs (Figure 3.1) was selected to investigate 
intercostal ultrasound propagation and the 9th ribs were used in the study of transcostal 
HIFU treatment (Chapter 4). To describe the difference in rib curvature, the height of the 
minor circular segment of the rib was measured. For an arc, different curvature results in 
different height of the circular segment if chord length is assumed to be constant. Figure 
3.2 depicts a minor circular segment with chord length 80 mm on the 9th rib. Hcs indicates 
the height of this circular segment. The height on the 9th and 10th ribs of the four ribcages 
is shown in Table 3.1. The width of the ribs was measured at three different positions on 
the 9th and 10th ribs. These positions were determined by the chord length of 20 mm, 
40 mm and 60 mm in the circular segment composed by the rib arch. For the 9th rib in 
Figure 3.3, w1 is the width at the end of the circular segment at 20 mm chord length. 
Likewise, w2 and w3 are at the end of the 40 mm and 60 mm chord, respectively. w4, w5 
and w6 are at the end of the 20 mm, 40 mm and 60 mm chord on the 10th rib. Spacing 
between the 9th and 10th ribs was also measured at three positions at 20 mm, 40 mm and 
60 mm chord length of the circular segment (s1-s3 in Figure 3.3). 
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Figure 3.1 3D model of human ribcage (the 9th and 10th ribs were selected in the current 
study) 
 
 
Figure 3.2 Top view of the ribcage model (Blue double headed arrow indicating height 
of minor circular segment of the 9th rib) 
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Figure 3.3 Dimensions of width and spacing of ribs. w1-w3 and w4-w6 indicate the 
widths of the 9th and 10th rib respectively. s1-s3 represent the spacing between 9th and 
10th rib. w1, w4 and s1 are at the chord length of the rib 20 mm; w2, w5 and s2 are at 40 
mm; w3, w6 and s3 are at 60 mm. 
 
Measurement results of these dimensions are summarised in Table 3.1. Results 
show that ribcage of No.2 patient has the biggest spacing between the 9th and 10th ribs, 
while ribcage of No.3 patient has the smallest. Patient No.3 and No.4 have similar width 
in the 9th rib, which is obviously wider than that of the other two. Costal groove results in 
an increase in the width at w3 and w6, and a decrease in the spacing at s3 position. 
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Table 3.1 Dimensions of patients’ ribs (mm, SD within ± 0.08 mm) 
 Patient No.1 Patient No.2 Patient No.3 Patient No.4 
w1 11.45 10.60 13.16 13.34 
w2 11.28 11.91 12.71 11.43 
w3 15.63 13.39 17.52 18.44 
w4 11.22 10.76 11.45 11.06 
w5 14.88 11.22 11.13 10.08 
w6 18.52 15.15 14.77 15.01 
s1 18.25 19.73 12.31 15.41 
s2 18.58 21.52 13.82 17.06 
s3 16.88 19.57 11.91 10.71 
Hcs(9
th) 16.03 15.94 23.47 17.20 
Hcs(10
th) 12.59 12.29 20.26 14.30 
 
3.1.2. DICOM 
DICOM , Digital Imaging and Communications in Medicine, is the international 
standard for medical images and related information (ISO 12052). It defines the formats 
for medical images that can be exchanged with the data and quality necessary for clinical 
use. DICOM is implemented in almost every radiology, cardiology imaging, and 
radiotherapy device (X-ray, CT, MRI, ultrasound, etc.), and increasingly in devices in 
other medical domains such as ophthalmology and dentistry. 
Thanks to DICOM standard, the medical data processing can be simplified by the 
standardised data file format definition and network communications protocol. As the CT 
scan data from patients used in this study complied with DICOM standard, it can be 
directly imported into most of the imaging processing software for the 3D model 
reconstruction. 
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3.1.3. Image processing of DICOM data 
In this section, the reconstruction from DICOM data to 3D computer generated 
model is described. The pixels of bones in CT images were brighter compared with soft 
tissues and this allowed better segmentation of the ribs from the raw image data. No.1 
patient’s data was used to describe the image processing. Before starting the 
reconstruction, in order to reduce the CPU and memory usage during the image 
processing, the CT images were cropped to contain only the whole ribcage area. 
Segmentation was performed to separate ribs and other tissues, so that a mask 
(representing the object of interest) of the ribcage can be extracted from the raw data. 
There could be over segmentation or cavities in the field of interest during the 
segmentation procedure limited by the image resolution and additional functions and 
filters, e.g. morphological filter and cavity fill filter, were applied to enhance the image 
quality. Finally, the 3D model was reconstructed based on this mask. 
3.1.3.1. Segmentation 
The segmentation on raw greyscale data (Figure 3.4(a)) was achieved through 
classification of pixels into appropriate groups by threshold values according to relative 
signal strength. The greyscale of pixels on raw CT images ranged from 0 to 4095. A lower 
threshold value of 1235 was selected to segment the ribcage area with 4095 as the upper 
threshold, because the rib parts possessed the highest grey value and all of these pixels 
should be included in the field of interest. The pixels that between the lower and upper 
threshold were segmented. 
A few dispersive regions were selected with the ribcage area in this mask (red area 
in Figure 3.4(b)). It can be seen in Figure 3.4(b) that, the red area on the top left and in 
the middle of the figure did not represent ribs (most likely liver and heart). Additional 
functions were then applied, such as region growing. Region growing kept only the 
connected pixels as ‘islands’. By using region growing, some of the unwanted parts in the 
segmented images were disconnected. It was also used to improve the lack of connectivity 
among the preservation area of the ribs. A better segmentation result was gained after 
further processing as shown in Figure 3.4(c). 
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3.1.3.2. Filter enhancement 
After segmentation, there were some excess areas connected with the target ribs 
(green in Figure 3.4(c)). A morphological filter was applied, which got rid of small 
spurious features that cannot be removed by segmentation. Some small holes might be 
still in the field of interest and a cavity fill filter was used to fill them. The cavity fill filter 
automatically filled those cavities that were completely closed. These filters can be 
repeated to obtain an ideal result. In Figure 3.4(d), only ribcage was selected and coloured 
in the active yellow mask after image processing. The mask of the ribcage is presented in 
green in the 3D view on the raw data in Figure 3.5. 
 
 
Figure 3.4 Image processing of CT data (a. Raw greyscale data; b. After basic 
segmentation; c. After region growing; d. After filter enhancement) 
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Figure 3.5 3D view of segmentation result of the ribcage from raw data 
 
3.1.3.3. From images to 3D model 
The segmented mask as shown in Figure 3.4(d) can be automatically converted 
into a 3D model (Figure 3.6(a)) by the software. The aim was to reconstruct the lower 
part of the ribcage, specifically from the 9th to 12th ribs, because the size of the whole 
ribcage was too large and thus expensive to produce and this lower part was the region in 
the beam path of the focused ultrasound wave in the treatment of abdominal organs. By 
reconstructing only the lower part, the processing time of the model was reduced. It was 
also much more convenient to use the smaller model in the experiments due to the limited 
size of MR scanner (allowing space for movement of phantom or for other devices). The 
region of interest (lower part of the ribcage) was selected from the whole ribcage using 
the editing tool in Simpleware. Because of the image resolution and slice thickness, as 
seen in Figure 3.6(b), the surface of this part was not smooth enough after modelling from 
2D images without any processing. The surface was smoothed using a Recursive 
Gaussian algorithm. A model with smoothed surface is depicted in Figure 3.6(c). The 
meshing procedure then assigned material properties (e.g. Young’s modulus and density) 
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and created surface or volume meshes. These were not used in this study but are very 
important for the models that would be utilised in finite element analysis. The meshed 
model is shown in Figure 3.6(d). Finally, the model was exported as ‘STL’ file format to 
be read by the prototyping machine. 
 
 
 
Figure 3.6 Reconstruction of lower part ribcage model (a. Whole ribcage model; b. 
Lower part of the ribcage model from 9th to 12th ribs; c. Model after surface smoothing; 
d. Model after meshing) 
 
3.1.4. Prototyping of the physical model 
Based on the computer reconstructed 3D ribcage model, the lower part of the 
ribcage was manufactured by a rapid prototyping machine uPrint SE (Stratasys Ltd., Eden 
Prairie, MN, USA) using Acrylonitrile Butadiene Styrene (ABS) thermoplastic material 
(ABSplusTM-P430, Stratasys Ltd., Eden Prairie, MN, USA). After import of the model 
file in ‘STL’ format to uPrint SE, the software of the machine calculates the path to 
extrude thermoplastic material. The machine heats the thermoplastic material up to 
operating temperature and the material extrusion head that protrudes from the liquefier 
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(headed thermoplastic material) then lays down a ribbon of material along the extrusion 
path. After each layer is finished, the Z stage platform lowers slightly to prepare for 
building the next layer. Each layer of molten plastic is deposited on top of the previous 
one and flattened slightly by the extrusion head fusing the layers. The physical ribcage 
models of all of the four patients made by the rapid prototyping machine are shown in 
Figure 3.7. 
 
 
Figure 3.7 Patient specific ribcage models 
 
To mimic the tissue around ribs, TMM was used to fabricate the surrounding 
tissue. As this phantom was to be used in a series of repeatability experiments to 
investigate the ribcage effect on HIFU treatment (in Chapter 4), it was not advisable to 
use a toxic material such as PAA phantom. The phantom needs to be preserved and used 
for a fortnight, 10% w/v polyvinyl alcohol (PVA) was selected, due to its long-term 
stability and non-toxicity. It is more elastic than agar. To fabricate the surrounding tissue, 
the solution of PVA powder (Sigma-Aldrich, Gillingham, Dorset, UK) was allowed to 
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rest for a few hours to allow air bubbles to rise to the surface. The solution was then 
processed through four freeze-thaw cycles. Figure 3.8(b) shows the lower part ribcage 
model embedded into PVA gel. 
 
 
Figure 3.8 3D reconstructed model: (a) prototyped physical model of No.2 patient’s 
lower part ribcage; (b) ribcage model embedded into PVA gel phantom 
 
3.2. 3D modelling of other organs 
The 3D modelling of human organs including kidney, liver, breast and prostate, 
are not included in the study on the ribcage effect, because as a phantom to mimic tissue 
for HIFU application, the shape of soft tissue is not as important as its properties. The 
priority of the present work is not to study the effect of the organ shape, but to investigate 
the effect of ribcage. The phantom is used as the substitute of tissue in the focused 
ultrasound propagation path. However, the 3D models of these organs can be used in 
finite element analysis and the phantom fabricated from these models can be used as 
tissue substitutes in other pre-clinical researches. This section reports the 3D modelling 
technique of other organs. 
3.2.1. Kidney 
The kidney model was created using Simpleware by a similar procedure to the 
reconstruction of ribcage. Based on the patient CT images, however, the reconstruction 
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of kidney model is more complicated due to different components of the anatomical 
structures of kidney. To simplify this model, it is assumed that the kidney contains two 
major regions, the cortex on the outside and the medulla on the inside. Guided by different 
brightness in pixels, these two parts were differentiated, Figure 3.9(a) for medulla and (b) 
for cortex. 
 
  
Figure 3.9 3D computer generated kidney model (a. medulla; b. cortex) 
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Figure 3.10 Computer generated kidney moulds (a. cortex mould; b. medulla mould) 
 
The kidney moulds were created in accordance with the surface of cortex and 
medulla part. The medulla mould was achieved by separating the kidney cortex model 
from its central plane directly as shown in Figure 3.10(b). The cortex mould was produced 
by separating the medulla shape within a cuboid. Each cuboid possessed half of the kidney 
medulla model as seen in Figure 3.10(a). The computer generated moulds were then 
prototyped using uPrint SE machine (Figure 3.11). 
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Figure 3.11 Rapid prototyped kidney moulds (a. medulla mould; b. cortex mould) 
 
3.2.2. Liver 
The liver model was reconstructed using a similar processing. Figure 3.12 depicts 
the computer generated model of the liver. 
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Figure 3.12 3D liver model 
 
3.2.3. Breast 
The breast phantom mould was created from MR images of a commercial breast 
phantom. To manufacture the breast phantom mould, a computer generated cuboid model 
was cut according to the outline of the breast model (Figure 3.13(a)). The physical mould 
of breast phantom was prototyped by uPrint SE using ABS material, as shown in Figure 
3.13(b). To mimic the breast tissue, the phantom was made of refined lard and fresh egg 
white (Freed et al. 2011). Lard has a similar composition to human adipose tissue and is 
very stable and readily available. Egg white was used to simulate the glandular portion of 
the breast as a large part of the glandular tissue is made up of proteins. For this particular 
mould, the total volume is 240 ml. 223 ml lard and 17 ml egg white based on calculations 
of breast composition on MR images of volunteers (Cui 2014). The lard was melted and 
stirred in a beaker on the hot plate and poured into the mould. The egg white was then put 
into the mould. Finally, the mould with phantom was placed into a refrigerator for cooling 
down and solidification. 
54 
 
  
Figure 3.13 Breast phantom mould (a. computer generated model of breast phantom 
mould; b. prototyped breast phantom mould) 
 
3.2.4. Prostate 
The prostate model is shown in the flowchart in Figure 3.14. The fabrication of 
prostate phantom started from a 3D model reconstructed from MR images of a 
commercial prostate phantom. The two-part prostate mould was created by removing the 
prostate model from a cuboid model and separating the cuboid from the central plane. 
Outlets were prepared on the mould for placing a tube to mimic the ureter in the centre of 
the phantom. The two-part mould was then prototyped into physical mould for prostate 
phantom fabrication. 
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Figure 3.14 Fabrication of prostate phantom based on prostate model (a. prostate model; 
b. computer generated prostate mould; c. rapid prototyped prostate mould; d. prostate 
phantom)  
 
3.3. TMM phantom fabrication 
Tissue mimicking material (TMM) is used as an alternative to human tissue or 
animal tissue in medical training and research. It must possesse similar relevant properties 
to human or animal tissue. In this section, TMMs were characterised in order to determine 
the best materials for creating phantom for HIFU sonication experiments. The fabrication 
method of several commonly used TMMs, silicone, PAA, agar and PVA is described here. 
Samples were prepared for characterisation experiments, including acoustic, thermal and 
elastic properties. 
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3.3.1. Silicone 
The silicone phantom was made of acetoxy cured silicone (Everbuild, Leeds, UK). 
It cures from a highly viscous liquid into an elastic solid at room temperature in 
approximate two hours (depending on temperature, i.e. the higher the temperature, the 
shorter the curing time). This material remains stable for months and is non-toxic. As the 
silicone polymer is anti-fungal, quick curing for fast application, it is suitable and easy to 
moulding into organ or tumour phantoms. 
3.3.2. Polyacrylamide (PAA) 
PAA based materials state in a liquid phase, after a chemical reaction it turns into 
a translucent solid. One of the advantages of polyacrylamide is that it can form rigid 
shapes within 15 minutes at room temperature. The PAA phantom was fabricated using 
degassed water, acrylamide, N, N’-Methylenebis (acrylamide), ammonium 
peroxodisulfate, N, N, N’, N’-Tetramethylethylenediamine (Sigma-Aldrich, Gillingham, 
Dorset, UK). The concentration and procedure utilised in this study were based on the 
previously reported methods (Lafon et al. 2001; Takegami et al. 2004). It should be noted 
that if a beaker is used for mixing the chemicals to fabricate PAA phantom, it is best to 
pour the stirred solution into the mould as fast as possible to prevent the solution from 
part solidifying in the beaker. Considering its high toxicity, care should be taken when 
using the material. The protection measures of fabricating PAA phantom and Control of 
Substances Hazardous to Health (COSHH) risk assessment forms of relevant materials 
are illustrated in Appendix. 
3.3.3. Agar 
Agar powder (Sigma-Aldrich, Gillingham, Dorset, UK) added degassed distilled, 
water was heated and stirred at above 95 °C till it was dissolved completely. The agar 
solution was then poured into the desired mould for cooling down and forming solid shape. 
During the heating and stirring procedure, an erlenmeyer flask was applied as the 
container. There was a small opening on its conical body for air out when connected to a 
pump (Sam 12 Suction Unit, Aerosol Products Ltd., London, UK). The main opening on 
the top was sealed and a pump connected to the side opening, so that the air pressure in 
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the flask could be reduced. This reduced the chance of trapping air bubbles in the agar 
solution. 
3.3.4. Polyvinyl alcohol (PVA) 
Fabrication of PVA gel phantom was time consuming due to the freezing and 
thawing cycle. It was fabricated using 10% w/v PVA particles (Sigma-Aldrich, 
Gillingham, Dorset, UK) dissolved in degassed, distilled water. The water was heated and 
stirred until the solution became transparent without any PVA particles. After cooling 
down to room temperature to allow air bubbles rising to the surface and be removed, the 
PVA solution was sealed to avoid formation of a dry surface on the top of the phantom 
and put into a freezer. The phantom was frozen at -20 °C for 12 hours and then recovered 
to room temperature for thawing (Surry et al. 2004). A total of four cycles were applied 
in this study. 
3.3.5. Specimen preparation 
Phantoms were fabricated in different shapes for the characterisation of different 
properties. For acoustic properties, including speed of sound, acoustic impedance and 
attenuation coefficient, approximate 10 mm thickness cylindrical samples were prepared. 
Two smooth parallel surfaces were required, because the accurate ultrasound propagation 
path was used to calculate the relevant parameters. These cylindrical samples were also 
used in the mechanical compression test for elasticity measurement. For thermal 
properties measurement, samples were made into cylinder shape with 45 mm diameter 
and 50 mm height. 
A phantom container was designed to characterise the elastic properties of TMMs 
using shear wave elastography. The phantom container (13.8 cm × 11.8 cm × 8.5 cm) was 
fabricated using perspex material. Inclusions that mimic the properties of tumours were 
placed into the phantom container at specific locations and embedded in agar gel 
background, and an opening was prepared for the ultrasound probe. In Figure 3.15, the 
blue circle indicates the probe opening. The inclusions in different sizes were made using 
the tumour mould, which consists of two halves with several cavities of different diameter 
as shown in Figure 3.16. In each isolated cavity of the mould, a tiny hole for exhausting 
air bubbles was drilled. 
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Figure 3.15 Tissue mimicking prostate phantom (the blue circle indicates the opening 
for ultrasound transrectal probe) 
 
 
Figure 3.16 Tumour mould used to manufacture the spherical TMM inclusions that are 
embedded in the TM phantom shown in Figure 3.15 
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3.3.6. Specimen storage 
Specimens were wrapped in cling film and stored in a refrigerator to reduce 
desiccation. Before the characterisation experiment, they were revered in room 
temperature for couple of hours. 
3.4. Characterisation of Tissue Mimicking Materials for HIFU application 
This section reports the characterisation of TMM properties. Material that has 
similar acoustic impedance and speed of sound to the tissue can provide an efficient path 
for ultrasonic propagation from the transducer to the target. If there is mismatch of 
impedance, there is significant reflection and refraction of the ultrasound beam at the 
interface. Thermal properties are the important factors to estimate the temperature rise in 
medical ultrasound field. Acoustic and thermal properties of TMMs were investigated to 
determine the suitable materials for the phantom used as the ultrasound beam path and 
focal target. Elastic properties of TMMs determined the best material for better imaging 
quality in the tumour mimicking tissue detection using elastography. Variations in elastic 
properties of tissues are considered as a good diagnostic sign of diseases such as cancer. 
Since elastography maps the stiffness of tissue, this medical imaging modality plays an 
important role in detecting diseased tissue. In order to determine the phantom used as the 
target in HIFU experiment (in Chapter 4), sonications were performed on DQA gel 
phantom (a commercial phantom used for HIFU sonication experiment, available from 
ATS Laboratories Inc., Bridgeport, CT, USA) and PAA egg white phantom to study the 
formation of the lesions induced by HIFU. Lesion size of each focus was measured after 
applying sonication on the phantom. 
3.4.1. Acoustic properties test 
The insertion/substitution technique described by Selfridge (Selfridge 1985) and 
Zell et al (Zell et al. 2007), was applied to measure the acoustic properties in this study. 
The ultrasound wave propagating from source to receiver with and without the sample in 
the beam path in a distilled degassed water environment was transmitted and detected 
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using a matched pair of SLIH transducers (Sonatest, Milton Keynes, UK). They can be 
used as ultrasound source and receiver respectively, as illustrated in Figure 3.17. The two 
transducers have to be coaxial to ensure the ultrasound wave completely detected by the 
receiver. As the frequency of HIFU device and imaging device was different, two pairs 
of transducers working at different frequencies were used. One pair of transducers have 
the peak frequency at 2 MHz the other at 4.8 MHz. The 2 MHz transducers were used for 
HIFU phantoms and the 4.8 MHz ones for imaging phantoms because higher frequency 
was used in imaging devices to provide a better spatial resolution. An arbitrary 
waveform/function generator (33220A, Agilent, Santa Clara, CA, USA) connected to the 
transmitter and was utilised to emit the sinusoidal wave in 5 bursts. A digital oscilloscope 
(DSOX2004A, Tektronix, Beaverton, OR, USA) was used to monitor the detected sound 
wave from the receiver transducer. The output of the generator was also connected to the 
oscilloscope as a reference signal. The sample of the phantom to be measured was inserted 
between the two transducers during the measurement with two parallel planes orthogonal 
to the coaxial line of the transducers. 
 
 
Figure 3.17 Schematic diagram used for the measurement of acoustic properties of 
tissue mimicking materials 
 
Figure 3.18 shows the experimental setup of the acoustic properties measurement 
in a water tank. The two transducers were fastened coaxially on the adjustable holders of 
the tank in degassed water. The original holder for the measured sample can be lift out of 
the water for placing the sample (black part in Figure 3.18(b)). However, the slot of the 
original holder was only as narrow as 4 mm and not stable for placing a piece of thicker 
sample. Therefore, a new sample holder (white part in Figure 3.18(b) and Figure 3.18(c)) 
61 
 
with an 8.4 mm width slot was designed and produced, which can be inserted into the 
original holder of the tank to hold the phantom sample more properly. 
 
 
 
Figure 3.18 Experimental setup of measurement of acoustic properties 
 
To calculate the longitudinal ultrasound velocity and acoustic attenuation 
coefficient, firstly the wave velocity in water is measured from the propagation time (𝑡0) 
of ultrasonic wave in water between the two transducers without the sample: 
𝑡0 =
𝐷
𝑣𝑤
                                                                          (3.1) 
where  𝑣𝑤  is the acoustic velocity in water and D is the distance of ultrasound 
transmission path. 
Difference in the transmission times (∆t) with and without the sample is measured. 
The acoustic sound speed in the sample is given by: 
𝑣𝑠 = 𝑣𝑤/(1 −
𝑣𝑤∆𝑡
ℎ
)                                                              (3.2) 
where 𝑣𝑠 is the acoustic velocity in the sample and h is the thickness of the sample. 
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For the acoustic attenuation coefficient, the amplitude of the ultrasonic wave with 
the sample, and the amplitude of the wave without the sample in place are measured. The 
acoustic attenuation coefficient (𝛼𝑠) is then given by: 
𝛼𝑠(𝑑𝐵/𝑐𝑚) =
1
ℎ(𝑐𝑚)
× 20 log10
𝐴𝑤
𝐴𝑠
𝑇𝑟2
+ 𝛼𝑤                                      (3.3) 
where 𝐴𝑤 and 𝐴𝑠 denote the amplitude of the received ultrasound pulse, indices w and s 
representing water and the sample, respectively. 𝛼𝑤 is the acoustic attenuation coefficient 
in water. Tr denotes the transmission coefficient through the sample wall if present. Tr is 
given by: 
𝑇𝑟 =
4𝑍1𝑍2
(𝑍1 + 𝑍2)2
                                                        (3.4) 
where Z1  and Z2  are the acoustic impedances of water and the sample respectively, 
depending on velocity (v) and density (ρ). Z is calculated by density multiplying acoustic 
velocity. 
Z = v ∙ ρ                                                                (3.5) 
The density (ρ) is obtained by mass divided by volume. The mass of the sample is 
measured by electronic balance, while its volume is obtained through measuring the 
sample mould’s volume. 
The attenuation in water is 𝛼𝑤 = 2.5 × 10
-4 𝑓2, where the frequency 𝑓 is given in 
MHz, and is ignored since it is small. 
To measure the acoustic properties of ABS material, a square sheet of ABS 
material was produced by the prototyping machine (Figure 3.19). For more accurate 
measurement, four thicknesses were used (1.12 mm, 1.62 mm, 2.16 mm, and 2.66 mm). 
The procedure of the acoustic properties measurement was the same as the measurement 
of TMM using the insertion/substitution technique and result was calculated according to 
equations 3.1 to 3.5. 
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Figure 3.19 Sample of ABS material with different thickness 
 
3.4.2. Thermal properties test 
The step-wise transient plane source method (Kubicar & Bohac 2000; Gao et al. 
2012) was applied to measure the thermal properties of TMM phantoms. Figure 3.20 
depicts the setup including a block of phantom, a thermocouple and a heat source. The 
specimen to be measured is divided into three sections: A, B and C. A thin layer planar 
heat source (represented by red line in Figure 3.20) is located between layer A and B to 
provide heat from the inside of the specimen. A thermocouple (blue line in Figure 3.20) 
is placed between layer B and C parallel to the heat source plane to record the temperature 
change during the heating and cooling procedure. The temperature response T(x, t) at a 
distance x from the heat source plane was recorded and used to calculate the thermal 
properties. 
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Figure 3.20 Principle of the step-wise method 
 
In the experimental setup in Figure 3.21, the phantom specimen was prepared into 
cylinders with 45 mm diameter and 50 mm height. They were wrapped and fixed by 
specifically designed foam plastic shells to reduce heat loss. The white prototyped shell 
was used for holding the blue shells. A 53 mm diameter, 408 Ω heat source planar 
(Kapton heater, Omega Engineering, UK) was placed between the two pieces of 
specimens and fully contacted with each of them. Two thermocouples (Type K 
thermocouple, T.M. Electronics Ltd., Sussex, UK), the metal wires as seen in Figure 3.21, 
were inserted into the centre of one piece of specimen through the holes on the shell at 
distance x = 9 mm and 15 mm from the heat source plane. An 8-Channel Thermocouple 
Input USB Data Acquisition DAQ Device (USB-TC, Measurement Computing 
Corporation, Norton, MA, USA) was used to collect data from the two thermocouples. 
The heat source was driven at 6 Watts. 
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Figure 3.21 Experimental setup of thermal properties measurement 
 
Theoretical calculation assuming the test specimens have no heat exchange with 
surrounding environment and the thickness of the heat source is zero, the measurement 
can be considered as the one-dimensional unsteady-state heat conduction problem in a 
semi-infinite solid (Carslaw & Jaeger 1959): 
𝑇(𝑥, 𝑡) =
𝑞
𝑘
[2√
𝛼𝑡
𝜋
exp (−
𝑥2
4𝛼𝑡
) − 𝑥𝑒𝑟𝑓𝑐 (
𝑥
√4𝛼𝑡
)]                        (3.6) 
where 𝑇 = 𝑇(𝑥, 𝑡)  is the temperature change during time t, 𝛼  denotes the thermal 
diffusivity, k represents the thermal conductivity, and q is the imposed constant heat flux. 
In the case of the step-wise method, q is given as: 
𝑞 = {
0(𝑡 = 0)
𝐼2𝑅
2𝐴
(𝑡 > 0)
                                                          (3.7) 
where I is the electric current, R is the resistance of the heat source, and A is the area of 
the heat source. 𝑒𝑟𝑓𝑐(𝑥) is the complementary error function, defined as: 
𝑒𝑟𝑓𝑐(𝑥) = 1 −
2
√𝜋
∫ 𝑒−𝑡
2
𝑑𝑡
𝑥
0
                                          (3.8) 
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Therefore, for the following equation: 
𝑘 = 𝜌 ∙ 𝛼 ∙ 𝑐                                                            (3.9) 
where ρ is the density of the sample, the required thermal parameters in equation 3.6, α 
(thermal diffusivity) and c (specific heat capacity) can be estimated simultaneously using 
the curve fitting method by MATLAB (The MathWorks, Inc., Natick, MA, USA). The 
thermal conductivity (k) can then be calculated from equation 3.9. 
3.4.3. Elasticity test 
Phantoms manufactured from these TMMs provide tissue substitutes in ultrasound 
and elastography research by simulating normal and diseased tissues. Young’s modulus 
is an important parameter for elastography phantoms. Two methods were used here, shear 
wave elastography machine and mechanical compression test to measure the elastic 
properties of samples made of TMMs. 
3.4.3.1 Young’s modulus measurement using the Aixplorer 
ShearWaveTM elastography, is a quantitative method for imaging the elasticity of 
biological tissues. It is capable of providing quantitative result by displaying a colour 
coded image superimposed on a B-mode image (Bercoff et al. 2004; Bercoff et al. 2008). 
Supersonic Imagine Aixplorer® (SuperSonic Imagine, Aix-en-Provence, France) is the 
machine that uses shear wave velocity to estimate the stiffness of the TMMs in this study. 
To display the elasticity result on the screen of the system, transient shear waves are 
produced and captured using the Supersonic Shear Imaging method (Bercoff et al. 2004). 
The measurement can be carried out in the phantom container described in Figure 
3.15, as it includes the TMMs inside and provides a probe opening for the imaging 
transducer. In Figure 3.22 the side view of the phantom container, the imaging transducer 
can scan the tumour phantom (blue rectangular) via the probe opening at the bottom of 
the container. 
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Figure 3.22 Schematic diagram showing placement of TMMs in agar background at 
different levels in relation to the imaging probe 
 
For the measurement using the Aixplorer machine, TMMs were prepared in 
different shapes to indicate different materials of the tumour phantom. The samples to be 
measured were placed into the phantom container, as shown in Figure 3.15, with 2% agar 
gel as the background, as this low concentration of agar is clear enough to observe the 
inclusions by eye to guide the insertion of the imaging probe of the Aixplorer machine 
into the probe opening on the phantom container. Cancer mimicking inclusions were 
implanted into the background phantom at different depths to investigate the effect of 
distance on the shear wave velocity measurement. 
Figure 3.23 is the elastography image of the tumour mimicking phantom acquired 
by the Aixplorer. The shear wave propagation speed in tissue or phantom was computed 
at each pixel and shown on the final speed map. The black and white B-scan image is on 
the bottom of this figure, while the shear wave elastography with a colour coded image 
superimposed on the B-mode image is displayed on the top. The colour bar on the top 
right indicates the elasticity value of the colour map. 
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Figure 3.23 Quantitative estimation of Young’s modulus in the TMM phantom using 
the Supersonic Imagine Aixplorer system 
 
3.4.3.2 Young’s modulus measurement by mechanical compression 
A mechanical compression test was used to measure the Young’s modulus using 
Tinius Olsen's line of Benchtop Materials Testing Machine (Tinius Olsen, Horsham, PA, 
USA) (Figure 3.24). The machine has two plates, one fixed on the base, the other on the 
column is connected to a force sensor and move up and down to stretch and compress the 
samples. The force change is measured by the force sensor in real time. The relation of 
stress-strain can be acquired and then applied to deduce the Young’s modulus of the 
samples using a quasi-static measurement. 
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Figure 3.24 Benchtop Materials Testing Machine 
 
A 5000 N load sensor (force accuracy: ± 0.5% of the indicated load) was applied 
to provide mechanical compression force to the sample. TMMs were fabricated in 
cylindrical samples with two parallel surfaces. To minimize the effects of the interface 
friction and the dehydration of the samples, the samples were dipped in water before the 
compression experiment. For the measurement, samples were placed onto the low plate 
of the testing machine. Full contact was needed between the top testing plate and the 
sample surface, and the compression was then applied after a 1 N to 2 N preload. The 
lower plate was fixed while the top one was moved downward at a rate of 0.5 mm/min 
(speed accuracy: ± 0.005% of set speed). A 2 mm quasi-static displacement was applied 
and a plot of force-displacement relationship was obtained using QMat Professional 
software (Tinius Olsen, Horsham, PA, USA), thus calculated a stress-strain relationship. 
With the known constant parameters of the area and the thickness of the samples, the 
Young’s modulus was obtained by: 
𝐸 =
𝜎
𝜀
=
𝐹/𝐴0
∆𝐿/𝐿0
                                                             (3.10) 
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where: 
E is the Young's modulus (modulus of elasticity); 
𝜎 is the stress; 
𝜀 is the strain; 
F is the force exerted on an object under tension; 
A0 is the original cross-sectional area through which the force is applied; 
ΔL is the amount by which the length of the object changes; 
L0 is the original length of the sample. 
3.4.4. HIFU sonication test 
Even if the TMMs possessed similar acoustic, thermal and elastic properties to the 
human or animal tissues, this does not prove that these materials are suitable as a focal 
target for HIFU sonication. In fact, agar and PVA both have low melting temperatures 
and could melt during the sonication. The PAA egg white phantom not only has similar 
acoustic properties to tissues, it can also provide visualisation of lesions of HIFU 
sonication due to protein denaturation. DQA gel as a commercial phantom has the 
capability of reuse as the target phantom for HIFU sonication. 
The work in this section was designed to determine the best phantom as the target 
in the HIFU sonication through ribcage. For this purpose, HIFU sonications were 
performed on DQA gel phantom and PAA egg white phantom and the size of the lesions 
on these two phantoms caused by HIFU was investigated. 
The PAA egg white phantom was fabricated following the procedures described 
in section 3.3. It was made into a 135 mm × 90 mm × 35 mm cuboid for better 
visualisation of the sonicated lesions. A transducer made in house using PZ26 (Ferroperm 
Piezoceramics A/S, Kvistgaard, Denmark) piezo-material, was used to perform the HIFU 
sonication on PAA egg white phantom. The parameters of the transducer is summarised 
in Table 3.2. 
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Table 3.2 Transducer parameters 
Parameters Value 
Frequency 1.107 MHz 
Diameter 64 mm 
Focal length 63 mm 
 
It was driven by the waveform/function generator (33220A, Agilent, Santa Clara, 
CA, USA) and the output was amplified by the power amplifier (1020L RF Amplifier, 
Electronics & Innovation, Ltd., Rochester, NY, USA). Continuous wave mode and pulse 
wave mode were applied to drive the transducer. The continuous wave cannot be used for 
long to prevent the transducer from damage by overheating. The pulse mode can extend 
the overall time by allowing some rest time during the HIFU application. For the pulse 
mode, the duty cycle determines the percentage of time of the sonication. The burst period 
indicated the overall time of one burst including the sonication time and the resting time. 
Different duty cycle (50% and 70%) and burst period (in the range of 90.90 μs and 
129.86 μs) were applied in the sonication on PAA egg white phantom. 
Another PAA egg white phantom was produced for the sonication using ExAblate 
2000 system (InSightec, Tirat Carmel, Haifa, Israel) using 60 W acoustic power and 30 s 
sonication time. Nine sonications were applied on the phantom. The ExAblate system is 
compatible with MRI and the phantom was imaged in a GE Signa HDxt 1.5T scanner 
(GE Healthcare, Waukesha, WI, USA), which was also used for temperature 
measurement. The MRI thermometry applied proton resonance frequency (PRF) shift, 
which based on the fact that the water proton resonance frequency changes with 
temperature and such change can be calculated from the phase of the gradient echo image 
(Ishihara et al. 1995). 
DQA gel phantom was sonicated by ExAblate 2000 system using 50 W acoustic 
power over different times ranged from 20 s to 60 s. At minimum of 3 sonications were 
applied at each duration time. Because the DQA gel phantom can re-solidify after an 
enough cooling time, the lesion resulted from HIFU can only be measured during the 
sonication. MRI thermometry provided monitoring of the focal temperature and was used 
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to depict the size of the focus on thermometry images according to the threshold of a 
selected temperature value. 
3.4.5. Results and discussion 
3.4.5.1 Acoustic properties test 
In terms of TMMs for imaging, the acoustic properties measured using 4.8 MHz 
are summarised in Table 3.3, including agar of different concentrations along with Al2O3, 
polyacrylamide, polyacrylamide mixed with Al2O3 and silicone. 
 
Table 3.3 Acoustic velocity, density, impedance and attenuation coefficient of TMMs at 
4.8 MHz (at room temperature 20 °C) 
Phantom 
Acoustic velocity 
(m/s) 
Density 
(103 kg/m3) 
Impedance 
(Mrayl) 
Attenuation 
coefficient 
(dB/cm/MHz) 
2% agar+1%Al2O3 1519±49 1.02±0.02 1.55±0.05 0.78±0.04 
3% agar+1%Al2O3 1522±40 1.03±0.03 1.57±0.07 0.61±0.04 
4% agar+1%Al2O3 1535±42 1.05±0.01 1.61±0.03 0.62±0.03 
5% agar+1%Al2O3 1528±57 1.06±0.02 1.59±0.08 0.50±0.03 
PAA 1469±20 0.96±0.05 1.42±0.06 0.26±0.04 
PAA+2%Al2O3 1472±32 1.01±0.03 1.49±0.05 0.70±0.04 
Silicone 1188±39 0.98±0.03 1.15±0.08 4.09±0.44 
 
For the materials used in HIFU sonication experiment, including DQA gel 
phantom, PVA phantom and ABS material, a lower frequency was applied in the acoustic 
properties measurement, because the frequency of operating HIFU transducer was around 
1 MHz. The lowest working frequency of ultrasonic transducers SLIH2-10 (Sonatest, 
Milton Keynes, UK) for properties measurement in our laboratory worked at 2 MHz. Its 
frequency can reach as low as 1.5 MHz. Thus, 1.5 MHz to 2.0 MHz was selected as the 
range of this measurement. The density of the DQA phantom was 1048.92 kg/m3. Results 
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of acoustic properties of DQA gel phantom, including the speed of sound and acoustic 
attenuation coefficient, and their variation with frequency are depicted in Figure 3.25. 
The speed of sound ranged from 1495.2 ± 35.33 m/s to 1497.3 ± 46.83 m/s within the 
investigation frequency range of 1.5 MHz to 2.0 MHz. The acoustic attenuation increased 
when applying higher frequency in the measurement. 
 
  
Figure 3.25 Acoustic properties of DQA gel phantom (a. Speed of sound; b. Attenuation 
coefficient) 
 
In terms of the PVA gel phantom, the frequency range of 1.5 MHz to 2.0 MHz 
was applied in the measurement of its acoustic properties. The PVA phantom has the 
density of 1050.00 kg/m3. Results of acoustic properties of PVA gel phantom, including 
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the speed of sound and acoustic attenuation coefficient, and their variation with frequency 
are displayed in Figure 3.26. The acoustic attenuation coefficient rose in general when 
increasing the measurement frequency. 
 
  
Figure 3.26 Acoustic properties of PVA gel phantom (a. Speed of sound; b. Attenuation 
coefficient) 
 
As mentioned in section 2.4.2, a wide range of sound speed was found in the 
previous measurement results. The average value was 1576 m/s in the range of 1478 m/s 
in fat and 1595 m/s in liver (Table 2.3). PVA, PAA or agar materials are all capable of 
mimicking the soft tissues. The only disadvantage of PVA was that its attenuation 
coefficient was found lower than that in soft tissues. 
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In terms of the ABS material for the ribcage model, the density of it was 
767.5 kg/m3, and the speed of ultrasound in ABS was 1717 ± 63 m/s. The ultrasound 
attenuation coefficient of ABS was 46.2 ± 2.6 dB/cm/MHz measured at 2 MHz. 
According to acoustic properties in Table 2.3, the acoustic properties of ABS material 
were within the range of bone acoustic properties and ABS was able to be the substitute 
material of ribcage. 
3.4.5.2 Thermal properties test 
Figure 3.27 shows the temperature rise acquired in the experiment (blue dots) and 
by the curve fitting (red dots). The thermal properties of TMMs were summarised in Table 
3.4. The thermal diffusivity and specific heat capacity of the TMMs were determined by 
curve fitting according to the experimental data. Both of the two parameters descend 
within the agar concentration ranged from 2% to 5%. The thermal conductivity, which 
was calculated from the previously measured parameters and the density of the material, 
also decreases with the agar concentration. 
 
Figure 3.27 Temperature rise in heating period on 2% agar phantom (blue dots: raw data 
in the measurement; red dots: curve fitting results) 
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Table 3.4 Thermal properties of tissue mimicking materials 
TMMs 
Thermal conductivity 
k (W·m-1·°C -1) 
Thermal diffusivity 
α (m2·s-1) 
Specific heat capacity 
c (J·kg-1·°C-1) 
2% agar 0.74±0.05 (1.87±0.06)×10-7 3883.5±99.8 
3% agar 0.67±0.04 (1.81±0.03)×10-7 3627.3±83.9 
4% agar 0.51±0.07 (1.57±0.06)×10-7 3096.3±132.5 
5% agar 0.43±0.05 (1.39±0.05)×10-7 2999.0±109.2 
DQA 0.62±0.03 (1.51±0.05)×10-7 3886.3±101.3 
 
According to the range of thermal properties in soft tissues summarised in Table 
2.6, all of the selected materials were qualified to mimic soft tissues in HIFU sonication 
experiment. 
Errors do exist in the measurement reported here. The problems of the step-wise 
transient method mainly result from differences between the ideal model and the real 
experimental setup (Gao et al. 2012). The size of the sample was limited rather than 
geometrically non-limited size in the ideal model. The sample was assumed to have no 
heat exchange with the surrounding environment, but the experiment was performed in 
not vacuum. The thickness of the heat source, the heat capacity of the thermocouple and 
the mass of the thermocouple are negligible in the ideal model. Finally, in the ideal model, 
the heat source was considered to possess the equivalent thermal properties to the sample. 
This cannot be achieved in this experiment. 
3.4.5.3 Elasticity test 
3.4.5.3.1 Shear wave measurements 
Stiffness quantification of the TMMs using shear wave imaging provided 
estimated Young’s modulus values of 86.2 ± 4.5 kPa for PAA mixed with 2% Al2O3 
particles and 271.5 ± 25.7 kPa for silicone respectively. The results for the different 
TMMs are listed in Table 3.5. 
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Table 3.5 Effect of depth on cancer mimicking phantom elasticity and width 
measurement 
Phantom Depth (±0.5 mm) 
Young’s modulus 
(kPa) 
Measured width 
(±0.5 mm) 
PAA+2%Al2O3 
64.0 84.6±26.8 NA 
52.4 93.8±4.4 11.5 
43.8 78.9±5.8 14.6 
36.6 86.2±4.5 16.5 
Silicone 30.6 271.5±25.7 NA 
 
PAA with a 2% Al2O3 concentration in an 18.5 mm width cubic shape was utilised 
to merge into agar background to investigate the effect of depth on the target. Distance 
between pixels on the colour coded image (Figure 3.23) can be measured using ‘Meas. 
Tools’ of the Aixplorer system. No clear trend was observed in the mean values of the 
Young's modulus values obtained at different depths. However the standard deviation of 
Young’s modulus demonstrated an increasing trend with depth. The measured width of 
the target phantom increased with a decrease of depth (Figure 3.28). At 64.0 mm depth, 
PAA with 2% Al2O3 phantom had higher standard deviation which reached ± 26.8 kPa 
but was similar to the standard deviation (SD) of silicone at 30.6 mm depth, ± 25.7 kPa. 
The standard deviations of the depth within 52.4 mm were all less than ± 5.8 kPa. The 
measured width of 16.5 mm at 36.6 mm distance approached to the real width value most 
compared with those at further depth. 
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Figure 3.28 Young’s Modulus and standard deviation of PAA with 2% Al2O3 measured 
by shear wave elastography at different depth 
 
The standard deviation of Young’s modulus measured using the Aixplorer was 
affected by the target depth. Measurements at larger depths about 64.0 mm showed low 
reliability with as large as ± 26.8 kPa standard deviation. The standard deviation was 
reduced for depths of 50 mm or less. The errors could be due to tissue attenuation at a 
higher depth. The cross section of the TM phantom inclusion interrogated by the system 
could also introduce some errors if surrounding background material is included in the 
measurements. However, the measurements up to a depth of 5 cm are fairly consistent 
with lower standard deviations. Measurements were performed using a transrectal 
transducer, where the ultrasound beams diverge with depth. This may also account for 
errors in the width measurements for shear wave images. Further research is needed to 
explore these factors in detail. 
3.4.5.3.2 Elasticity of phantoms using mechanical compression testing 
Using mechanical compression method, TMM phantoms showed a clear trend of 
higher Young’s Modulus with an increased agar concentrations for the same 1% Al2O3 
level as seen in Table 3.6. Silicone TMM had higher Young’s modulus values when 
compared with PAA with 2% Al2O3. The Young's modulus of silicone compared 
favourably with the stiffness value obtained with the 3% agar and 1% Al2O3 TMM. PAA 
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with 2% Al2O3 TMM had the smallest Young's modulus value of 104.3 ± 5.6 kPa and can 
be utilised to mimic prostate cancer especially for quasi-static elastography at a 2% pre-
compression level (Krouskop et al. 1998), while TMM utilizing an appropriate 
concentration between 2 - 3% can produce TMMs to mimic tumour at a 4% pre-
compression level (Krouskop et al. 1998). 
 
Table 3.6 Young’s modulus results of TMM phantoms from Mechanical compression 
test 
Phantom Young’s modulus (kPa) 
2% agar + 1% Al2O3 157.8±9.2 
3% agar + 1% Al2O3 299.4±7.1 
4% agar + 1% Al2O3 331.8±8.8 
5% agar + 1% Al2O3 443.0±11.3 
PAA+2% Al2O3 104.3±5.6 
Silicone 297.3±6.7 
 
A comparison between the Young’s modulus measurements obtained using shear 
wave elastography from the Aixplorer and using mechanical compression testing is 
summarised in Figure 3.29. In general, quasi-static mechanical testing provided higher 
values of Young’s modulus for the same TMM. 
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Figure 3.29 Comparison of the Young’s modulus values obtained by tracking the shear 
waves using the Supersonic Imagine Aixplorer system and mechanical compression test 
 
As stated in Table 2.8, the Young’s Modulus range of tumour tissues was between 
30.1 kPa to 221 kPa. Amongst the phantom materials, PAA with 2% Al2O3 possessed 
Young’s modulus values closer to human prostate and liver tumours. Silicone used for 
tumour mimicking materials can be distinguished in elasticity images, but the stiffness of 
silicone was almost three times higher than Young’s modulus of prostate cancer and much 
higher than that of liver cancerous tissue. What is more, the ultrasound velocity in silicone 
was lower than that in human tissues which could result in unrealistic refraction at the 
boundary of a simulated cancer phantom. Therefore, PAA with 2% Al2O3 provided the 
best fit to mimic tumour tissues. 
A limitation of this study is related to the desiccation of the TMMs samples. The 
elastic properties of TMMs are time and moisture dependent. The samples were wrapped 
with cling film and stored in refrigerator to reduce desiccation and they were coated with 
water or gel to minimize the dehydration during the mechanical compression test. 
3.4.5.4 HIFU sonication test 
The HIFU has a cigar-shaped focal volume and creates elliptical lesions within 
the tissue or phantom. The size of the focal lesion can be represented by the length of the 
lesion and the diameter of its ellipsoid cross section. In Figure 3.30(a), lesions of the 
protein denaturation located within the phantom are obvious. The numbers on this figure 
indicate the sequence of the sonication as listed in the first column of Table 3.7. The 
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yellow circle in Figure 3.30(b) shows the longitudinal section of lesion 1 acquired by 
SonixTablet (ULTRASONIX, British Columbia, Canada). The diameter and length of the 
lesions on the PAA egg white phantom caused by single element HIFU transducer are 
reported in Table 3.7. The parameters of each sonication, input power, sonication time, 
and duty cycle, are included in the table. 
 
 
Figure 3.30 Lesions on PAA egg white phantom (a. 12 lesions on the phantom; b. 
longitudinal section of lesion 1 indicated by the yellow circle) 
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Table 3.7 Parameters of HIFU and size of lesions on PAA egg white phantom induced 
by HIFU (1 to 5 used continuous wave; 6 to 12 used pulse wave) 
No. 
Freq. 
(MHz) 
Input 
electric 
power (W) 
Duty 
cycle (%) 
Burst 
period 
(μs) 
Total 
time 
(min) 
Diameter 
(mm) 
Length 
(mm) 
1 1.107 40 NA NA 3 3.5 9 
2 1.107 40 NA NA 4 4 5.5 
3 1.107 40 NA NA 5 5 9 
4 1.107 40 NA NA 6 2.5 10 
5 1.107 40 NA NA 7 3 6 
6 1.107 40 50 90.90 8 5 13 
7 1.107 40 50 127.26 8 6 13 
8 1.107 40 70 90.90 8 7 10 
9 1.107 50 70 90.90 8 7 15 
10 1.107 40 70 129.86 8 6 14 
11 1.107 50 70 129.86 8 7 16 
12 1.107 50 70 129.86 15 8 21 
 
Dimensions were found not closely related to the energy applied. For lesion 1 to 
5 using 40 W input power, the lesion size did not expand (either in diameter or length) 
related to the increase of sonication time. Using the same input power (40 W) and burst 
period (90.90 μs), lesion 8 generated by a higher duty cycle 70% was bigger in diameter 
but smaller in length than lesion 6 produced by 50% duty cycle. There was no obvious 
trend in the changes of lesion size from increasing the duty cycle or sonication time. These 
could be explained by the inhomogeneity of the PAA egg white phantom. The egg white 
was difficult homogeneous to be mixed with the polyacrylamide. 
In the sonication on PAA egg white phantom using the ExAblate 2000, 60 W 
acoustic power and 30 s duration time was used in every sonication. The thermometry 
images were utilised to evaluate the lesion size by colouring the focal region above 50 °C 
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(baseline temperature of the system was body temperature 37 °C). These images were 
acquired after each single sonication. The red area within the blue rectangular on each 
subfigure of Figure 3.31 indicates the focal lesion. The blue rectangular was the planned 
focus location. There were only three lesions (sonication No. 1, 6, 8) producing obvious 
protein necrosis (lesion turned white). These three focal lesions appear a larger area 
compared with the other sonications as shown in Figure 3.31. Some sonications caused a 
very small lesion area that over 50 °C, such as lesion 4 and lesion 7. This also proved that 
the PAA egg white phantom could be inhomogeneous. 
 
 
Figure 3.31 Focal lesion over 50 °C using 60 W acoustic power for 30 s on PAA egg 
white phantom acquired by MRI thermometry using ExAblate 2000 system (the number 
on each subfigure is the sonication number; red area indicates the focal region over 
50 °C; blue rectangular represents the planned location of the focus) 
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For the sonications on DQA gel phantom using ExAblate 2000 system, the lesion 
size was also estimated by colouring the focal region over 50 °C (system baseline 
temperature was 37 °C). All the sonications applied constant a 50 W acoustic power but 
over different times in the range of 20 s to 60 s. Longer sonication times resulted in a 
larger lesion as shown in Figure 3.32. Lengths and diameters of the lesions are listed in 
Table 3.8. It is noticeable that the dimension of the focal lesion increased with the time 
of sonication, which suggests that the DQA gel phantom is more suitable as a target 
phantom in HIFU sonication. 
 
 
Figure 3.32 Focal lesion over 50 °C using 50 W acoustic power over different times 
ranged from 20 s to 60 s on DQA gel phantom acquired by MRI thermometry using 
ExAblate 2000 system (red area indicates the focal region over 50 °C; blue rectangular 
represents the planned location of the focus) 
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Table 3.8 Length and diameter of focal lesion on DQA gel phantom using 50 W 
acoustic power sonicated by ExAblate 2000 (lesion pattern over 50 °C) 
Time (s) Length (±0.05mm) Diameter (±0.05mm) 
 14.3 2.6 
20 15.9 2.8 
 16.7 2.9 
 29.5 4.9 
30 30.1 4.8 
 28.6 5.1 
 33.4 5.6 
40 32.5 5.5 
 33.0 5.6 
 40.1 6.5 
50 34.4 6.4 
 35.2 5.8 
 44.3 7.0 
60 40.1 6.9 
 37.6 6.3 
 
3.4.5.5 Determination of the best materials 
The measurements of acoustic and thermal properties of optional TMMs showed 
similar results to soft tissues. The acoustic attenuation coefficient of PVA is a 
disadvantage for this material as ribcage surrounding tissues, but this did not affect the 
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accuracy of imaging or location of HIFU focus. For a phantom block with a ribcage model 
inside, PAA gel is highly toxic and expensive to make phantom in this size for long-term 
usage. Agar gel is more easily broken because of the segmentation by the ribcage model. 
PVA is non-toxic during the fabrication and the utilization, has long-term stability, and is 
elastic and strong enough to include the ribcage inside. Considering its benefits, PVA is 
determined as the best material for fabricating the surrounding tissue of ribcage. ABS was 
selected be the substitute material of ribcage. To mimic tumour for elastography, PAA 
with 2% Al2O3 was chosen, as it possessed Young’s Modulus close to tumour tissues and 
was easily identified by elastography. DQA phantom was the best material for target 
phantom in HIFU sonication experiment, because it matched the acoustic and thermal 
properties and showed a proportional dimension change of lesion to acoustic energy. 
Table 3.9 shows the applications and main advantages of the selected TMMs. 
 
Table 3.9 Applications and advantages of selected TMMs 
TMMs Applications Advantages 
PVA 
Ribcage surrounding 
tissue 
Non-toxic, long-term stability, capable 
of embedding ribcage model inside 
ABS Ribcage Strong and stable over time 
PAA+2%Al2O3 Tumour Easily identified by elastography 
DQA HIFU sonication target 
Lesion dimension closely related to 
acoustic energy 
 
3.5. Summary 
A physical ribcage model was proposed in this study to investigate the effect of 
ribcage on HIFU treatment and help to determine the sonication parameters and optimise 
the treatment protocols. To mimic the human anatomical features and structures, the 3D 
modelling and rapid prototyping technique have been developed based on patient images. 
This is a fast, accurate and reproducible technique, and the reconstructed models could 
be used for pre-treatment planning. In this technique, image processing was used to 
extract the contour of the region of interest from raw image data. A computer generated 
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3D model was reconstructed base on this contour using Simpleware. Finally, a physical 
3D ribcage model was produced on the prototyping machine. This may take up to one 
day. 
The fabrication and characterisation of different tissue mimicking materials have 
been performed in order to determine the best materials for phantoms used in the HIFU 
sonication or diagnostic imaging. The acoustic properties, elastic properties and thermal 
properties have been investigated. PVA was found the best suitable material for 
surrounding tissue and ABS was used for the ribcage. The optimal TMM to mimic the 
tumour for elastography was PAA with 2% Al2O3. This provided useful information to 
create TMM phantom in the diagnostic stage and pre-surgical planning stage for 
mimicking the anatomical structures and features of the patients. HIFU sonications can 
be performed in the planning stage using the TMM phantom and sonication parameters 
that would be used in the treatment can be verified and further optimised. 
In terms of the TMMs used for HIFU sonication, PVA and agar both possess low 
melting temperatures, and agar gel with low concentration is easily damaged. PAA 
material is highly toxic and not suitable for routine use. Lesions created by HIFU on PAA 
egg white phantom appear no obvious trend in the changes of lesion size by increasing 
the duty cycle or sonication time. However, results of the sonication on DQA gel phantom 
show a proportional size change in the lesion induced by HIFU sonication. The DQA 
phantom is non-toxic and can be reusable. Therefore, the DQA gel phantom was 
determined to be the target phantom in the HIFU sonication through ribcage in the 
following study. 
It should be noted that the physical model of any abdominal organs, such as liver 
and kidney, are not used in the further studies on HIFU sonication experiments. The 
propagation of ultrasound is determined more by the properties of the medium than by 
the shape of it. The priority of the present work is not to study the effect of the organ 
shape, but to investigate the effect of ribcage on HIFU treatment. Therefore, a DQA gel 
phantom with similar properties to human tissues in a simple cone shape is used as the 
target phantom in the following experiment. However, details of the reconstruction of 
human organs were still described in section 3.2 for future applications.  
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Chapter 4 Effect of Ribcage on 
Focused Ultrasound Field 
As a non-invasive treatment, it is necessary to ensure the acoustic energy being 
delivered at the correct level and deposited to the accurate location in tissue ablation using 
HIFU. However, considering the differences in the anatomical structures among patients, 
a constant protocol of HIFU treatment could not be applicable to different wave 
propagation circumstances. Applying the same acoustic energy on varied patient may 
cause insufficient heat deposition at focus or potential risk of overheating. Ribcage, as 
one of the barriers in the focused ultrasound beam path in the treatment of liver and kidney 
diseases, decreased the focal temperature elevation by affecting the ultrasound wave 
propagation. Patient-specific treatment plan of HIFU through ribs is yet to be investigated. 
To study the influence of the ribcage in focused ultrasound field, it is more efficient to 
use an alternative model that possesses human anatomical structures in the planning and 
verifying stage of HIFU treatment. In this study, it has used four different ribcage models 
based on CT scan image data from four patients to find out how they affected the delivery 
of HIFU energy. 
This chapter describes the characterisation of HIFU device and the quantification 
of the effect of ribcage on focused ultrasound field. Before placing the ribcage in focused 
ultrasound beam path, the features of focused ultrasound field were characterised in free 
field, including acoustic pressure distribution, acoustic power and focal temperature (on 
TMM phantom). Subsequently, the experiments with the ribcage in the ultrasound beam 
path are presented. Basic effects on the ultrasound field are described in section 4.1 to 4.3, 
including the acoustic pressure distribution, acoustic power delivery and heat deposition 
at focal region. To study the complicated situations in the HIFU treatment, further details 
of HIFU sonication with the ribcage model are illustrated in section 4.4, including varying 
acoustic power and sonication time, applying sonication at different focal distance, and 
changing the location of the ribcage model. Image guidance and temperature 
measurement have been taken into consideration during the sonication. It should be noted 
that the ablation of each focal volume of the tissue or phantom is described as a sonication 
in this study. 
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4.1. Effect on acoustic pressure distribution 
Acoustic pressure is the local pressure deviation from the ambient atmospheric 
pressure caused by a sound wave. A map of the acoustic pressure distribution of a focused 
ultrasound field can provide a visualised profile of the ultrasound beam. Region of the 
damaged tissue induced by focused ultrasound therefore could be predicted according to 
the ultrasound beam profile. Changes in focal area affected by ribcage in the beam path 
can also be visualised by comparing with the focused beam in free field. 
Acoustic pressure distribution mapping was acquired using a needle hydrophone 
based scanning system. A high resolution 3D scanning system (Cao et al. 2012) was used 
to drive the hydrophone in the acoustic field. The entire setup consisted of a motor 
controller and automated 3D stages capable of moving in three orthogonal directions with 
3.8 µm resolution as the positioning unit (Figure 4.1). 
 
 
Figure 4.1 Scanning tank for acoustic field mapping 
 
A homemade single element HIFU transducer (parameters are listed in Table 3.2) 
was used to generate the acoustic field with continuous sine wave using 5 Vpp input from 
a waveform/function generator (33220A, Agilent, Santa Clara, CA, USA). To maximize 
the range of the scanning field, the transducer was located and fixed at the central bottom 
of a water tank (47 cm × 41 cm × 30 cm) with piezoelectric material facing up. Output 
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signal of the transducer was recorded by a needle hydrophone (0.5 mm diameter probe 
with 9 µm thick gold electroded polyvinylidene fluoride (PVdF) film, Precision 
Acoustics, Dorchester, Dorset, UK), which was faced to the transducer and mounted on 
and moved by the 3D stages. A piece of acoustic absorber material (approximate 10 mm) 
was placed about 20 mm behind the needle hydrophone to reduce the multipath artefact. 
Figure 4.2 depicts the schematic diagram of the acoustic pressure field scanning. 
 
 
Figure 4.2 Schematic diagram of acoustic field scanning setup in the water tank 
 
PicoScope 4262 (Pico Technology, St Neots, Cambridgeshire, UK) was 
connected to the needle hydrophone through the signal output of a DC coupler (DCPS160, 
Precision Acoustics, Dorchester, Dorset, UK) for data acquisition. A computer with 
LabVIEW program (National Instruments, Austin, TX, USA) controlled the motion of 
the 3D stages and data acquisition unit. The 3D acoustic scanning was carried out in 
degassed water environment. As water possesses similar acoustic properties to tissue and 
TMMs, it can be used to characterise the acoustic properties when the measurement in a 
phantom is difficult to approach. Measurement was performed at lower output level than 
that used for clinical therapy to avoid damaging the hydrophone. The scanning resolution 
was set to 0.2 mm for accurate acoustic field mapping. 
To investigate the acoustic pressure field with the presence of ribcage model, a 
model was placed in the focused ultrasound beam path, orthogonal to the acoustic 
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propagation axis. The ribcage model was fixed on the same holder for the transducer to 
keep a constant distance between transducer and ribcage (approximate 20 mm). 
Transcostal and intercostal propagation was studied respectively. A piece of ribs was 
placed in the central front position of the transducer (with the rib on the axis of the 
ultrasound beam) (Figure 4.3(a)) for transcostal position. Ultrasound wave propagated 
through both sides of the central rib in this setup. Figure 4.3(b) depicts the ribcage model 
placing with two pieces of ribs above the transducer leaving the axis of the transducer off 
the ribs. 
 
 
 
Figure 4.3 Setup of acoustic field mapping. (a) transcostal position; (b) intercostal 
position (pictures were captured without needle hydrophone in the field) 
 
4.2. Effect on acoustic power delivery 
Acoustic power has a direct relation to the dose applied to patients in HIFU 
treatment. The input electric power of the focused ultrasound transducer is converted to 
output acoustic power and then be delivered to diseased target tissue to create local 
heating and tissue damaging. 
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To achieve an effective and safe HIFU ablation, acoustic power was required to 
be determined in the planning stage of a customized treatment. This section reports the 
experimental methods for measurement of the acoustic power generated by a homemade 
HIFU transducer. The power conversion ratio of acoustic power and electric power of 
this HIFU transducer is also included. 
Radiation force balance (RFB) is the most commonly used measurement method 
to determine the acoustic power. The acoustic power is acquired by measuring the 
radiation force experienced by a target, normally a piece of acoustic absorber. For an 
ultrasound wave perpendicular to the target, the momentum of the ultrasound is 
transferred to the target, resulting in a force. This force is measured by a change in mass 
using an analytical balance. The total acoustic power Pvert corresponding to the vertical 
component of radiation force is related to the mass reading on the balance, mrad, and 
calculated by equation 4.1. 
𝑃𝑣𝑒𝑟𝑡 = 𝑚𝑟𝑎𝑑 ∙ 𝑣𝑤 ∙ 𝑔 ∙ 𝐹𝑎                                                (4.1) 
where: 
𝑣𝑤: speed of sound in water 
𝑔: gravitational acceleration 
𝐹𝑎: calibration factor for absorbing target (0.99 for this device according to the calibration 
certificate provided by Precision Acoustics) 
In the current study, the homemade HIFU transducer (parameters are listed in 
Table 3.2) was driven by waveform/function generator (33220A, Agilent, Santa Clara, 
CA, USA) and amplified by a power amplifier (1020L RF Amplifier, Electronics & 
Innovation, Ltd., Rochester, NY, USA). The RFB (Precision Acoustics, Dorchester, 
Dorset, UK) used in this measurement is able to determine total ultrasonic power radiated 
in the forward direction from transducers operating in the frequency range 1 to 10 MHz. 
Figure 4.4 describes the schematic diagram of the acoustic power measurement. 
The RFB measurement system included a force balance with a serial interface placed on 
the plexiglass plinth, an anechoic absorber target placing into a water container, and four 
supporting wires for connecting the balance and the absorber target. The transducer to be 
measured was held by a clamp to ensure that the piezoelectric material surface of the 
transducer was fully immersed into the water and positioned centrally above and parallel 
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to the absorber. To eliminate the possibility of cavitation, measurements were performed 
in freshly degassed and distilled water. Because the force balance is extremely sensitive, 
the RFB setup was placed on the optical table and a draught shield was used to cover the 
whole setup to reduce the effect of vibration and air flow in the lab. The measurement 
data was transferred to a computer via serial communication for calculating the results 
according to equation 4.1. 
 
 
Figure 4.4 Schematic diagram of acoustic power measurement 
 
Input electric power of the HIFU transducer ranged from 10 W to 50 W (10 W per 
step). The power conversion ratio of acoustic power and electric power was calculated at 
each power level using the detected acoustic power divided by the input electric power. 
Cooling time was required between two power-on times to avoid damaging the acoustic 
absorber or giving rise to transducer overheating during the measurement. 
After measuring the acoustic power in free field, effect of ribcage on acoustic 
power delivery was investigated. Power conversion ratio was used to describe the 
acoustic power converted from the electric power by the transducer. The acoustic power 
produced by the transducer did not change even if the ribcage in place. In order to evaluate 
the effect of ribcage model on energy delivery in the acoustic field, the RFB was used to 
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measure the force experienced by the absorber target in the HIFU field with the presence 
of ribcage model. As this result was related to the acoustic energy affected by the ribcage 
model, the measured force was used to calculate the power conversion ratio. The ratio 
was calculated using the measured acoustic power by the RFB with the ribcage models 
in ultrasound field divided by the input electric power of the transducer. 
To study the effect of ribcage, the ribcage model was placed in the beam path of 
the transducer and above the absorber target (Figure 4.5). Distance from transducer to the 
surface of the absorber target was set to 25 mm which allowed placing the ribcage model 
in the beam path. Both transcostal and intercostal propagation was investigated using all 
of the four ribcage models. For the transcostal position, the model was placed above the 
absorber target approximately 10 mm away to the transducer, with the axis of the HIFU 
transducer on a rib. In terms of the intercostal propagation, two ribs placing in the beam 
path allowing the axis of the transducer in the intercostal space. The acoustic power 
calculated from the measured force was considered to be related to the energy deposition 
at focus affected by the ribcage model. Different input electric powers ranged from 10 W 
to 50 W were applied to drive the transducer. 
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Figure 4.5 Acoustic power measurement with ribcage model in the beam path using 
RFB 
 
4.3. Effect on heat deposition at focus 
Heat deposition in ultrasound field provides the temperature information at focal 
region and may be used to determine the therapeutic parameters. The most commonly 
used method to acquire the temperature map is to use thermal camera by non-contact 
measurement without affecting the temperature field. In order to obtain the heat 
deposition at focal region of a focused ultrasound field, the temperature field of the 
transverse focal plane was captured by focusing the beam on the surface of an object. 
Figure 4.6 depicts the schematic diagram of the temperature distribution mapping. 
The aim was to focus the beam on a smooth surface of a piece of agar phantom and 
capture the temperature field from the phantom surface. A 3D scanning system (Figure 
4.1) with a water tank and a thermal camera (thermoIMAGER TIM 160, Micro-Epsilon, 
Ortenburg, Germany) was used in this measurement. The thermal camera was fixed on 
the 3D stages above the water tank with image sensor facing down. A homemade HIFU 
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transducer (parameters are listed in Table 3.2) was positioned in the water tank with 
piezoelectric surface upwards to the water surface aligned with the thermal camera. The 
depth of the transducer in the water was 5 mm shorter than the focal length. The phantom 
was placed in the tank with its top surface 5 mm out of the water to avoid focal heat 
diffusion by the water. This position ensured that the focus of the transducer was exactly 
located on the phantom upper surface. 
 
 
Figure 4.6 Schematic diagram of heat deposition measurement setup in a water tank 
 
Experiment was performed with and without the ribcage model using 24 W 
electric power over 10 s duration time at room temperature 20 °C. The temperature field 
map was captured by the thermal camera and recorded using TIM Connect software 
(Micro-Epsilon, Ortenburg, Germany) in real time. 
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4.4. Effect on focal temperature elevation 
The aim of the experiments in this section was to study the effect of ribcage model 
on focal temperature by performing HIFU sonication on TMM phantom with the model 
in ultrasound beam path. For this purpose, the experiments required image guidance to 
locate the focus, temperature measurement to monitor the focal temperature change, and 
mechanical device to accurately move the target or ribcage position. MRI is able to 
provide the image guidance and temperature measurement simultaneously. In order to 
implement the HIFU sonication experiments in MRI environment, both HIFU system (for 
sonication) and mechanical device (for moving target or ribcage) have to be MRI 
compatible. 
The experimental systems are described in section 4.4.1. In the rest of section 4.4, 
considering various situations in the HIFU treatment through ribcage, sonication 
experiments on phantom using various parameters at different locations were conducted 
to study the influence of the ribcage. The ribcage model of No.2 patient was selected in 
this experiment placing in the beam path, because the difference in ultrasound 
propagation between transcostal and intercostal position was found maximum using this 
model in all of the four models (results are stated in section 4.5.1 and 4.5.2). To study the 
ribcage effect at different positions, the phantom or ribcage model was moved accurately 
along axial or radial direction of the transducer by a robotic arm in MRI suite. Transcostal 
and intercostal propagation were both investigated and compared with the shadow area 
of the ribcage projected on the transducer. 
4.4.1. HIFU system and robotic assistance system 
HIFU platform used for providing sonication and robotic assistance system used 
for controlling the movement of phantom or ribcage locations are described in this section. 
4.4.1.1. HIFU system: ExAblate 2000 
ExAblate 2000 (InSightec, Tirat Carmel, Haifa, Israel) focused ultrasound system 
operates with 1.5 Tesla MR scanner (Signa HDxt 1.5T, GE Healthcare, Waukesha, WI, 
USA). This magnetic resonance-guided focused ultrasound surgery (MRgFUS) system 
integrates two well established technologies, focused ultrasound and MRI, to non-
invasively ablate targeted tissue lying within the body while sparing the surrounding 
98 
 
tissue. The MRI provides patient’s anatomy in the planning stage of the treatment and 
measures the temperature change inside the body/phantom during the HIFU treatment. 
With the temperature maps, physicians are aware of the extent of thermal ablation and 
will ensure safety and efficacy of the treatment. 
Figure 4.7 depicts the patient table of ExAblate 2000 which contains the focused 
ultrasound transducer embedded into the patient table along with the mechanical 
positioning unit that moves the transducer. The water circulation system is also included 
in the patient table for the transducer. Focused ultrasound propagates through a membrane 
located on top of the transducer. With MRgFUS, HIFU beam can be simulated and 
displayed on MR images before the treatment to ensure that the ultrasound wave travels 
through a safe pathway to the focus. 
ExAblate 2000 system possesses a phased array transducer and the phase of the 
sinusoidal signal produced by each element on this transducer can be adjusted 
independently with respect to the target position. This can benefit the HIFU sonication 
experiments at different focal distances and locations. Sonication parameters can be 
adjusted in planning stage according to the result of continuously temperature monitoring 
inside the tissue or phantom. 
 
99 
 
 
Figure 4.7 ExAblate 2000 system (a. Patient table; b. Focused ultrasound transducer and 
positioning and cooling system) 
 
ExAblate system provides a graphic user interface to perform the panning and the 
treatment. InSightec MR protocols, which have been pre-loaded into the GE Signa 
prorocol database, are used for the scanning before and during the treatment. Pelvic coil 
(InSightec, Tirat Carmel, Haifa, Israel) is used with ExAblate 2000 system in the 
following experiments in this chapter. After positioning the phantom and coil, an MRI 
3D localizer is scanned firstly to ensure that the phantom is properly positioned and there 
are no trapped air bubbles in the potential beam path. The MR images of the 3D localizer, 
meantime, provide the system with the position information of the transducer to 
determine its home position and orientation. A spin echo scan (TE 120.0, TR 2000.0) is 
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then automatically performed to obtain images to determine the region of treatment 
(ROT), skin line, beam path and etc. The ROT is defined via drawing it on the MR images. 
The system calculates the beam path according to its position and may deny a ROT if it 
is too close to the skin line. 
In Figure 4.8, the MR image shows a phantom placed on patient table of ExAblate 
2000 system with a HIFU transducer in the patient table underneath the phantom. The 
blue area indicates the ultrasonic beam path from the transducer to the target, which can 
be visualised in every slice of MR images within the beam path zone. Adjustment has to 
be made if there is unacceptable medium in the energy pass zone (e.g. air bubbles) for the 
selected ROT. Sonication parameters including acoustic power, sonication duration time, 
frequency and cooling duration time are determined afterwards. The frequency is selected 
as 1.15 MHz, which is the default working frequency of ExAblate 2000 system (The 
transducer can work at frequency in the range of 0.95 MHz to 1.35 MHz). 
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Figure 4.8 Planning stage on ExAblate system (blue area indicates the energy pass zone, 
which was generated from the transducer according to the ROT on the phantom) 
 
4.4.1.2. HIFU system: ExAblate 2100 
ExAblate 2100 system (also called CBS, Conformal Bone System, InSightec, 
Tirat Carmel, Haifa, Israel) is MRI compatible. Its patient table (Figure 4.9(a)) 
incorporates the focused ultrasound transducer (Figure 4.9(b)) along with the transducer’s 
water interface unit, including a water balloon created by a porous membrane that ensures 
sufficient acoustic coupling and straps that secure the transducer in place. The transducer 
has watermarks at entry and exit points of water hoses, which are used in the 3D localizer 
scan. The markers in the MR images help the system to calibrate the transducer’s home 
position and orientation. 
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The system provides a graphic user interface and MR protocols. An 8 channel 
body coil (GE Healthcare, Waukesha, WI, USA) is used with ExAblate 2100 system in 
the experiments in this chapter. A spin echo scan (TE 85.0, TR 1306.8) is used to obtain 
images and determine the ROT, beam path and etc. after a 3D localizer scan. The ROT is 
defined on the MR images and the beam pass zone is validated by the system according 
to the calibrated transducer location. It is necessary to check the beam path on every slice 
to ensure a safe ultrasound propagation. 
 
 
Figure 4.9 ExAblate 2100 system (a. Patient table; b. CBS transducer with the water 
balloon; c. Transducer before filling the balloon with water) 
 
Compared with ExAblate 2000, the ExAblate 2100 has a flexible transducer and 
enables more options to place the transducer in the experimental setup. The elements of 
the transducer is in 80 mm × 80 mm square and also has the capability to vary the location 
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of the focus by adjusting the phase of the sinusoidal signal of each element on the phased 
array transducer. This transducer operates at a lower frequency (0.55 MHz) than 
ExAblate 2000 system does, because it is originally designed for bone treatment. 
4.4.1.3. INNOMOTION robotic assistance system 
INNOMOTION robotic assistance system (IBSMM Engineering, spol. s. r.o., 
Brno, South Moravian Region, Czech Republic) can be assembled onto the patient table 
of ExAblate 2100 system working in MR environment. In Figure 4.10, the patient table 
of ExAblate 2100 with the robotic assistance system assembled is docked to the MR 
scanner. Front end of the robotic arm can be moved into the MR scanner by the patient 
table. This MRI-compatible robotic system is a pneumatically driven system with 5 
degrees of freedom. Its positioning accuracy is ± 1 mm in translational direction and ± 1° 
in angular direction. The front end of the robotic arm can hold the biopsy needle, as it 
was designed for needle biopsy research. In the current study, holder for phantom and 
ribcage model was produced, which can be mounted on to the robotic arm. The motion 
of phantom and ribcage model in MRI suite was driven by this robotic assistance system. 
 
 
Figure 4.10 Robotic assistance system assembled on ExAblate 2100 system patient 
table in front of the 1.5T MR scanner 
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4.4.2. Sonication on TMM phantom 
DQA phantom (ATS Laboratories, Bridgeport, CT, USA) was selected as the 
target to obtain the information of focal temperature elevation. A number of sonications 
were performed on DQA gel phantom to analyse its performance at focus in HIFU 
sonication using ExAblate 2000 system before applying the ribcage in the focused 
ultrasound beam path. As the DQA gel phantom can maintain steady acoustic properties 
after cooling down from heating effect by HIFU, results of the repetition experiment on 
this phantom are reliable. 
The DQA phantom, in a simple truncated cone shape (Figure 4.11, short diameter 
90 mm, long diameter 108 mm, height 130 mm), was located in a small water container 
positioned on the patient table of ExAblate 2000 system above the focused ultrasound 
transducer. The container was filled with distilled and degassed water for acoustic 
coupling and to minimize reflection at the surface of the phantom. The sonications lasted 
for 10 s, 20 s, 30 s, 40 s, 50 s and 60 s using a constant acoustic power 50 W at near, 
medium and far focal distance. Figure 4.11(b) indicates the location of the sonication 
spots on the DQA phantom. Six spots were selected with three different depth: spot 1 at 
focal distance 80 mm, spot 2 - 4 at 120 mm and spot 5 and 6 at 150 mm. A time interval 
of at least five minutes was allowed for cooling time of the phantom after each sonication. 
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Figure 4.11 Sonication spots located on DQA gel phantom (a. DQA gel phantom; b. 
Location of the focal spots) 
 
4.4.3. Varying parameters in HIFU sonication through ribcage 
This experiment was to investigate the effect of the ribcage in case of varying the 
sonication parameters, such as acoustic power and sonication time. For this purpose, a 
two-layer phantom was produced containing the ribcage model. The first layer was the 
ribcage model embedded into a cuboid PVA gel phantom (Figure 3.8(b)). The PVA gel 
mimicked the surrounding tissue of the ribcage. DQA gel phantom as the second layer 
was carefully placed onto the PVA phantom without any bubbles at interface to ensure 
continuous ultrasound coupling. The phantom in a container with degassed water was 
placed on to the patient table of ExAblate 2000 system above the HIFU transducer, as 
shown in the sagittal view of MR image Figure 4.12. Ultrasound wave propagated from 
the transducer passed through the first layer phantom and focused on the DQA phantom. 
A time interval of at least five minutes was allowed for the cooling time of the phantom 
after each sonication. Focal length was fixed in this experiment using varied acoustic 
power and sonication time. This experimental setup was used in every experiment section 
4.4.3. 
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Figure 4.12 Sagittal view of MR image of the two-layer phantom containing ribcage 
model on patient table of ExAblate 2000 system 
 
Using varied acoustic power 
This experiment was designed to investigate the ribcage effect on focal 
temperature elevation using different acoustic powers at a transcostal position. ExAblate 
2000 system combined with 1.5 Tesla MR scanner was applied to perform the sonications 
on the two-layer phantom and temperature measurement. Sonications applied a constant 
20 s duration time, but different acoustic powers (ranged from 25 W to 150 W, 25 W per 
step). 
Using varied sonication duration time 
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In order to estimate the influence of ribcage model using different sonication times, 
a constant 50 W acoustic power over varied sonication times (in the range of 10 s to 60 s, 
10 s per step) was used. 
Using constant acoustic energy 
This was to study the difference in focal temperature change between extending 
sonication time and increasing acoustic power when applying the same total acoustic 
energy in transcostal HIFU. Sonications were performed using totally six acoustic energy 
levels ranged from 500 J to 3000 J (500 J per step). At each energy level, a lower acoustic 
power over longer sonication time and a higher acoustic power over shorter sonication 
time was performed respectively. 
Control experiment 
Control experiment was designed to investigate the focal temperature elevation 
without the effect of ribcage model. A piece of pure PVA gel phantom was fabricated in 
the same thickness as the first layer of the two-layer phantom used in the previous 
experiments in section 4.4.3. The DQA gel phantom was placed on top of the pure PVA 
gel layer. This setup was to provide a similar wave propagation circumstance as the 
experiments with the ribcage model. Sonications also applied the same parameters to 
those experiments with ribcage model. 
4.4.4. Varying target phantom locations 
This section was to study the effect of ribcage model at different focal lengths. By 
fixing transducer and ribcage model, sonications were performed on DQA phantom 
whose position can be moved along the axis direction of the transducer. 
ExAblate 2100 system was used, as it has a flexible transducer. Compared with 
ExAblate 2000 system with a transducer embedded within the patient table, the flexible 
transducer provides more positioning options in the experimental setup. 
In Figure 4.13, the computer generated models depict the HIFU sonication using 
different focal distances. Both of the transducer and the ribcage model were at a fixed 
position and the phantom was moved by the MRI compatible INNOMOTION robotic 
assistance arm. The ultrasound wave produced by the transducer focused on the phantom 
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through the ribcage model. For a fixed transducer, focusing at different positions can be 
achieved by adjusting the phase of each element on the transducer. The double headed 
arrow in Figure 4.13 indicates the phantom was moved along the axial direction of the 
transducer. 
 
 
Figure 4.13 Schematic diagram of varying focal length in transcostal HIFU experiment 
 
Figure 4.14 describes the experimental setup: by setting the transducer and the 
ribcage phantom at fixed position in a water tank full of degassed water, the truncated 
DQA phantom was placed in the same tank underneath the robotic arm. The transducer 
was sealed into a water proof bag facing to the phantom to avoid immersing into water. 
The ribcage model was placed at transcostal position with the axis of the transducer on a 
piece of ribs. The phantom was placed onto the smooth surface of a gel pad to minimize 
the moving resistance in the tank. A specially designed plastic clamp, which can be 
mounted onto the front end of the robotic arm, was used to hold the phantom from its top. 
The robotic arm can move the DQA phantom to different focal distance using this clamp. 
The target phantom was moved to a new position 15 mm away from its previous one 
along the axis of the transducer with at least three sonications at each position. The focal 
distances achieved in this experiment was in the range of 130 mm to 190 mm. 1000 J 
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acoustic energy was applied in each sonication. Sonications without ribcage model were 
then performed for control experiment using the same parameters. 
 
 
Figure 4.14 Experimental setup of sonication with different focal distance in transcostal 
HIFU 
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4.4.5. Varying ribcage model locations 
This section reports the effect of ribcage model with varied ribcage model 
locations. By fixing transducer and target phantom, sonications were performed through 
ribcage with varied ribcage positions along the radial direction of the transducer. To 
understand the difference between transcostal and intercostal propagation, both 
transcostal and intercostal positions are included. 
In Figure 4.15, transducer and target phantom were fixed in position, while the 
ribcage model was moved by the robotic arm along the radial direction of the transducer 
(indicated by double headed arrow). 
 
 
Figure 4.15 Schematic diagram of varying ribcage location along the radial direction of 
the transducer elements plane 
 
In Figure 4.16, the experiment was set up on ExAblate 2100 patient table. The 
ribcage model was held by the plastic clamp connecting to the front end of the robotic 
arm, while the phantom and transducer were fixed in the water tank. The ribcage model 
was moved by the robotic arm with 5 mm per step in ± 20 mm motion range in radial 
direction of the transducer (same to sagittal direction of the MR scanner). At least three 
sonications were used at each position. 1000 J acoustic energy was applied in each 
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sonication. The sonication started at transcostal position with axis of the transducer on a 
piece of ribs. 
 
 
Figure 4.16 Experimental setup of sonication with different ribcage location 
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4.4.6. Validation of focal temperature change 
In order to investigate the relation between temperature change and shadow area 
on transducer plane caused by the ribcage model, the total occluded area was estimated 
using a computer generated ribcage model placing between a transducer and phantom 
with the same dimensions as the real ones. The location of the phantom and ribcage 
models was varied in both axis and radial direction of the transducer. 
The blocked area in the beam path was projected onto the transducer plane 
according to the spatial positions. Considering the focused ultrasound beam as a radiation 
from the focus to the transducer, as seen in Figure 4.17(a), the actual shadow area on the 
transducer was larger than that in the beam path. Therefore, this projection used the ray 
tracing from the focal point to the transducer plane. 
In the sonications with varied focal distances (section 4.4.4), transducer and 
phantom were in fixed position. Different target phantom positions were according to the 
same relative position in the experiment. For different ribcage locations with a fixed focal 
length (section 4.4.5), the ribcage model was placed at varied locations the same to that 
in the experiment. Results were then be compared with the focal temperature changes. 
This projection can be better understood by the ray tracing from focus to 
transducer in Figure 4.17(b), coronal view of MR image. It is the top view of the 
experimental setup of sonication with ribcage in the beam path. The field of view includes 
a phantom, a transducer and a ribcage model within a water tank. Focus (yellow point) of 
the sonication was determined within the phantom. The elements of the transducer 
appeared to be a straight line from this view and were marked by a yellow solid line. The 
cross section of the ribs in this view was represented by green circles. The shadow area 
was projected by oblique ray tracing (red dashed line) from the focus passing the edge of 
the green circles onto the transducer plane. The shadow area on transducer in this image 
slice was drawn by cyan blue lines. 
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Figure 4.17 Propagation of ultrasound beam through ribcage: (a) 3D model of the 
ultrasound propagation through ribcage; (b) Projection of ribcage on transducer surface 
(Spin Echo, TE 85.0, TR 1306.8) 
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4.5. Results and discussion 
The results of acoustic pressure distribution and acoustic power were normalised 
because different power levels were used in the two different types of measurement. They 
were compared with the dimensions of the four ribcage models. Results of the effect of 
ribcage on focal temperature elevation are described and discussed subsequently. 
4.5.1. Effect of ribcage on acoustic pressure distribution 
4.5.1.1. Changes in peak acoustic pressure of acoustic field 
Acoustic field distribution was visualised by acoustic pressure mapping in three 
orthogonal views. In Figure 4.18, the three images in each row indicate the three 
orthogonal views of acoustic pressure at focal region in free field (a, b, c), with the effect 
of the ribcage model of patient No.1 in transcostal position (d, e, f), and with the presence 
of the same ribcage model in intercostal position (g, h, i) respectively. Within the 
transverse plane of the focal region, the focal shape was round in free field as shown in 
Figure 4.18(a) and it distorted with the presence of ribcage. Focus splitting occurred in 
transcostal propagation (Figure 4.18(d)), while the radius of the focus expanded in y axis 
direction at intercostal position (Figure 4.18(g)). Details of focus distortion will be 
presented in section 4.5.1.2. 
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Figure 4.18 Acoustic pressure distribution in three orthogonal focal planes in free field 
(a, b and c); with the ribcage in transcostal position (d, e and f); and with the ribcage in 
intercostal position (g, h and i) using No.1 patient’s ribcage model 
 
Peak value of the acoustic pressure at focus varied according to the width or 
spacing dimension of the ribs. Peak acoustic pressure at focus was 0.669 MPa in free field, 
and it decreased significantly owing to both transcostal and intercostal wave propagation. 
Results were normalised using peak acoustic pressure in transcostal and intercostal 
propagation divided by the peak value obtained in free field. In three (patient No.1, 2 and 
4) out of four models, the peak pressure of acoustic filed using intercostal setup was 
apparently higher than that using transcostal setup (Table 4.1). Considering the ultrasound 
wave generated from piezo-material concentrating to a focus, most of the energy 
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propagated via the sides of the single rib at transcostal position and through the spacing 
of two ribs at intercostal position (Figure 4.3). Compared with intercostal propagation, 
more acoustic energy was blocked by the ribcage model in the pathway in transcostal 
position and resulted in a lower focal peak pressure. 
 
Table 4.1 Ratio of peak acoustic pressure in transcostal (and intercostal) propagation 
and free field propagation 
Patient No. Transcostal propagation Intercostal propagation 
1 0.482 0.542 
2 0.445 0.680 
3 0.417 0.411 
4 0.360 0.557 
 
In the measurement result of the width and spacing dimensions of the ribcage 
models (section 3.1.1), the spacing between 9th and 10th ribs of No.3 patient’s ribcage 
model is the smallest in all of the four models. This resulted in minimal ultrasound wave 
propagating through intercostal space using No.3 patient’s ribcage model. Peak acoustic 
pressure at focus using this model showed the lowest intercostal value. On the other hand, 
a larger spacing implies more energy could be delivered to the focus through the 
intercostal spaces. The highest peak acoustic pressure was found in the measurement 
using No.2 patient’s ribcage model, as this model has the largest spacing between 9th and 
10th ribs. 
In HIFU treatment with the ribcage in the beam path, the intercostal setup can 
provide a wider acoustic window through the ribcage to reduce the energy loss in most of 
the cases. In terms of transcostal setup, the width of the ribs affected the wave propagation. 
Because the width is varied at different position of a rib and it is not easy to compare two 
ribs considering the difference in curvature. An effective method was needed to determine 
the effect of ribcage. The shadow area on the transducer resulted from the ribcage was 
selected to study the relation between ribs occlusion and focal temperature change. The 
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validation study of the focal temperature change related to the shadow area is illustrated 
in section 4.5.4.5. 
4.5.1.2. Distortion at focal region 
Results of acoustic field mapping with the presence of all of the four ribcage 
models in the focused ultrasound beam path showed similar focal pressure distribution 
pattern to Figure 4.18. By placing different ribcage models in the ultrasound beam path, 
the focus splitting occurred at transcostal wave propagation and focal radius expanded in 
y axis direction using intercostal propagation. The location of the peak acoustic pressure 
at focal region shifted within 0.1 mm to 0.3 mm in different propagation circumstances. 
Considering the extent of HIFU should include the tumour lesion and its marginal tissue 
about 1.5 cm to 2.0 cm around the tumour (Wu et al. 2003b), shift within this scale could 
be negligible when treating large tumours. 
In the acoustic pressure field mapping at transcostal position, the focus was 
splitted into three main parts in transverse focal plane, which has been investigated using 
numerical modelling and tissue ablation in vitro (Khokhlova et al. 2010). The rib model 
on ultrasound beam axis was parallel to the x axis of the 3D stages as shown in Figure 
4.19. The ultrasound wave was interfered by the rib and concentrated to form a main 
focus with another two secondary foci located on both sides of the main one. To better 
understand the acoustic pressure distribution of the focal region, the transverse view of 
the acoustic field was superposed on the transcostal propagation setup in Figure 4.19(a). 
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Figure 4.19 (a) Transcostal acoustic field and (b) intercostal acoustic field superposed 
on the two setups respectively using No.1 patient’s ribcage model (x, y in the figure 
indicate the x and y axis of the scanning system) 
 
Figure 4.20 indicate that the focused ultrasound wave provided similar acoustic 
pressure distribution at focus with the four ribcage models. In each subfigure, two 
secondary foci located next to the main focus along y axis direction within 2 mm. The 
peak acoustic pressures of the secondary foci were different and all in the range between 
70% (patient No.1) and 85% (patient No.4) of the peak acoustic pressure of the main 
focus. The two secondary foci may be not in the same transverse plane (xy plane) with 
the main focus. In Figure 4.18(f), the left secondary focus stayed in the same focal 
distance with the main one, but the right secondary focus was approximately 2 mm closer 
to the transducer. 
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Figure 4.20 Focus splitting in transverse focal plane 
 
In terms of propagating through intercostal space, the focal shape in transverse 
plane turned into elliptical shape (Figure 4.18(g)), which was completely different 
compared with the focus in free field (round shape, Figure 4.18(a)) or at transcostal 
position (focus splitting, Figure 4.18(d)). The ultrasonic wave deflected by the ribs 
distributed surrounding the original focus and formed a wider focal pattern in y axis 
direction in the transverse plane. This distortion was superposed onto the experimental 
intercostal propagation setup, as displayed in Figure 4.19(b). 
Since a decrease has been observed in the peak acoustic pressure at focus with the 
presence of ribcage model, the focal temperature rise could be affected if more than one 
single focus appears or the focal area becomes larger. Effect on focal temperature change 
were be verified in the following experiments. 
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4.5.2. Effect of ribcage on acoustic power delivery 
For the single element transducer, power conversion ratio of acoustic power and 
electric power in free field was 0.622 ± 0.016 using input electric power in the range of 
10 W to 50 W. This ratio was reduced owing to the ribcage by absorption, scattering and 
reflection to ultrasound wave. The power conversion ratio through intercostal propagation 
was found to be higher than that via transcostal propagation with all of the four ribcage 
models in the beam path, as depicted in Figure 4.21. 
 
 
Figure 4.21 Power conversion ratio of acoustic power (output) and electric power 
(input). a: patient No.1; b: patient No.2; c: patient No.3; d: patient No.4 
 
This ratio at intercostal position was just slightly higher than that at transcostal 
position regarding the model of No.3 patient (Figure 4.21(c)). The difference in power 
delivery between intercostal and transcostal position was the smallest using No.3 patient’s 
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ribcage in all of the four models, which is in good agreement with the result in acoustic 
pressure mapping. The peak acoustic pressure using intercostal and transcostal setup 
provided highly close result. 
Ribcage model of patient No.1 and No.2 at intercostal position showed higher 
power conversion ratio compared with the results that using transcostal setup or the other 
models. Likewise, the maximum peak acoustic pressure of the focal region was also 
acquired at intercostal position when using No.2 patient’s ribcage model (Table 4.1). This 
can be verified using the dimensions of the ribs. In Table 3.1, No.2 patient’s ribcage 
model has the biggest spacing of 9th and 10th ribs in all of the four models. 
The lowest power conversion ratio was obtained in transcostal setup with No.4 
patient’s ribcage model in place. Similarly, the minimum peak acoustic pressure also 
occurred in transcostal setup using No.4 patient’s ribcage model. According to the widths 
at three positions (w1-w3 in Table 3.1) on a rib, the model of patient No.4 has the widest 
9th rib compared with the other three models. Therefore, least energy was delivered to the 
focus with the influence of No.4 patient’s ribcage model placing at transcostal position. 
However, differences still existed between the effect of ribcage models on 
acoustic pressure and acoustic power, because different setups were used in the 
measurement of these two parameters. It should be noted that acoustic pressure and 
acoustic power cannot be measured simultaneously or measured in the same environment. 
The measurement of acoustic power required a water environment as small as possible to 
ensure the stability of the radiation force balance and the acoustic absorber target, but this 
will definitely limit the range of the acoustic pressure field scanning. The supporting 
wires for connecting the force balance and the absorber target could narrow down the 
space for the movement of the needle hydrophone driven by the 3D stages. The variation 
in curvature of the four ribcage models could be another reason that caused different 
results in acoustic pressure and power measurement, even if no obvious trend related to 
rib curvature was found. 
This study was not to find out the relation between the acoustic pressure and 
acoustic power of HIFU transducer, as the input for the transducer in the two 
measurements was in different levels considering the safety of needle hydrophone in 
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acoustic field mapping. However, the relative position of the ribcage model placing in the 
two setups was ensured as similar as possible. 
Because of the remarkable difference in peak focal pressure and acoustic power 
delivery between transcostal and intercostal setup using No.2 patient’s ribcage model, 
this model was selected as the obstacle in HIFU sonication experiment to investigate the 
focal temperature change. 
4.5.3. Effect of ribcage on heat deposition at focus 
Temperature field was captured on a smooth surface of the TMM phantom. 29 °C 
temperature rise was observed at focus without any barriers in the acoustic field, while 
25 °C increase with the effect of ribcage model. The temperature field mapping at 
transverse plane of the focus was shown in Figure 4.22. The two subfigures were cropped 
from the original temperature field mapping of the whole field of view of the thermal 
camera for a larger display. More energy was delivered to the focus in free field and 
obvious distortion can be seen from the temperature contours due to the effect of ribcage 
model. It was a nearly round focus in Figure 4.22(a) even there was a little spread at 5 mm 
away from the focal centre. It may be resulted from the inhomogeneous heat diffusion of 
the phantom at that area. The focus appeared as an ellipse shape with the presence of the 
ribcage (Figure 4.22(b)). No focus splitting was observed because this was not a steady 
thermal field during the HIFU sonication. As the thermal image was captured at the end 
of each sonication, heat deposited at focus may have been exchanged with surrounding 
area. This could cause the whole focal region a high temperature and result in secondary 
foci not significant. 
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Figure 4.22 Heat deposition at focus using transcostal propagation (a and c are IR 
images; b and d are contour maps of temperatures; a and b: in free field; c and d: with 
the presence of ribcage model) 
 
Atomization and fountain formation (Simon et al. 2012) at focal area on the 
phantom surface was occasionally observed at the end of the sonication. The water based 
phantom could be boiled at focus and produce vapour bubble. As part of the energy at 
focus was consumed for atomization, less heat deposited at focus along with the 
atomization and fountain formation. As a result, the temperature field mapping on a 
phantom exposed in the air may not provide accurate temperature distribution at focal 
region, even if the thermal field captured by the thermal camera showed obviously 
different focal shape with and without the ribcage model in the beam path. The 
temperature measurement at focus of HIFU needs to be carried out within the tissue or 
phantom with less heat loss to ensure a more reliable result. 
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4.5.4. Effect of ribcage on focal temperature elevation 
The ribcage model of patient No.2 was selected to place into the HIFU beam path 
to study the ribcage effect by HIFU sonication using varied sonication parameters and 
locations of target phantom and ribcage model. As the experiments have covered as many 
as the circumstances, including both transcostal and intercostal propagation and different 
focal distance, it was reasonable to use only one ribcage model for the sonication 
experiment and presumably a waste of resources to apply all of the ribcage models to 
repeat these sonications. 
The initial temperature of the phantom was determined by the room temperature, 
which was 20.0 °C and the room temperature was controlled by the air conditioner in 
MRI suite. It was different from the commonly accepted average core body temperature 
(taken internally) 37.0 °C. However, acoustic energy applied in this study was high 
enough to provide a maximum temperature rise over 40 °C on the TMM phantom, which 
would be definitely enough to result in protein necrosis and damage the diseased tissue. 
4.5.4.1. Sonications on TMM phantom 
Sonications were performed at different locations on DQA phantom without any 
barriers in the focused ultrasound field. The temperature rise of six sonication spots on 
the phantom using 50 W acoustic power over varied duration time was shown in Figure 
4.23. According to the spot location number marked in Figure 4.11(b), higher temperature 
rise was obtained at a closer focal distance (spot 1, 2, 3 and 4), while the temperature rise 
at spot 5 and 6 was obviously lower than that at the other 4 spots. Longer focal distance 
resulted in more acoustic attenuation during ultrasound wave propagating in the phantom. 
Therefore, to study the temperature change at different focal distance, it is necessary to 
locate the focus at a fixed depth in the target phantom. 
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Figure 4.23 Focal temperature at different locations 
 
4.5.4.2. Varying sonication parameters 
Acoustic power was varied in the sonications over a constant time of 20 s. In 
Figure 4.24(a), difference between temperature rise with and without the ribcage effect 
was gradually getting larger when a higher acoustic power was applied. The presence of 
the ribcage model caused a 5.5 °C decrease in focal temperature change at 25 W and 9 °C 
at 150 W. 
Then the sonication time was varied (from 10 s to 60 s, 10 s per step) in the 
sonications using a constant acoustic power of 50 W. The similar trend was observed in 
the temperature difference with and without ribcage model. Figure 4.24(b) shows the 
temperature difference induced by ribcage model was 3.2 °C using 10 s exposure time, 
while it was 7.3 °C over 60 s. 
The effect of ribcage on focal temperature was varied by increasing acoustic 
power or extending sonication time. The thermal diffusion in the phantom may varied at 
different temperature, which could result in the different effect in Figure 4.24. 
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Figure 4.24 Temperature change using (a) a constant sonication time and (b) a constant 
acoustic power (a. Temperature rise at focus using 25 W – 150 W acoustic power over 
20 s; b. Temperature rise at focus using 50 W acoustic power over 10 s – 60 s sonication 
time) 
 
To compare and analyse the difference in efficacy between increasing acoustic 
power and extending sonication time, sonications were performed using the same total 
acoustic energy. Figure 4.25 shows the focal temperature rise on phantom using acoustic 
energy in the range of 500 J to 3000 J (500 J per step). Increasing acoustic power (red 
square markers) over constant sonication time and extending sonication time (blue dot 
markers) using constant acoustic power was compared. Figure 4.25(a) is the result 
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without the presence of ribcage model. The red line denotes the results using 25 W to 
150 W acoustic power over constant 20 s and blue line indicates sonication results using 
constant 50 W over 10 s to 60 s. The focal temperature change reveal that in the use of 
25 W to 150 W over constant 20 s, temperature rose more rapidly than using 50 W over 
10 s to 60 s. 
 
  
Figure 4.25 Comparison of using constant power and constant duration time (a. Free 
field; b. With the presence of ribcage model) 
 
128 
 
Results with the presence of ribcage phantom (Figure 4.25(b)) indicate the similar 
trend. Temperature rise with increasing acoustic power or extending sonication time 
agreed well below 1500 J. When the total acoustic energy exceeded 2000 J, focal 
temperature rise of sonications using growing acoustic power (red line in Figure 4.25(b)) 
was dramatically higher than sonications using extending sonication time (blue line in 
Figure 4.25(b)). The most significant difference in temperature elevation occurred when 
highest acoustic energy 3000 J was applied. 
Therefore, in the case of using the same total energy (within the range of 500 J to 
3000 J), high acoustic power over short sonication time can provide a higher efficiency 
in the acoustic energy delivery and lead to a higher temperature rise at focus than using 
low acoustic power over long sonication time. This was due to more energy attenuated in 
the beam path during a longer sonication time. It suggested that to improve the efficacy 
of HIFU treatment, it is best to apply higher acoustic power over a short time period with 
the power below the tolerability of the patients. When comes to the treatment on patients, 
the complicated structures of the tissues and different characteristics of humans should 
be considered. There may not be a strictly safety value for all the cases in HIFU treatment 
and more research is needed to determine the individual safe thermal dose. The TMM 
phantom presented in Chapter 3 could pave the way for this thermal dose study. 
It should be note that the measurement of ribcage effect on acoustic power 
delivery (section 4.5.2) and on focal temperature elevation (section 4.5.4) used different 
HIFU transducer and experimental setup, which resulted in different circumstances for 
focused ultrasound wave propagation. The RFB device cannot work with MR scanner 
and the acoustic power of multi-element transducer of ExAblate patient table works only 
with the MR scanner. It is impossible to evaluate the acoustic pressure distribution or 
focal acoustic energy in MRI environment using needle hydrophone or RFB device. 
Therefore, the homemade single element transducer was selected to determine the ribcage 
effect on acoustic pressure and acoustic power out of MRI environment. The multi-
element transducer of ExAblate 2100 system was used to investigate the influence of the 
ribcage on focal temperature using MRI thermometry. 
RFB setup (section 4.2) for acoustic power measurement applied water as the 
medium and used acoustic absorber as a target to experience the radiation force. 
Ultrasound wave propagated through the water with less energy loss compared with the 
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propagation in tissue or phantom. The phantom was used in the sonication experiment 
and the acoustic attenuation of the phantom cannot be neglected. Therefore, some of the 
energy lost during the ultrasound wave propagation in the phantom before approaching 
to the focus. The loss of energy may be absorbed by the phantom in the pathway, produce 
mechanical effect, be reflected at the interface of two different materials (water and 
phantom) and etc. 
4.5.4.3. Varying target phantom locations 
Focal length of HIFU sonication was varied with and without the presence of 
ribcage model. The results of focal temperature change at various focal lengths within 
130 mm to 190 mm were reported in Figure 4.26. By extending the focal length, focal 
temperatures with and without the effect of ribcage model were both decreased. This was 
because more energy was lost during longer pathway of the ultrasound wave propagation. 
It can be seen that the ribcage model resulted in a reduction in focal temperature rise and 
this reduction was dependent on the focal distance. When beam focusing at a closer 
location, the ribcage model affected slightly more on the focal temperature than that with 
a longer focal distance, because the shadow area on transducer blocked by the ribcage 
model was generally becoming smaller with longer focal length (it is verified in 
section 4.5.4.5). Specifically, 3.33 °C decreased owing to the ribcage model at 130 mm 
focal distance and 2.67 °C at 190 mm. 
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Figure 4.26 Focal temperature rise at different focal distance 
 
4.5.4.4. Varying ribcage model locations 
By changing the position of ribcage model along radial direction of the transducer, 
the wave propagation at both transcostal and intercostal space were studied. This variation 
did not provide much difference in focal temperature rise. The focal temperature 
increased 5.72 ± 0.67 °C when moving the ribcage model along the radial direction of the 
transducer. Ribcage model at different radial positions had almost the same influence on 
the focal temperature rise and no trend in temperature change was found. This could be 
explained by similar blocked area by the ribcage at different locations. The validation of 
the relation between shadow area and temperature difference will be presented in 
section 4.5.4.5. 
By varying the position of the phantom and the ribcage model in the HIFU beam 
path, different focal length and both transcostal and intercostal propagation can be 
investigated. Other ribcage models were not applied to repeat the same sonication 
experiments. 
4.5.4.5. Validation calculation of focal temperature change 
In this validation study, projection of the blocked area on transducer elements was 
calculated at varied focal distance and varied ribcage radial locations. 
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For sonication at varied focal length, Figure 4.27 shows the occluded area owing 
to the ribcage at different focal length. The five subfigures indicate the shadow area at 
varied focal distance ranged from 130 mm to 190 mm. The blocked area on transducer 
decreased with longer focal length, which is listed in Table 4.2. 
 
 
Figure 4.27 Shadow area on the transducer owing to the ribcage at varied focal length 
 
Table 4.2 Blocked area on the transducer at different focal length 
Focal length (mm) Blocked area (mm2) 
130 2515.20 
145 2328.96 
160 2150.40 
175 2022.40 
190 1937.28 
 
Compared with temperature differences in Figure 4.26, effect of ribcage model 
was becoming slightly smaller by extending the focal distance. This indicates that the 
effect of ribcage on focal temperature elevation related to ribcage induced shadow area 
on HIFU transducer. 
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 In terms of different ribcage location in radial direction of the transducer plane, 
the total blocked areas on transducer were similar when moving the ribcage within 
± 20 mm. Figure 4.28 denotes ribcage projection on the transducer plane at different 
radial locations. The calculated results of the each shadow area are listed in Table 4.3. 
The elements area of the transducer is 80 mm × 80 mm, which is bigger than the 
projection of the interval space of the ribs. Therefore, when a piece of ribs moved out of 
the transducer elements area another piece moved into it, which resulted in the total 
blocked area to be almost constant (Table 4.3) if varying the ribcage location along the 
radial direction of the transducer. 
 
 
Figure 4.28 Shadow area on HIFU transducer owing to the ribcage model at varied 
ribcage location in radial direction of the transducer in the range of ± 20 mm 
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Table 4.3 Blocked area on the transducer at different radial position 
Position Blocked area (mm2) 
-20 2563.20 
-15 2518.40 
-10 2473.60 
-5 2451.84 
0 2515.20 
+5 2536.96 
+10 2538.88 
+15 2536.32 
+20 2493.44 
 
Movement range of the ribcage was within ± 20 mm, which was large enough to 
reach both transcostal position and intercostal position. Effect of the ribcage model did 
not show much difference on focal temperature at transcostal and intercostal positions by 
using a transducer with elements area in an 80 mm × 80 mm square. By comparing the 
temperature rise and the shadow area on transducer elements for validation, the 
temperature change in the transcostal and intercostal sonication can be related to the 
coverage area on the transducer elements owing to the ribcage. This enables the prediction 
of the focal temperature change with the ribcage at different locations. 
Slice thickness of MRI during the sonications was 3 mm with 1 mm spacing. If 
estimating the projection using the combination of the discrete projection parts on every 
single image slice, the interval between two slices may not as accurate as the direct 
projection from a 3D model. Estimation of the shadow area was not to calculate the exact 
value of this area, but to validate the trend of the temperature change at focus. Therefore, 
the computer generated model was use to acquire and estimate the accurate shadow area 
for better agreement with the structure profile of the ribcage. 
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4.6. Summary 
Using the reconstructed physical ribcage models based on image data from 
patients, influence of this model on acoustic pressure, acoustic power and focal 
temperature rise was investigated. Both transcostal and intercostal propagation were 
studied. Results reveal that three in four ribcage models delivered more energy to focus 
when ultrasound beam focusing through intercostal space. The results also suggest that 
the acoustic pressure and acoustic power delivered to focus was closely related to the 
width and spacing of the ribcage, while the curvature did not affect as significantly as the 
width and spacing of the ribcage. 
For HIFU sonication on TMM phantom through ribcage model, effect on focal 
temperature rise was related to the energy applied as well as the focal distance. By using 
a constant sonication time, the ribcage affected more on the focal temperature change 
when increasing the acoustic power. Similarly, extending sonication time enhanced the 
effect of ribcage on focal temperature rise using a constant acoustic power. In the case of 
using the same total acoustic energy in the sonication, high power applied over a short 
time (e.g. 150 W for 20 s) provided more temperature rise at the focus than low power 
applied over a long time (e.g. 50 W for 60 s). The temperature change at focus was found 
to be related to the shadow area on the transducer blocked by the ribcage. The beam path 
should be determined for a minimal shadow area on transducer occluded by the ribcage. 
Patients-specific models based on patients’ clinical image data was successfully 
used to investigate the parameters of HIFU treatment in simulated experiments, in 
particular, the effect of the ribcage. The patient-specific model presented in this study can 
be used for the further research in abdominal HIFU treatment for mimicking the real 
situation and could act as a potential step towards stratification of treatment protocols. 
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Chapter 5 Feasibility Studies 
To achieve the human anatomy structure as realistic as possible, Thiel embalmed 
cadaver was used to test HIFU sonication process. The cadaver sonication experiments 
helped to verify the results from the experiments using ribcage models. This study was to 
investigate the feasibility of the application of HIFU on Thiel embalmed cadaver in 
MRgFUS treatment through ribcage. HIFU effects rely on rapid rise in focal tissue 
temperature which in turn causes damage of the target tissues. The cooling effect of blood 
flow through vessels in target area may lead to substantially different HIFU treatment 
outcomes compared with focusing on tissues with slow or without flow. In this chapter, 
the blood flow effect was taken into consideration and tested during HIFU application. 
The influence of blood flow on focal temperature change was tested on phantom and ex-
vivo tissue before experiments on the Thiel cadaver for the sonication test. Firstly, a TMM 
phantom was designed and fabricated with tubing inside mimicking blood vessels. This 
TMM phantom was perfused using dynamic flow and used to study the flow effect on 
HIFU sonication. Further sonication study on perfused ex-vivo organ was then performed 
with static perfusion and dynamic flow perfusion respectively. The static perfusion 
indicates the perfusion material (gel or fluid) within the vessels is static, while the 
dynamic perfusion is with a flowing fluid in the vessels. Finally, sonications on the liver 
of a Thiel embalming cadaver are performed using ExAblate system. 
5.1. Sonications on dynamic perfused gel phantom 
Blood flow near the sonication focus absorbed heat from the focal region resulting 
in less energy accumulation at the target and this affected the efficacy of the sonication. 
To investigate the blood flow effect on focal temperature in HIFU sonication, a flow 
circulation system was established and phantom study was conducted before tests on ex-
vivo animal tissue. This was to validate the performance of dynamic flow perfusion in 
MRI environment. 
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5.1.1. TMM phantom for dynamic perfusion 
For dynamic flow perfused phantom, a proper soft tube to mimic the vessel in the 
phantom was used. The typical vessel walls (Burton 1954) of human main arteries have 
2000 µm inner radius and 3000 µm outer radius. Veins have 2500 µm inner radius and 
3000 µm outer radius. A selection of vessels parameters (Crezee & Lagendijk 1992) for 
human circulation was summarised by Crezee et al. They reported that the diameter of 
large arteries was in the range of 2 to 6 mm with blood velocity 20 to 50 cm/s, large veins 
had diameters 5 to 10 mm with 15 to 20 cm/s blood flow velocity and renal artery had 
4 mm diameter with 50 cm/s blood velocity. To enhance the flow effect on focal 
temperature in the sonication, the vessel mimicking material C-Flex tubing (6424-71, 
Cole-Parmer Instrument Co. Ltd., London, UK) with 6.350 mm inner diameter and 
1.588 mm wall thickness was applied to mimic the vessel. The acoustic properties of C-
Flex have been reported by Hoskins’ group previously (Hoskins 2008). 
For HIFU sonication, the DQA phantom was found unsuitable as tube 
implantation to produce a blood vessels containing phantom could have caused rapped 
air bubbles in the phantom when inserting the tubes. Polyacrylamide (PAA) material was 
selected to fabricate the phantom with C-Flex tubes inside. Its fabrication procedure has 
been presented in section 3.3. Two C-Flex tubes were placed into the PAA solution before 
the PAA curded. The tubes can be smoothly embedded within the phantom and no air 
bubbles trapping could have been possible. 
5.1.2. Flow circulation system on the phantom 
 Maquet Jostra HL30 Heart-Lung Perfusionist Machine (Moquet, Rastatt, 
Germany), as shown in Figure 5.1, provided the dynamic flow perfusion with a constant 
flow rate. It can provide up to four channels of flow circulation simultaneously using 
roller pumps. The flow rate of all the channels is adjustable during the circulation. 
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Figure 5.1 Maquet Jostra HL30 Heart-Lung Perfusionist Machine (a. Control unit panel 
to manage flow rate and channel selection; b. Roller pumps to provide the flow 
circulation) 
 
The Hear-Lung Perfusionist Machine was located out of the MRI suite because it 
is not MRI compatible. For one circulation using a single channel, a flexible silicone tube 
was required, which must be long enough to connect the C-Flex tube (in MR suite) and 
the perfusionist machine (out of MRI suite). This flexible tube was placed into a roller 
pump of the machine for the circulation by squeezing the tube periodically. Both ends of 
this long tube were extended into MRI suite through a small hole on the wall of the lab. 
As shown in Figure 5.2, the roller pump sends the flow circulation to the C-Flex tube 
through the silicone tube. Both of the other ends of the C-Flex tube and the silicone tube 
were extended into a water bucket filled with degassed distilled water. This was to allow 
the air bubbles in the tubes getting out of the circulation. The two C-Flex tubes in the 
phantom applied the same flow rate via two channels. When the setup was ready, the 
circulation system needed to be turned on to working status to remove the air within the 
tubes before applying the sonication on the phantom, because the tubes were initially full 
of air and the trapped air bubbles affect the ultrasound propagation. The removal of air in 
C-Flex tube within the phantom was verified by MR images. 
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Figure 5.2 One channel circulation on phantom with vessel mimicking tube 
 
5.1.3. Sonications on dynamic perfused phantom 
Sonications were performed using ExAblate 2100 system. Figure 5.3 depicts the 
sagittal view of MR image of the setup for sonication on the dynamic perfused phantom. 
The PAA gel phantom with vessel mimicking tubing was put into a container full of 
degassed distilled water. This container was for better acoustic coupling and prevented 
water leakage from the tubing in MR scanner. It was carefully placed on the top of the 
HIFU transducer without air bubbles at interface. An acoustic window was cut at the 
central bottom of the container and sealed using a piece of thin polymer film for the 
pathway of the focused ultrasound beam. A gel pad was placed underneath the phantom 
in the container, because a larger phantom can provide a better contact with the polymer 
film and the transducer for a better acoustic coupling. DuoFLEX 24 cm × 24 cm coil set 
(MR Instruments Incorporated, Minneapolis, MN, USA) was placed on both sides of the 
container with phantom for MR imaging. 
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Figure 5.3 Perfusion in vessel mimicking tubing phantom (Spin Echo, TE 85.0, TR 
1306.8) 
 
Considering the operation of the flow in the C-Flex tubes within the phantom was 
on the patient table inside the MR scanner, the flow velocity in the C-Flex tubes cannot 
reach as high as the realistic value. For the safety reason, flow perfusion established in 
the PAA phantom through the vessel mimicking tubing was set to a flow rate of 
398 ml/min. 800 J acoustic energy was applied to each sonication. The focal temperature 
was measured by MRI thermometry. Sonications were located surrounding the C-Flex 
tube with flow circulation as shown in Figure 5.4. Position No. 1 and 3 were at the back 
of the tube with the dynamic perfusion. Position No.2 was performed without the tube in 
the beam path. Position No.4 located in front of the tube with flow. The distance between 
the focus and the C-Flex tube is indicated in Figure 5.4. 
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Figure 5.4 Focal positions on flow perfused phantom (1. 4.6 mm at the back of the tube; 
2. 4.6 mm at the back without tube; 3. 10.0 mm at the back; 4. 4.4 mm at the front)  
 
5.2. Sonications on static and dynamic perfused ex-vivo organs 
After performing the flow circulation in the phantom, a sheep liver was applied as 
the sonication target with static and dynamic perfusion. The sheep liver used in this 
experiment was preserved using Thiel embalming technique (Thiel 1992). For static 
perfusion, tissue mimicking material was injected into the liver vessels. In terms of 
dynamic perfusion, a bag for the flow circulation on liver was produced to perform the 
perfusion with the perfusionist machine. 
5.2.1. Sonications on ex-vivo organs with static perfusion 
2% agar mixed with MRI contrast agent was used to fill in the vessels of the liver. 
The agar solution was injected through the portal vein of the liver and then solidified into 
gel status when cooling down within the vessels. The vessels were full of agar gel and air 
in the vessels was removed. During the sonication, the liver was placed into a well-sealed 
polymer bag filled with degassed and distilled water. This bag was put onto the patient 
table of ExAblate 2000 system. HD single channel surface coil (GE Healthcare, 
Waukesha, WI, USA) was placed on top of the liver bag for MR imaging. 1000 J acoustic 
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energy was applied for each sonication on this static perfused liver and the sonication 
spots were selected surrounding the vessels. 
5.2.2. Sonications on ex-vivo organs with dynamic perfusion 
5.2.2.1. Preparation of liver bag for dynamic perfusion 
A dynamic flow perfused liver model was established to study the effect of the 
vessels with flow on focal temperature change in HIFU sonication. The tissue has to be 
within a water environment during the sonication for flow circulation in the vessels, 
thereby a bag (Figure 5.5) for dynamic perfusion in liver was created using polymer film. 
Firstly, three edges of the polymer plastic bag were sealed and three small holes were cut 
on the top side of the bag. Three plastic tube connectors were then fixed through the small 
holes. Two connectors were in the centre for water inlet (port 1 in Figure 5.5) and air 
outlet (port 3) and the other one was located near the edge for water outlet (port 2). After 
placing the liver in the centre of the bag, the water inlet connector was inserted into the 
liver from the hepatic portal vein and fastened using a cable tie. Finally, the last opening 
edge of the bag was sealed. It is important to prevent leakage of liquid during the 
experiment on ExAblate patient table in MR scanner. The sealing of the perfusion bag 
has to be tested for water tightness before using it in MR scanner. What is more, the bag 
was placed into an empty water tank during the perfusion and sonication to ensure extra 
safety. The central bottom of the tank was cut and sealed by a thin polymer film for the 
acoustic window. 
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Figure 5.5 Perfused liver bag with saline solution (1. water inlet; 2. water outlet; 3. air 
outlet) 
 
5.2.2.2. Dynamic flow circulation system on the liver 
HIFU sonication procedures were applied on ex-vivo Thiel liver with dynamic 
flow perfusion in the vessels. The flow circulation was provided by Maquet Jostra HL30 
Heart-Lung Perfusionist Machine. Two pumps of the machine were used in this setup to 
separate water inlet and outlet circulation. In Figure 5.6, pump 1 was connected to the 
water outlet and pump 2 was connected to the water inlet by long flexible tubes. Both the 
other ends of the long tubes were put into a bucket filled with degassed and distilled water. 
The purpose of using two pumps in the liver perfusion was to maintain a steady state fluid 
level within the bag. This can prevent bubbles from being sucked into the water outlet, 
because each end of inlet and outlet used an individual roller pump. To keep the balance 
of the water pressure in the bag, the water line in the water bucket can be monitored and 
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adjusted the flow rate according to increasing or decreasing level of the line. Flow was 
established in the liver through the hepatic portal vein at a flow rate 400 ml/min. 
 
 
 
Figure 5.6 Flow circulation in the sheep liver 
 
5.2.2.3. Sonications on dynamic perfused liver 
ExAblate 2000 system combined with 1.5 Tesla MR scanner was applied to 
perform the sonication and monitoring of the temperature. HD single channel surface coil 
(GE Healthcare, Waukesha, WI, USA) was placed on top of the liver bag for MR imaging. 
Total acoustic energy 800 J was applied on the liver tissue both in front of and back of 
the vessels, and directly on the vessels. All sonications located around two different 
vessels. One diameter was 3.57 mm and another one was 1.56 mm. A total number of 9 
sonications were performed, including 4 on the tissue at the back of the vessels, 3 on the 
tissue in front of the vessels and 2 on the vessels. 
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5.3. Sonications on Thiel cadaver: a feasibility study 
5.3.1. Thiel embalmed cadaver 
The Thiel cadaver was provided by Centre of Anatomy & Human Identification 
(University of Dundee, UK), which is one of the few departments in the UK to embalm 
bodies using the Thiel soft-fix method. This method can preserve the cadavers with life-
like flexibility and tissue quality. Thiel embalming technique (Thiel 1992) has been 
reported as an alternative preservation method that keeps the tissues life-like colour, 
odourless, native articular joint mobility and relative long-time preservation. The research 
on the cadaver in this study was in accordance to UK Anatomy Act (2006). 
5.3.2. Sonications on Thiel cadaver 
Before moving the cadaver from the Thiel room to the MRI lab, the Thiel 
embalming liquid in the cadaver bag must be pumped out, because any leakage of the 
liquid inside the MR scanner could lead to damage the ExAblate system or MR scanner. 
To enable the use of CBS transducer of ExAblate 2100 system on Thiel cadaver, the 
transducer except the membrane area was wrapped using cling film to prevent contacting 
with the Thiel embalming liquid on the cadaver. As the location of the sonication target 
was on the liver, the transducer was positioned at upper abdomen facing to anatomical 
location of the liver. 
The cadaver in the bag was placed on the patient table of ExAblate 2100 system 
docked with MR scanner. An 8 channel cardiac coil (GE Healthcare, Waukesha, WI, USA) 
was used for imaging. MRI was used not only to provide images of the cadaver anatomy 
and prepare the appropriate treatment plan, but also to measure the temperature maps to 
ensure the safety and efficacy of the sonication. Totally 10 sonications were applied on 
the cadaver using 800 J or 1000 J acoustic energy. 
5.4. Results and discussion 
5.4.1. Sonications on dynamic perfused gel phantom 
The vessel mimicking tube showed significant effect on the temperature rise at 
focus. For position No.1 (Figure 5.4) at focus 4.6 mm behind the vessel mimicking tube 
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with flow, temperature rise was only for 2.0 °C. Sonications at the same focal distance 
without the tube in the beam path provided 9.5 °C rise in the temperature on an average. 
The temperature rise at the positions 4.4 mm in front of the vessel mimicking tube was 
11.0 °C. There was a 2.2 °C temperature rise when the focus located 10.0 mm behind the 
tube. All the results are summarised in Table 5.1. The results indicate that vessels with a 
6.4 mm inner diameter conducted heat from the focal region and affected the efficacy 
significantly when the target located behind the tube. 
 
Table 5.1 The effect of vessel mimicking tube with flow on focal temperature rise 
Position No. Distance to tube (mm) Temperature rise at focus (°C) 
1 4.6 (back) 2.0 
2 4.6 (without tube) 9.5 
3 10.0 (back) 2.2 
4 4.4 (front) 11.0 
 
The focal position without the tube in the ultrasound beam path or 4.4 mm in front 
of the tube can both be heated up approximate 10 °C, which means that there was not 
much effect when the flow was out of the ultrasound beam path. This could be explained 
by the insufficient flow rate. For safety reason, up to approximate 400ml/min flow rate 
was used. All the setup was based on the ExAblate patient table within the MR scanner, 
therefore the flow has to be limited at a safe value to ensure no splash or leakage during 
the experiments. 
5.4.2. Sonications on static and dynamic perfused ex-vivo organs 
The results of sonications on static perfused liver showed that the effect of blood 
vessel with agar gel can almost be negligible. The temperature rise with and without the 
vessel were very close. This could be explained that the static agar gel in the vessels 
possessed similar acoustic properties to the liver tissue and this static perfusion in the 
vessels cannot lead to substantial heat loss during the HIFU sonication. 
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In terms of the dynamic flow perfused liver, 400 ml/min flow was perfused from 
the portal vein. The complex vascular system of the liver was clearly observed in the 
coronal MR images (Figure 5.7). For the sonication with focus on the vessel, focal 
temperature rise was over 10 °C lower than focusing on the liver tissue. There was not 
evident temperature change at focal spot at the front or back of the flow vessel. On the 
other hand, no visualised lesion was found by using elastography ultrasound imaging or 
observed by eye. The protein denaturation in liver tissue caused by the embalming 
material could result in no necrosis formed at foal region. However, the protein 
denaturation did not significantly affect the temperature rise. The ex-vivo Thiel liver tissue 
in HIFU sonication experiments showed a logical temperature rise and can be used as the 
focal target. 
 
 
Figure 5.7 Coronal MR image of perfused Thiel sheep liver (Fast spin echo, TE 88.9, 
TR 3340.0) 
 
The flow effect was not apparent mostly because the vessels near the sonication 
focus had smaller diameters than the C-Flex tube used in the phantom study. This may 
lead to less heat loss at focal region which was not enough to significantly affect focal 
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temperature change. As discussed in section 5.4.1, the flow rate has to be limited at 
400 ml/min level for safety reasons in the MRI lab. 
5.4.3. Sonications on Thiel cadaver 
This cadaver model was not ideal for HIFU sonication on the liver through ribcage. 
As seen in the MR images of the cadaver in Figure 5.8, the thoracic cavity of the cadaver 
was full of air. The cadaver was lying on the patient table and the viscera in the body were 
shrunk to the bottom. This resulted in an empty chamber on the top of the chest. To 
prevent ultrasound wave propagation through air chamber in the chest, lower part of the 
liver was selected as the sonication target in the experiment. In Figure 5.8(b), the red area 
was the region of treatment pointed out by a green arrow. 
 
 
Figure 5.8 (a) Axial and (b) sagittal view of MR images of the Thiel cadaver. The red 
circular area in b indicates the region of treatment (ROT). (FIESTA:  fast imaging 
employing steady state acquisition, TE 1.3, TR 3.2) 
  
In the cadaver applied in this experiment, the air chamber in the chest affected the 
sonication pathway significantly. This cadaver was not fresh enough when used in this 
experiment, which resulted in vacancy in the thoracic cavity. It would be a better model 
with compact viscera in the body for liver sonication test. 
Because of the vacancy chamber in the thoracic cavity, it was not easy to find a 
proper path for ultrasound wave propagation. Some sonications show artefact in the 
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temperature field mapping. Ten sonications were applied but only three of them provided 
reliable profile in thermometry result. Focal temperature changes in the three sonications 
were summarised in Table 5.2. Potential ways may change this situation, such as to 
perfuse the organs of the cadaver to expand the volume and make a better pathway for 
the ultrasound beam. However, it is best to apply a fresh cadaver model without losing 
much water. It should be noted that MRI thermometry of Thiel embalmed tissue has 
higher temperature differences compared with the fresh organs (Karakitsios et al. 2013). 
This indicated that calibration for the MRI thermometry on Thiel embalmed tissue is 
necessary in the future work. 
 
Table 5.2 Focal temperature rise on the liver of Thiel cadaver 
Acoustic power (W) Acoustic energy (J) Temperature rise (°C) 
40 800 11 
50 1000 35 
50 1000 34 
 
Despite these difficulties in cadaver experiment, the temperature change on 
cadaver tissue caused by HIFU sonication still showed positive outcomes. Considering 
the human anatomy and the good agreement with tissue properties, the Thiel cadaver 
should be explored in HIFU test for further studies. 
5.5. Summary 
The feasibility of performing HIFU sonication test on Thiel embalming cadaver 
model has been studied. The blood flow was taken into consideration and investigated on 
a TMM phantom and ex-vivo organs with static and dynamic perfusion. Thiel sheep liver 
was selected as the ex-vivo sonication target tissue to study the static or dynamic perfusion 
effect on animal tissue. The effect of the flow in vessel mimicking tubing on focal 
temperature change was evident in phantom study, while the focal temperature on liver 
tissue was not affected apparently by static or dynamic perfusion in the vessels. The 
application of HIFU on Thiel tissue has been validated. However, the viscera shrunk and 
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left a vacancy chamber filled with air in the chest of the cadaver used in this experiment. 
Because of this situation, it was impossible to locate the focus of HIFU onto the liver 
tissue through the ribs. A Thiel cadaver with a vacancy chamber in the body was not an 
ideal cadaver model for HIFU test on the liver through ribcage, however, HIFU sonication 
on cadaver still showed positive outcomes. 
Thiel cadaver provided anatomical structures and tissue properties of human, 
which made it possible to be a substitute in the HIFU test. This study provided validation 
results and exposed the potential issues of its application to test HIFU procedure. For a 
cadaver with compact organs in the body, it can be considered as a valuable model for 
HIFU test in pre-clinical stage. 
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Chapter 6 Conclusions and Future 
Work 
This study was to investigate the influence of the ribcage on HIFU applications 
using the reconstructed ribcage model that possessed patient’s anatomical structures, 
which could help translate HIFU technology into more widespread clinical applications. 
This chapter gives summary of the work reported in the above chapters and indicate the 
possible work to be furthered in the future. 
6.1. Conclusions 
HIFU therapy has been approved for cancer diseases treatment in many countries 
and a number of clinical applications proved HIFU a promising non-invasive treatment. 
A review of literatures showed that the ribs located in the focused ultrasound beam path 
affected the therapeutic process and a lot of work has been done to overcome this 
challenge. It was noted that there was not an investigation provided full effect of the 
ribcage on HIFU treatment due to the lack of physical practice with human anatomical 
structures. Therefore this study conducted HIFU experiment through ribcage with human 
anatomical structures and tissue mimicking properties in order to bridge the gap between 
HIFU and abdominal non-invasive treatment. The physical model with the structures of 
human anatomy based on medical images provided a way to evaluate the effect of the 
ribcage and help to develop patient-specific treatment plan. To predict the sonication 
effect of HIFU treatment through ribcage accurately, a specialised model was required 
for individual patient. The investigation on the reconstructed ribcage model should serve 
as an illustration of its effect on focused ultrasound field. With the benefit of 3D 
reconstruction, the HIFU sonication experiments using realistic phantoms based on 
patient’s data would be a step towards translation of HIFU technology into widespread 
clinical practice. 
6.1.1. Reconstruction of ribcage model 
A rapid 3D modelling technique was developed to prototype models with original 
human anatomical structures. The 3D modelling of patient-specific ribcage models 
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applied DICOM data from totally four patients. Physical ribcage models were 
manufactured using rapid prototyping technique based on the computer generated 3D 
models. These ribcage models therefore possessed the anatomical structures and features 
of the patients, which made it possible to fully investigate the ribcage effect on HIFU 
treatment of each individual patient. This 3D modelling technique could bring broader 
implication into the surgery by providing reliable tissue mimicking models with human 
anatomical structures and assisting to physically simulate the surgical circumstance. 
The TMMs were characterised to determine the best material for the phantom used 
in HIFU sonication through the ribcage. The acoustic, thermal and elastic properties of 
most commonly used TMMs have been measured, which may also provide reference 
results for other researches. According to Table 3.9, ABS thermoplastic material and PVA 
phantom was used for ribcage model and surrounding tissue respectively. PAA with 2% 
Al2O3 was the best tumour mimicking material for elastography. DQA phantom was the 
best to be the sonication target because it possessed tissue mimicking acoustic properties 
and thermal properties, and was suitable to apply repeatable high power sonication when 
allowing enough cooling time. The materials and methodology used in the present study 
could bridge the gap from tissue and organ substitutes used in research to anatomical 
structures of human and form the basis for designing future TMM phantoms and 
associated researches. 
6.1.2. Investigation of the effect of ribcage on focused ultrasound field 
To evaluate ribcage effect, HIFU experiments were implemented using the 
patient-specific models with focused ultrasound covering both transcostal and intercostal 
propagation. The effects were investigated on acoustic pressure distribution, acoustic 
power and focal temperature rise. 
Acoustic pressure distribution and acoustic power in focused ultrasound field by 
both intercostal and transcostal propagation was investigated and then compared with 
ribcage dimensions. The width and spacing of the ribs were found to be closely related to 
the effect of ribcage on acoustic pressure distribution and acoustic power. Results also 
revealed that the intercostal position allowed more energy deposition at focus and 
transcostal position caused significant focus distortion, specifically, focus splitting into 
three main parts. For the HIFU sonication on phantom at varied focal locations, 
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temperature change at focal region was proved to be highly associated with the shadow 
area of the ribcage projected from the focus onto the transducer. 
To enhance the efficacy of HIFU treatment, the intercostal position should be the 
best option for the treatment if the HIFU beam is possible to be focused to the target 
through the intercostal spaces. In this case, the ultrasound wave has a minimal energy loss 
and the focal temperature elevation can reach the maximum. When the cancerous tissue 
located exactly behind the rib, the first option could be shifting the beam path to 
intercostal space by physically moving the transducer or adjusting the phase of each 
element on the transducer. This technique has been already available in some of the 
existing HIFU systems. However, if the beam cannot be adjusted to the ideal path or this 
adjustment is not technically feasible, it is best to locate the transducer to achieve a 
minimal shadow area on the elements by the ribcage in transcostal propagation. This 
would ensure the most energy delivered through the ribs in the current circumstance. 
6.1.3. Feasibility studies on Thiel cadaver model 
HIFU sonication test has been conducted on liver tissue of a cadaver, which 
showed that the cadaver can be a good model for the investigation of HIFU because of 
the tissue properties and anatomical structures. However, the sonication through the ribs 
was not available on this cadaver model. The potential wave propagation path was full of 
air if locating the focus on the liver tissue, because the loss of water resulted in viscera 
shrunk during the long-term storage. A possible way to address this is to perform the 
perfusion in the abdominal organs of the cadaver to expand their volume and recover to 
normal size. Apart from this complicated potential solution, it would be the best to apply 
an ideal cadaver model, which should be as fresh as possible and without any air in the 
chest, for the sonication through the ribs. 
6.2. Suggestions for future work 
The work reported in this thesis was the first stage investigation into the effect of 
patient-specific ribcage on HIFU application. This research contributed to establish a 
unique HIFU treatment plan for each individual patient based on the models with patient’s 
anatomical structures and human tissue properties. Some improvements and suggestions 
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for the future work are presented in this section based on the summary and analysis of the 
completed research. 
One practical issue of this work is that the characterisation of TMMs was carried 
out in constant room temperature (20 °C), but as a matter of fact the acoustic and thermal 
properties are temperature dependent. What is more, the stiffness of the tissue varied after 
protein denaturation. Taking these factors into consideration, the evaluation result of focal 
temperature change using phantom would be slight different compared with that using 
human tissue. Therefore it is best to measure these properties at various temperature 
conditions to provide more comprehensive analysis. By using the proper temperature 
dependent TMM material, the temperature change at focus would be more accurate to 
determine the treatment plan. 
MRI thermometry was used to monitor the focal temperature in the current study. 
As the focal lesion became stiffer after HIFU sonication and elastography can measure 
stiffness the lesion formation, elastography could be used to evaluate the result of HIFU 
sonication by providing the dimension of the lesion. This will be helpful when MRI 
thermometry is not feasible or not available in the HIFU treatment. 
Apart from the challenge of ribcage in abdominal HIFU treatment, the research 
on overcoming organ motion is underway. The 3D modelling technique could assist the 
study of tracking the organ movement. By using the reconstructed target organs, a patient-
specific model can be created with a simulated movement for image tracking. The Thiel 
cadaver could be used as the model for organ tracking and HIFU sonication to verify the 
tracking results. 
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Appendix I: Protection measures for 
PAA phantom fabrication 
Due to the strong toxicity of parts of the components to fabricate the PAA 
phantom, personal protection of acrylamide and N, N, N’, N’-
Tetramethylethylenediamine is listed to provide useful information for potential users. 
All the contact with skin, eyes and clothing should be avoided. Hands must be washed 
before breaks and immediately after handling the materials. 
 
Personal protection: 
Eye/face protection 
Face shield and safety glassed. Use equipment for eye protection tested and approved 
under appropriate government standards such as NIOSH (US) or EN 166 (EU). 
Skin protection 
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal 
technique (without touching glove’s outer surface) to avoid skin contact with this product. 
Dispose of contaminated gloves after use in accordance with applicable laws and good 
laboratory practices. 
Body protection 
Complete suit protecting against chemicals. The type of protective equipment must be 
selected according to the concentration and amount of the dangerous substance at the 
specific workplace. 
Respiratory protection 
Where risk assessment shows air-purifying respirators are appropriate use a full-face 
particle respirator type N100 (US) or type P3 (EN143) respirator cartridges as a backup 
to engineering controls. If the respirator is the sole means of protection, use a full-face 
supplied air respirator. Use respirators and components tested and approved under 
appropriate government standards such as NIOSH (US) or CEN (EU). 
Control of environmental exposure 
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Prevent further leakage or spillage if safe to do so. Do not let product enter drains. 
Discharge into the environment must be avoided. 
First aid measures 
For general advice, consult a physician. If breathed in, move person into fresh air. If not 
breathing, give artificial respiration. In case of skin contact, wash off with soap and plenty 
of water. Take victim immediately to hospital. In case of eye contact, rinse thoroughly 
with plenty of water for at least 15 minutes. If swallowed, never give anything by mouth 
to an unconscious person. Rinse mouth with water. 
All the above information of personal protection is from the safety data sheet of 
the materials provided by the supplier (Sigma-Aldrich, Gillingham, Dorset, UK). 
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Appendix II: COSHH Special Risk 
Assessment Form of Acrylamide/Bis-
acrylamide 
1. Name and brief description of procedure 
Acrylamide/Bis-acrylamide 
Laboratory chemicals, manufacture of substances 
 
2. Name, amount and form of  hazardous substances used or created in procedure  
Acute toxicity, oral; acute toxicity, inhalation; acute toxicity, dermal; skin irritation; eye 
irritation; skin sensitisation; germ cell mutagenicity; carcinogenicity; reproductive toxicity; 
specific target organ toxicity-repeated exposure 
 
3. Human health effects identified  
Toxic if swallowed. Harmful in contact with skin. Causes skin irritation. May cause an allergic 
skin reaction. Causes serious eye irritation. Harmful if inhaled. May cause genetic defects. May 
cause cancer. Suspected of damaging fertility. Causes damage to organs through prolonged or 
repeated exposure. 
 
4. Information sources used   
Safety data sheet from SIGMA-ALDRICH 
 
5. Can the procedure be modified to reduce risk of ill health? If so, why not  
No data available 
 
6. Control measures  
Avoid exposure. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. 
Provide appropriate exhaust ventilation at places where dust is formed. 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Light 
sensitive. 
 
7. Level of supervision required 
Approval will be needed. 
 
8. Level of training required 
PhD student lab training. 
 
 
9. Lone working permissible 
Yes. 
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10. Testing and maintenance of control measures 
 No. 
 
 
11. Is environmental monitoring required 
No data available 
 
 
12. Is health surveillance required 
No data available 
 
 
13. Disposal procedures 
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the 
material with a combustible solvent and burn in a chemical incinerator equipped with an 
afterburner and scrubber. 
 
14. Emergency procedures  
a. First aid measures 
Consult a physician. Show safety data sheet to the doctor in attendance. If breathed in, move 
person into fresh aire. If not breathing, give artificial respiration. Consult a physician. Wash off 
with soap and plenty of water. Take victim immediately to hospital. Consult a physician. Rinse 
thoroughly with plenty of water for at least 15 minutes and consult a physician. Never give 
anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 
b. Firefighting measures 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Special hazards 
arising from the substance or mixture: carbon oxides, nitrogen oxides (NOx). Wear self-
contained breathing apparatus for firefighting if necessary. 
c. Accidental release measures 
Wear protective gloves/clothing and eye/face protection. Prevent further leakage or spillage if 
safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. 
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, 
closed containers for disposal. 
 
15. Monitoring procedures 
Standard 
 
16. Special risk factors and additional control measures  
As described in emergency procedures. 
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Appendix III: COSHH Special Risk 
Assessment Form of N,N,N’N’-
Tetramethylethylenediamine 
1. Name and brief description of procedure 
N,N,N’N’-Tetramethylethylenediamine 
Laboratory chemicals, manufacture of substances 
 
2. Name, amount and form of  hazardous substances used or created in procedure  
N,N,N’N’-Tetramethylethylenediamine 
Flammable liquids; skin corrosion; acute toxicity, inhalation; acute toxicity, oral 
 
3. Human health effects identified  
Highly flammable liquid and vapour. Harmful if swallowed. Causes severe skin burns and eye 
damage. Harmful if inhaled. 
 
4. Information sources used   
Safety data sheet from SIGMA-ALDRICH. 
 
5. Can the procedure be modified to reduce risk of ill health? If so, why not  
No data available. 
 
6. Control measures  
a. Precautions for safe handling 
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist. Keep away from sources 
of ignition. Take measure to prevent the build up of electrostatic charge. 
b. Conditions for safe storage, including any incompatibilities 
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers 
which are opened must be carefully resealed and kept upright to prevent leakage. Handle and 
store under inert gas. Air and moisture sensitive. 
 
 
7. Level of supervision required 
Approval is needed. 
 
8. Level of training required 
PhD student lab training. 
 
 
9. Lone working permissible 
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Yes. 
 
 
10. Testing and maintenance of control measures 
 No. 
 
11. Is environmental monitoring required 
No data available 
 
 
12. Is health surveillance required 
No data available 
 
13. Disposal procedures 
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the 
material with a combustible solvent and burn in a chemical incinerator equipped with an 
afterburner and scrubber. 
 
14. Emergency procedures  
a. First aid measures 
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a 
physician. In case of skin contact, take off contaminated clothing and shoes immediately. Wash 
off with soap and plenty of water. Take victim immediately to hospital. Consult a physician. In 
case of eye contact, rinse thoroughly with plenty of water for at least 15 minutes and consult a 
physician.  If swallowed, do not induce vomiting. Never give anything by mouth to an 
unconscious person. Rinse mouth with water. Consult a physician. 
b. Firefighting measures 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Special hazards 
arising from the substance or mixture: carbon oxides, nitrogen oxides (NOx). Wear self 
contained breathing apparatus for fire fighting if necessary. Use water spray to cool unopened 
containers. 
c. Accidental release measures 
Wear respiratory protection. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. 
Remove all sources of ignition. Evacuate personnel to safe areas. Beware of vapours 
accumulating to form explosive concentrations. Vapours can accumulate in low areas. Prevent 
further leakage or spillage if safe to do so. Do not let product enter drains. Contain spillage, and 
then collect with an electrically protected vacuum cleaner or by wet-brushing and place in 
container for disposal according to local regulations. 
 
15. Monitoring procedures 
Standard  
 
16. Special risk factors and additional control measures  
As described in emergency procedures. 
 
